10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

or

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________________ to __________________________

Commission File Number 001-31921

Compass Minerals International, Inc.

(Exact name of registrant as specified in its charter)

Delaware	36-3972986
(State or other jurisdiction of  incorporation or organization)	(I.R.S. Employer Identification Number)

9900 West 109th Street

Suite 100

Overland Park, KS 66210

(913) 344-9200

(Address of principal executive offices, zip code and telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, $0.01 par value	CMP	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days.	Yes	☑	No	☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files)	Yes	☑	No	☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer	☑	Accelerated filer	☐	Non-accelerated filer	☐	Smaller reporting company	☐
						Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The number of shares outstanding of the registrant’s common stock, $0.01 par value per share, as of May 1, 2020, was 33,904,602 shares.

COMPASS MINERALS INTERNATIONAL, INC.

TABLE OF CONTENTS

		Page
	PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Balance Sheets as of March 31, 2020 (unaudited) and December 31, 2019	2
	Consolidated Statements of Operations for the three months ended March 31, 2020 and 2019 (unaudited)	3
	Consolidated Statements of Comprehensive (Loss) Income for the three months ended March 31, 2020 and 2019 (unaudited)	4
	Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2020 and 2019 (unaudited)	5
	Consolidated Statements of Cash Flows for the three months ended March 31, 2020 and 2019 (unaudited)	6
	Notes to Consolidated Financial Statements (unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	33
Item 4.	Controls and Procedures	33
	PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults Upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	36
SIGNATURES		37

1

PART I. FINANCIAL INFORMATION

Item 1.    Financial Statements

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	(Unaudited)
	March 31, 2020			December 31, 2019
ASSETS
Current assets:
Cash and cash equivalents	$	109.8		$	34.7
Receivables, less allowance for doubtful accounts of $9.5 in 2020 and $10.7 in 2019	225.0			342.4
Inventories	254.2			311.5
Other	37.2			96.4
Total current assets	626.2			785.0
Property, plant and equipment, net	953.8			1,030.8
Intangible assets, net	88.6			103.0
Goodwill	274.7			343.0
Investment in equity investee	23.1			24.9
Other	144.4			156.5
Total assets	$	2,110.8		$	2,443.2
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	40.1		$	52.1
Accounts payable	112.8			126.2
Accrued salaries and wages	24.7			34.4
Income taxes payable	2.7			10.4
Accrued interest	16.9			11.3
Accrued expenses and other current liabilities	62.1			61.5
Total current liabilities	259.3			295.9
Long-term debt, net of current portion	1,253.7			1,363.9
Deferred income taxes, net	81.9			89.9
Other noncurrent liabilities	154.4			163.9
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock: $0.01 par value, 200,000,000 authorized shares; 35,367,264 issued shares	0.4			0.4
Additional paid-in capital	119.6			117.1
Treasury stock, at cost — 1,475,196 shares at March 31, 2020 and 1,481,611 shares at December 31, 2019	(3.3		)	(3.2		)
Retained earnings	610.1			607.4
Accumulated other comprehensive loss	(365.3		)	(192.1		)
Total stockholders’ equity	361.5			529.6
Total liabilities and stockholders’ equity	$	2,110.8		$	2,443.2

The accompanying notes are an integral part of the consolidated financial statements.

2

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in millions, except share and per share data)

	Three Months Ended March 31,
	2020			2019
Sales	$	413.9		$	403.7
Shipping and handling cost	101.8			112.9
Product cost	224.8			218.2
Gross profit	87.3			72.6
Selling, general and administrative expenses	43.1			39.4
Operating earnings	44.2			33.2
Other expense (income):
Interest expense	19.0			16.2
Net loss in equity investee	0.1			0.1
(Gain) loss on foreign exchange	(14.3		)	5.0
Other, net	0.1			(0.6		)
Earnings before income taxes	39.3			12.5
Income tax expense	11.7			4.9
Net earnings	$	27.6		$	7.6
Basic net earnings per common share	$	0.80		$	0.22
Diluted net earnings per common share	$	0.80		$	0.22
Weighted-average common shares outstanding (in thousands):
Basic	33,892			33,874
Diluted	33,892			33,874

The accompanying notes are an integral part of the consolidated financial statements.

3

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Unaudited, in millions)

	Three Months Ended March 31,
	2020			2019
Net earnings	$	27.6		$	7.6
Other comprehensive income (loss):
Unrealized gain from change in pension obligations, net of tax of $(0.0) in both 2020 and 2019	0.2			0.1
Unrealized gain on cash flow hedges, net of tax of $(0.0) in both 2020 and 2019	0.1			0.1
Cumulative translation adjustment	(173.5		)	14.5
Comprehensive (loss) income	$	(145.6	)	$	22.3

The accompanying notes are an integral part of the consolidated financial statements.

4

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the three months ended March 31, 2020 and 2019

(Unaudited, in millions)

	Common Stock		Additional Paid-In Capital		Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balance, December 31, 2019	$	0.4	$	117.1	$	(3.2	)	$	607.4		$	(192.1	)	$	529.6
Comprehensive income (loss)								27.6			(173.2		)	(145.6		)
Dividends on common stock ($0.72 per share)			0.1					(24.9		)				(24.8		)
Shares issued for stock units, net of shares withheld for taxes					(0.1		)							(0.1		)
Stock-based compensation			2.4											2.4
Balance, March 31, 2020	$	0.4	$	119.6	$	(3.3	)	$	610.1		$	(365.3	)	$	361.5

	Common Stock		Additional Paid-In Capital		Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balance, December 31, 2018	$	0.4	$	110.1	$	(2.9	)	$	643.5		$	(210.9	)	$	540.2
Comprehensive income								7.6			14.7			22.3
Cumulative effect of change in accounting principle								(0.1		)				(0.1		)
Dividends on common stock ($0.72 per share)			0.1					(24.6		)				(24.5		)
Shares issued for stock units, net of shares withheld for taxes					(0.2		)							(0.2		)
Stock-based compensation			1.1											1.1
Balance, March 31, 2019	$	0.4	$	111.3	$	(3.1	)	$	626.4		$	(196.2	)	$	538.8

The accompanying notes are an integral part of the consolidated financial statements.

5

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in millions)

	Three Months Ended March 31,
	2020			2019
Cash flows from operating activities:
Net earnings	$	27.6		$	7.6
Adjustments to reconcile net earnings to net cash flows provided by operating activities:
Depreciation, depletion and amortization	33.1			35.0
Finance fee amortization	0.8			0.7
Stock-based compensation	2.4			1.1
Deferred income taxes	7.5			(0.1		)
Net loss in equity investee	0.1			0.1
Unrealized foreign exchange (gain) loss	(18.0		)	5.1
Other, net	3.4			1.4
Changes in operating assets and liabilities:
Receivables	87.1			72.0
Inventories	36.6			41.0
Other assets	54.5			17.3
Accounts payable and accrued expenses and other current liabilities	(4.9		)	(46.7		)
Other liabilities	(1.6		)	(6.1		)
Net cash provided by operating activities	228.6			128.4
Cash flows from investing activities:
Capital expenditures	(25.3		)	(21.5		)
Other, net	(0.6		)	(0.3		)
Net cash used in investing activities	(25.9		)	(21.8		)
Cash flows from financing activities:
Proceeds from revolving credit facility borrowings	46.2			61.7
Principal payments on revolving credit facility borrowings	(147.2		)	(139.6		)
Proceeds from issuance of long-term debt	22.0			18.5
Principal payments on long-term debt	(18.7		)	(5.5		)
Dividends paid	(24.8		)	(24.6		)
Deferred financing costs	(0.1		)	—
Shares withheld to satisfy employee tax obligations	(0.1		)	(0.2		)
Other, net	(0.1		)	(0.3		)
Net cash used in financing activities	(122.8		)	(90.0		)
Effect of exchange rate changes on cash and cash equivalents	(4.8		)	0.2
Net change in cash and cash equivalents	75.1			16.8
Cash and cash equivalents, beginning of the year	34.7			27.0
Cash and cash equivalents, end of period	$	109.8		$	43.8

Supplemental cash flow information:
Interest paid, net of amounts capitalized	$	11.3		$	17.3
Income taxes paid, net of refunds	$	(37.7	)	$	10.2

The accompanying notes are an integral part of the consolidated financial statements.

6

COMPASS MINERALS INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Accounting Policies and Basis of Presentation:

Compass Minerals International, Inc. (“CMI”), through its subsidiaries (collectively, the “Company”), is a leading producer of essential minerals that solve nature’s challenges, including salt for winter roadway safety and other consumer, industrial and agricultural uses, specialty plant nutrition minerals that improve the quality and yield of crops, and specialty chemicals for water treatment and other industrial processes. The Company’s principal products are salt, consisting of sodium chloride and magnesium chloride; plant nutrients, consisting of sulfate of potash (“SOP”), secondary nutrients and micronutrients; and specialty chemicals. The Company also provides records management services to businesses located in the United Kingdom (the “U.K.”). The Company’s production sites are located in the United States (“U.S.”), Canada, Brazil and the U.K. Except where otherwise noted, references to North America include only the continental U.S. and Canada, and references to the U.K. include only England, Scotland and Wales. References to “Compass Minerals,” “our,” “us” and “we” refer to CMI and its consolidated subsidiaries.

CMI is a holding company with no significant operations other than those of its wholly-owned subsidiaries. The consolidated financial statements include the accounts of CMI and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company uses the equity method of accounting for equity securities when it has significant influence or when it has more than a minor ownership interest or more than minor influence over an investee’s operations but does not have a controlling financial interest. Initial investments are recorded at cost (including certain transaction costs) and are adjusted by the Company’s share of the investees’ undistributed earnings and losses.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2019, as filed with the Securities and Exchange Commission in its Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included.

The Company experiences a substantial amount of seasonality in its sales with respect to its deicing salt products. As a result, sales and operating earnings are generally higher in the first and fourth quarters and lower during the second and third quarters of each year. In particular, sales of highway and consumer deicing salt and magnesium chloride products vary based on the severity of the winter conditions in areas where the products are used. Following industry practice in North America and the U.K., the Company seeks to stockpile sufficient quantities of deicing salt throughout the second, third and fourth quarters to meet the estimated requirements for the upcoming winter season. Production of deicing salt can also vary based on the severity or mildness of the preceding winter season. Due to the seasonal nature of the deicing product lines, operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.

The Company’s plant nutrition business is also seasonal. For example, the strongest demand for the Company’s plant nutrition products in Brazil typically occurs during the spring planting season. As a result, the Company and its customers generally build inventories during the low demand periods of the year to ensure timely product availability during the peak sales season. The seasonality of this demand results in the Company’s sales volumes and operating income for the Plant Nutrition South America segment usually being the highest during the third and fourth quarters of each year (as the spring planting season begins in September in Brazil).

Significant Accounting Policies

The Company’s significant accounting policies are detailed in “Note 2 – Summary of Significant Accounting Policies” within Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Recent Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed

7

the carrying amount of goodwill. All other goodwill impairment guidance remains largely unchanged. The adoption of this guidance on January 1, 2020 did not have an impact on the Company’s consolidated financial statements.

On January 1, 2020, the Company adopted guidance related to credit losses for financial instruments, which replaces the incurred lost methodology with a current expected credit loss methodology (“CECL”). The Company has determined that its trade receivables are the only financial instrument that is within scope of the new CECL guidance issued by FASB. The CECL methodology requires financial assets to be recorded at the net amount expected to be collected over the lifetime of the asset such that the estimated losses are accrued on the day the asset is acquired. The CECL methodology also requires financial assets to be aggregated and evaluated within pools with similar risk characteristics.

The Company has accrued an allowance on its trade receivables based on historical loss rates modified to consider supportable forecasts related to customer-specific and macroeconomic factors. For instance, the Company’s first quarter 2020 allowance for doubtful accounts considered the potential impact that the coronavirus (“COVID-19”) pandemic could have on the collectability of its outstanding receivables. The Company’s customer pools are comprised of North American highway deicing customers, North American consumer and industrial customers, Plant Nutrition North America customers, Plant Nutrition South America customers and customers whose outstanding receivable balances have been sent to collections. Customers grouped within these pools have similar risk characteristics. The Company’s allowance for doubtful accounts consists of estimates of expected credit losses and accruals for returns and allowances. At the transition date of January 1, 2020, the implementation of CECL had an immaterial impact of less than $0.1 million on the Company’s consolidated financial statements. Under CECL, the Company had an allowance for doubtful accounts of $9.4 million and $7.9 million as of January 1, 2020, and March 31, 2020, respectively.

2.    Revenue Recognition:

Nature of Products and Services

The Company’s Salt segment products include salt and magnesium chloride for use in road deicing and dust control, food processing, water softeners, and agricultural and industrial applications. The Company’s plant nutrition products include SOP, secondary nutrients, micronutrients and chemicals for the industrial chemical industry. In the U.K., the Company operates a records management business utilizing excavated areas of the Winsford salt mine with one other location in London, England.

Identifying the Contract

The Company accounts for a customer contract when there is approval and commitment from both parties, the rights of the parties and payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

Identifying the Performance Obligations

At contract inception, the Company assesses the goods and services it has promised to its customers and identifies a performance obligation for each promise to transfer to the customer a distinct good or service (or bundle of goods or services). Determining whether products and services are considered distinct performance obligations that should be accounted for separately or aggregated together may require significant judgment.

Identifying and Allocating the Transaction Price

The Company’s revenues are measured based on consideration specified in the customer contract, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. In certain cases, the Company’s customer contracts may include promises to transfer multiple products and services to a customer. For multiple-element arrangements, the Company generally allocates the transaction price to each performance obligation in proportion to its stand-alone selling price.

When Performance Obligations Are Satisfied

The vast majority of the Company’s revenues are recognized at a point in time when the performance obligations are satisfied based upon transfer of control of the product or service to a customer. To determine when the control of goods is transferred, the Company typically assesses, among other things, the shipping terms of the contract, as shipping is an indicator of transfer of control. Some of the Company’s products are sold when the control of the goods transfers to the customer at the time of shipment. There are also instances when the Company provides shipping services to deliver its products. Shipping and handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs. The Company recognizes shipping and handling costs that are incurred after the customer obtains control of the goods as fulfillment costs which are accrued at the time of revenue recognition.

8

Significant Payment Terms

The customer contract states the final terms of the sale, including the description, quantity and price of each product or service purchased. Payment is typically due in full within 30 days of delivery. The Company does not adjust the consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the good or service is transferred to the customer and when the customer pays for that good or service will be one year or less.

Refunds, Returns and Warranties

The Company’s products are generally not sold with a right of return and the Company does not generally provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized. The Company uses historical experience to estimate accruals for refunds due to manufacturing or other defects.

See Note 10 for disaggregation of revenue by segment, type and geographical region.

3. Leases:

In February 2016, the FASB issued guidance which requires lessees to recognize on their balance sheet a right-of-use asset which represents a lessee’s right to use the underlying asset and a lease liability which represents a lessee’s obligation to make lease payments for the right to use the asset. In addition, the guidance requires expanded qualitative and quantitative disclosures. The Company has adopted this guidance beginning in the first quarter of 2019, using a modified retrospective transition method, which required the cumulative effect of this change in accounting of $0.1 million to be recorded as an adjustment to beginning retained earnings. The Company elected the package of transition provisions available for existing contracts, which allowed entities to carryforward the historical assessment of whether the contract contained a lease and the lease classification.

The Company enters into leases for warehouses and depots, rail cars, vehicles, mobile equipment, office space and certain other types of property and equipment. The Company determines whether an arrangement is or contains a lease at the inception of the contract. The right-of-use asset and lease liability are recognized based on the present value of the future minimum lease payments over the estimated lease term. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company estimates its incremental borrowing rate for each lease based upon the estimated lease term, the type of asset and the location of the leased asset. The most significant judgments in the application of the FASB guidance include whether a contract contains a lease and the lease term.

Leases with an initial term of 12 months or less are not recorded on the Company’s Consolidated Balance Sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. Many of the Company’s leases include one or more options to renew and extend the initial lease term. The exercise of lease renewal options is generally at the Company’s discretion. The lease term includes renewal periods in only those instances in which the Company determines it is reasonably assured of renewal.

The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. In these instances, the assets are depreciated over the useful life of the asset.

The Company has elected the practical expedient available under the FASB guidance to not separate lease and nonlease components on all of its lease categories. As a result, many of the Company’s leases include variable payments for services (such as handling or storage) or payments based on the usage of the asset. In addition, certain of the Company’s lease agreements include rental payments that are adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or any material restrictive covenants. The Company’s sublease income is immaterial.

9

The Company’s Consolidated Balance Sheets includes the following (in millions):

	Consolidated Balance Sheets Location	March 31, 2020		December 31, 2019
Assets
Operating lease assets	Other assets	$	49.7	$	53.7
Finance lease assets	Property, plant and equipment, net	5.9		5.8
Total leased assets		$	55.6	$	59.5
Liabilities
Current liabilities:
Operating	Accrued expenses and other current liabilities	$	9.5	$	12.8
Finance	Accrued expenses and other current liabilities	1.7		1.1
Noncurrent liabilities:
Operating	Other noncurrent liabilities	40.4		41.0
Finance	Other noncurrent liabilities	5.3		6.2
Total lease liabilities		$	56.9	$	61.1

The Company’s components of lease cost are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Finance lease cost:
Amortization of lease assets	$	0.5	$	0.3
Interest on lease liabilities	0.1		0.2
Operating lease cost	4.6		4.8
Variable lease cost(a)	5.1		6.1
Net lease cost	$	10.3	$	11.4

(a) Short-term leases are immaterial and included in variable lease cost.

Maturities of lease liabilities under the new guidance (“Topic 842”) are as follows (in millions):

Topic 842
March 31, 2020	Operating Leases			Finance Leases			Total
Remainder of 2020	$	8.7		$	1.6		$	10.3
2021	10.1			1.6			11.7
2022	7.5			0.9			8.4
2023	6.2			0.9			7.1
2024	5.3			0.9			6.2
After 2024	22.4			2.8			25.2
Total lease payments	60.2			8.7			68.9
Less: Interest	(10.3		)	(1.7		)	(12.0		)
Present value of lease liabilities	$	49.9		$	7.0		$	56.9

10

Topic 842
December 31, 2019	Operating Leases			Finance Leases			Total
2020	$	13.0		$	1.6		$	14.6
2021	10.0			1.3			11.3
2022	7.5			1.1			8.6
2023	6.3			1.1			7.4
2024	5.3			1.1			6.4
After 2024	22.8			3.3			26.1
Total lease payments	64.9			9.5			74.4
Less: Interest	(11.1		)	(2.2		)	(13.3		)
Present value of lease liabilities	$	53.8		$	7.3		$	61.1

Supplemental lease term and discount rate information related to leases is as follows:

	March 31, 2020		December 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.7		7.7
Finance leases	6.2		7.2
Weighted-average discount rate
Operating leases	4.3	%	4.3	%
Finance leases	7.1	%	7.6	%

Supplemental cash flow information related to leases is as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4.5	$	4.9
Operating cash flows from finance leases	0.1		0.2
Financing cash flows from finance leases	0.5		0.3
Leased assets obtained in exchange for new operating lease liabilities	1.0		2.4
Leased assets obtained in exchange for new finance lease liabilities	1.2		—

4. Inventories:

Inventories consist of the following (in millions):

	March 31, 2020		December 31, 2019
Finished goods	$	185.6	$	235.3
Raw materials and supplies	68.6		76.2
Total inventories	$	254.2	$	311.5

11

5. Property, Plant and Equipment, Net:

Property, plant and equipment, net, consists of the following (in millions):

	March 31, 2020			December 31, 2019
Land, buildings and structures, and leasehold improvements	$	578.3		$	596.0
Machinery and equipment	974.8			1,001.9
Office furniture and equipment	62.4			60.7
Mineral interests	165.9			171.1
Construction in progress	136.2			141.3
	1,917.6			1,971.0
Less accumulated depreciation and depletion	(963.8		)	(940.2		)
Property, plant and equipment, net	$	953.8		$	1,030.8

6. Goodwill and Intangible Assets, Net:

Amounts related to the Company’s amortization of intangible assets are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Aggregate amortization expense	$	3.2	$	3.6

Amounts related to the Company’s goodwill are as follows (in millions):

	March 31, 2020		December 31, 2019
Goodwill - Plant Nutrition North America Segment	$	50.5	$	55.4
Goodwill - Plant Nutrition South America Segment	218.4		281.6
Other	5.8		6.0
Total	$	274.7	$	343.0

The change in goodwill between December 31, 2019 and March 31, 2020 was due to the impact from translating foreign-denominated amounts to U.S. dollars.

7. Income Taxes:

The Company’s effective income tax rate differs from the U.S. statutory federal income tax rate primarily due to U.S. statutory depletion, state income taxes (net of federal tax benefit), foreign income, mining and withholding taxes, global intangible low-taxed income and interest expense recognition differences for book and tax purposes. The Company’s effective rate is impacted by permanent tax deductions which have a less favorable impact as pretax income increases.

The Company had $14.8 million and $18.8 million as of March 31, 2020 and December 31, 2019, respectively, of gross foreign federal net operating loss (“NOL”) carryforwards that have no expiration date, $1.2 million and $1.7 million, respectively, of gross foreign federal NOL carryforwards which expire beginning in 2033 and $0.2 million and $0.3 million, respectively, of net operating tax-effected state NOL carryforwards which expire beginning in 2027.

Canadian provincial tax authorities have challenged tax positions claimed by one of the Company’s Canadian subsidiaries and have issued tax reassessments for years 2002-2014. The reassessments are a result of ongoing audits and total $120.4 million, including interest, through March 31, 2020. The Company disputes these reassessments and will continue to work with the appropriate authorities in Canada to resolve the dispute. There is a reasonable possibility that the ultimate resolution of this dispute, and any related disputes for other open tax years, may be materially higher or lower than the amounts the Company has reserved for such disputes. In connection with this dispute, local regulations require the Company to post security with the tax authority

12

until the dispute is resolved. The Company has posted collateral in the form of an $89.6 million performance bond and has paid $34.8 million to the Canadian tax authorities (most of which is recorded in other assets in the Consolidated Balance Sheets).

The Company expects that it will be required by local regulations to provide security for additional interest on the above unresolved disputed amounts and for any future reassessments issued by these Canadian tax authorities in the form of cash, letters of credit, performance bonds, asset liens or other arrangements agreeable with the tax authorities until the disputes are resolved.

The Company expects that the ultimate outcome of these matters will not have a material impact on its results of operations or financial condition. However, the Company can provide no assurance as to the ultimate outcome of these matters, and the impact could be material if they are not resolved in the Company’s favor. As of March 31, 2020, the Company believes it has adequately reserved for these reassessments.

Additionally, the Company has other uncertain tax positions as well as assessments and disputed positions with taxing authorities in its various jurisdictions, which are consistent with those matters disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Settlements

In the fourth quarter of 2017, the Company, the Canadian Revenue Authority (“CRA”) and the U.S. Internal Revenue Service (“IRS”) reached a settlement agreement on transfer pricing issues for the Company’s 2007-2012 tax years. As a result of this settlement agreement, the Company recognized $13.8 million of tax expense in its 2017 Consolidated Statements of Operations related to the Company’s Canadian tax positions for the years 2007-2016. The recording of this settlement resulted in increased sales for the Company’s Canadian subsidiary of $85.7 million and increased offsetting expenses for the Company’s U.S. subsidiary in 2017 causing a domestic loss and significant foreign income. During 2018, in accordance with the settlement agreement, the Company’s U.S. subsidiary made intercompany cash payments of $85.7 million to its Canadian subsidiary and tax payments to Canadian taxing authorities of $17.5 million. The remaining liability was satisfied in 2019 with tax payments of $5.3 million. Corresponding tax refunds of $21.4 million were received in 2019 from U.S. taxing authorities, with the remaining refund of approximately $1.6 million expected in 2020 (recorded in other current assets in the Consolidated Balance Sheets).

In the fourth quarter of 2018, the Company, the CRA and the IRS reached a settlement agreement on transfer pricing and management fees as part of an advanced pricing agreement that covers tax years 2013-2021. The tax expense was previously recognized in 2017, however the recording of this settlement resulted in increased sales for the Company’s Canadian subsidiary of $106.1 million and offsetting expenses for the Company’s U.S. subsidiary in 2018 causing a domestic loss and significant foreign income. During 2019, in accordance with the settlement agreement, the Company’s U.S. subsidiary made intercompany cash payments of $106.1 million to its Canadian subsidiary and tax payments to Canadian taxing authorities of $29.9 million, with the remaining $1.3 million of tax payments to be paid during 2020. Corresponding tax refunds of $59.2 million have been received as of March 31, 2020 from U.S. taxing authorities, of which $55 million was received during the first quarter of 2020, with the remaining $2.4 million expected in 2020 (recorded in other current assets in its Consolidated Balance Sheets).

13

8. Long-Term Debt:

Long-term debt consists of the following (in millions):

	March 31, 2020			December 31, 2019
4.875% Senior Notes due July 2024	$	250.0		$	250.0
Term Loan due January 2025	397.5			400.0
Revolving Credit Facility due January 2025	59.0			160.0
6.75% Senior Notes due December 2027	500.0			500.0
3.7% Banco Itaú loan due March 2020	—			15.4
Banco Santander loan due October 2020	12.5			16.2
Banco Itaú loan due February 2021	9.4			—
Banco Rabobank loan due July 2021	13.5			17.4
Banco Santander loan due September 2021	15.4			19.9
Banco do Brasil loan due September 2021	9.6			12.4
Banco Rabobank loan due November 2021	13.5			17.4
Banco Santander loan due December 2021	11.6			14.9
Banco Votorantim loan due February 2022	7.7			—
Banco Santander loan due March 2022	2.9			—
Financiadora de Estudos e Projetos loan due November 2023	5.2			7.2
	1,307.8			1,430.8
Less unamortized debt issuance costs	(14.0		)	(14.8		)
Total debt	1,293.8			1,416.0
Less current portion	(40.1		)	(52.1		)
Long-term debt	$	1,253.7		$	1,363.9

In the first quarter of 2020, the Company entered into three loans totaling $20.0 million which mature between February 2021 and March 2022, respectively. Two of the loans were denominated in Brazilian reais and one loan was denominated in euros. In connection with the loan denominated in euros, the Company entered into a swap to exchange principal and interest payments denominated in euros to Brazilian reais (see Note 12). These loans bear interest ranging from 143% - 150% of CDI. As of March 31, 2020, the weighted average interest rate of all the Company’s outstanding debt was approximated 5.69%.

During the first quarter of 2020, the Company sold approximately $3.4 million of Brazilian receivables for $3.3 million. The proceeds of the transaction were used to maintain liquidity for working capital needs. The Company is contingently liable for up to 20% of the sale balance up to $0.7 million if the banks are unable to collect on these accounts.

As of March 31, 2020, the term loans and revolving credit facility under the Company’s credit agreement were secured by substantially all existing and future U.S. assets, the Goderich mine in Ontario, Canada and capital stock of certain subsidiaries.

9. Commitments and Contingencies:

The Wisconsin Department of Agriculture, Trade and Consumer Protection (“DATCP”) and the Wisconsin Department of Natural Resources (“DNR”) have information indicating that agricultural chemicals are present within the subsurface area of the Company’s property located in Kenosha, Wisconsin. The agricultural chemicals were used by previous owners and operators of the site. None of the identified chemicals have been used in association with the Company’s operations since it acquired the property in 2002. DATCP and DNR have directed the Company to conduct further investigations into the environmental conditions at the Kenosha property. The Company continues on-property investigations and has provided the findings to DATCP and DNR as they have become available. All investigations and mitigation activities to date, and any potential future remediation work, are being conducted under the Wisconsin Agricultural Chemical Cleanup Program, which provides for reimbursement of some of the costs.

The Company conducts business operations in several countries and is subject to various federal and local labor, social security, environmental and tax laws. While the Company believes it complies with such laws, they are complex and subject to interpretation.

14

In addition to the tax assessments discussed in Note 7, the Company’s Brazilian subsidiaries are party to administrative tax proceedings and claims which totaled $7.9 million and $15.8 million as of March 31, 2020 and December 31, 2019, respectively, and relate primarily to value added tax, state tax (ICMS) and social security tax (PIS and COFINS) assessments. The Company has assessed the likelihood of a loss at less than probable and therefore, has not established a reserve for these matters. The Company also assumed liabilities for labor-related matters in connection with the 2016 acquisition of Compass Minerals South America, which are primarily related to compensation, labor benefits and consequential tax claims that totaled $3.9 million and $5.6 million as of March 31, 2020 and December 31, 2019, respectively. The Company believes the maximum exposure for these other labor matters totaled approximately $18 million and $25 million as of March 31, 2020 and December 31, 2019, respectively.

The Division of Enforcement of the U.S. Securities and Exchange Commission (“SEC”) is investigating the Company’s disclosures concerning the operation of the Goderich mine. The Company has cooperated with this investigation and will continue to do so. While it is not possible to predict the timing or the outcome of the SEC inquiry, the Company believes that this matter will not have a material impact on its results of operation, cash flows or financial position.

The Company is also involved in legal and administrative proceedings and claims of various types from the ordinary course of the Company’s business.

Management cannot predict the outcome of legal claims and proceedings with certainty. Nevertheless, management believes the outcome of legal proceedings and claims, which are pending or known to be threatened, even if determined adversely, will not, individually or in the aggregate, have a material adverse effect on the Company’s results of operations, cash flows or financial position.

10. Operating Segments:

The Company’s reportable segments are strategic business units that offer different products and services, and each business requires different technology and marketing strategies. The Company has three reportable segments: Salt, Plant Nutrition North America and Plant Nutrition South America. The Salt segment produces and markets salt, consisting of sodium chloride and magnesium chloride, for use in road deicing for winter roadway safety and for dust control, food processing, water softeners and other consumer, agricultural and industrial applications. Plant nutrients, including SOP, secondary nutrients and micronutrients are produced and marketed through the Plant Nutrition North America segment. The Plant Nutrition South America segment operates two primary businesses in Brazil – agricultural productivity and chemical solutions. The agricultural productivity division manufactures and distributes a broad offering of specialty plant nutrition solution-based products that are used in direct soil and foliar applications, as well as through irrigation systems and for seed treatment. The chemical solutions division manufactures and markets specialty chemicals for the industrial chemical industry.

Segment information is as follows (in millions):

Three Months Ended March 31, 2020	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	287.8	$	60.6	$	62.8	$	2.7		$	413.9
Intersegment sales	—		0.3		0.1		(0.4		)	—
Shipping and handling cost	89.8		9.0		3.0		—			101.8
Operating earnings (loss)	56.9		5.2		0.3		(18.2		)	44.2
Depreciation, depletion and amortization	14.6		10.5		5.0		3.0			33.1
Total assets (as of end of period)	956.5		552.3		561.0		41.0			2,110.8

15

Three Months Ended March 31, 2019	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)			Total
Sales to external customers	$	306.4	$	37.2		$	57.7		$	2.4		$	403.7
Intersegment sales	—		0.5			1.5			(2.0		)	—
Shipping and handling cost	103.7		6.0			3.2			—			112.9
Operating earnings (loss)	52.3		(1.6		)	(2.6		)	(14.9		)	33.2
Depreciation, depletion and amortization	15.3		11.6			5.6			2.5			35.0
Total assets (as of end of period)	889.7		594.1			710.6			114.2			2,308.6

Disaggregated revenue by product type is as follows (in millions):

Three Months Ended March 31, 2020	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)		Total
Highway Deicing Salt	$	215.1	$	—		$	—		$	—	$	215.1
Consumer & Industrial Salt	72.7		—			—			—		72.7
SOP and Specialty Plant Nutrients	—		60.9			41.1			—		102.0
Industrial Chemicals	—		—			21.8			—		21.8
Eliminations & Other	—		(0.3		)	(0.1		)	2.7		2.3
Sales to external customers	$	287.8	$	60.6		$	62.8		$	2.7	$	413.9

Three Months Ended March 31, 2019	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)		Total
Highway Deicing Salt	$	218.7	$	—		$	—		$	—	$	218.7
Consumer & Industrial Salt	87.7		—			—			—		87.7
SOP and Specialty Plant Nutrients	—		37.7			36.6			—		74.3
Industrial Chemicals	—		—			22.6			—		22.6
Eliminations & Other	—		(0.5		)	(1.5		)	2.4		0.4
Sales to external customers	$	306.4	$	37.2		$	57.7		$	2.4	$	403.7

(a) Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.

The Company’s revenue by geographic area is as follows (in millions):

	Three Months Ended March 31,
Revenue	2020		2019
United States(a)	$	257.9	$	238.3
Canada	77.4		87.4
Brazil	62.1		55.7
United Kingdom	11.8		17.3
Other	4.7		5.0
Total revenue	$	413.9	$	403.7

(a) United States sales exclude product sold to foreign customers at U.S. ports.

16

11. Stockholders’ Equity and Equity Instruments:

In May 2015, the Company’s stockholders approved the 2015 Incentive Award Plan (as amended, the “2015 Plan”), which authorizes the issuance of 3,000,000 shares of Company common stock. Since the date the 2015 Plan was approved, the Company ceased issuing equity awards under the 2005 Incentive Award Plan (as amended, the “2005 Plan”). The 2005 Plan and 2015 Plan allow for grants of equity awards to executive officers, other employees and directors, including restricted stock units (“RSUs”), performance stock units (“PSUs”), stock options and deferred stock units. The grants occur following approval by the compensation committee of the Company’s board of directors, with the amount and terms communicated to employees shortly thereafter. 

Options

Most of the stock options granted under the 2005 Plan and 2015 Plan vest ratably, in tranches, over a four-year service period. Unexercised options expire after seven years. Options do not have dividend or voting rights. Upon vesting, each option can be exercised to purchase one share of the Company’s common stock. The exercise price of options is equal to the closing stock price on the grant date.

To estimate the fair value of options on the grant date, the Company uses the Black-Scholes option valuation model. Award recipients are grouped according to expected exercise behavior. Unless better information is available to estimate the expected term of the options, the estimate is based on historical exercise experience. The risk-free rate, using U.S. Treasury yield curves in effect at the time of grant, is selected based on the expected term of each group. The Company’s historical stock price is used to estimate expected volatility. The fair value and inputs used to calculate fair value for options granted in 2020 are included in the table below:

Fair value of options granted	$10.91
Exercise price	$58.91
Expected term (years)	4.75
Expected volatility	29.3%
Dividend yield	3.5%
Risk-free rate of return	1.6%

RSUs

Typically, the RSUs granted under the 2015 Plan vest after three years of service. RSUs entitle the holders to one share of common stock for each vested RSU. Unvested RSUs do not have voting rights but are entitled to receive non-forfeitable dividends (generally after a performance hurdle has been satisfied for the year of the grant) or other distributions equal to those declared on the Company’s common stock for RSUs that are earned as a result of the satisfaction of the performance hurdle. The closing stock price on the grant date is used to determine the fair value of RSUs.

PSUs

The PSUs granted under the 2015 Plan are either total shareholder return PSUs (“TSR PSUs”) or return on invested capital PSUs (“ROIC PSUs”). The actual number of shares of the Company’s common stock that may be earned with respect to TSR PSUs is calculated by comparing the Company’s total shareholder return to the total shareholder return for each company comprising the Russell 3000 Index (for TSR PSUs granted in 2017 and earlier) or the Company’s peer group (for TSR PSUs granted in 2018 and later) over the three-year performance period and may range from 0% to 200% of the target number of shares based upon the attainment of these market conditions. The actual number of shares of common stock that may be earned with respect to ROIC PSUs is calculated based on the average of the Company’s annual return on invested capital for each year in the three-year performance period and may range from 0% to 200% of the target number of shares based upon the attainment of these performance conditions.

PSUs represent a target number of shares of the Company’s common stock that may be earned before adjustment based upon the attainment of certain conditions. Holders of PSUs do not have voting rights but are entitled to receive non-forfeitable dividends or other distributions equal to those declared on the Company’s common stock for PSUs that are earned, which are paid when the shares underlying the PSUs are paid.

To estimate the fair value of the TSR PSUs on the grant date, the Company uses a Monte-Carlo simulation model, which simulates future stock prices of the Company as well as the companies comprising the Russell 3000 Index or the Company’s peer group

17

depending on the year granted. This model uses historical stock prices to estimate expected volatility and the Company’s correlation to the Russell 3000 Index or peer group. The risk-free rate was determined using the same methodology as the option valuations as discussed above. The Company’s closing stock price on the grant date was used to estimate the fair value of the ROIC PSUs. The Company will adjust the expense of the ROIC PSUs based upon its estimate of the number of shares that will ultimately vest at each interim date during the vesting period.

During the three months ended March 31, 2020, the Company reissued the following number of shares from treasury stock: no shares related to the exercise of stock options, 4,517 shares related to the release of RSUs which vested and 3,377 shares related to stock payments. In 2019, the Company issued 32,197 shares from treasury stock. The Company withheld 1,479 shares with a fair value of $0.1 million related to the vesting of RSUs during the first three months of 2020. The fair value of the shares were valued at the closing price at the vesting date and represent the employee tax withholding for the employee’s compensation. The Company recognized a tax deficiency of $0.2 million from its equity compensation awards as an increase to income tax expense during the first three months of 2020. During the first three months of 2020 and 2019, the Company recorded $2.9 million (includes $0.5 million to be paid in cash) and $1.1 million, respectively, of compensation expense pursuant to its stock-based compensation plans. No amounts have been capitalized. The following table summarizes stock-based compensation activity during the three months ended March 31, 2020:

	Stock Options				RSUs				PSUs(a)
	Number		Weighted-average exercise price		Number		Weighted-average fair value		Number		Weighted-average fair value
Outstanding at December 31, 2019	887,867		$	64.21	217,413		$	52.07	179,397		$	61.43
Granted	94,945		58.91		83,337		58.92		69,635		82.38
Exercised(b)	—		—		—		—		—		—
Released from restriction(b)	—		—		(4,517	)	39.75		—		—
Cancelled/expired	(64,666	)	72.67		(27,981	)	50.18		(26,899	)	67.55
Outstanding at March 31, 2020	918,146		$	63.07	268,252		$	54.61	222,133		$	67.26

(a) Until the performance period is completed, PSUs are included in the table at the target level at their grant date and at that level represent one share of common stock per PSU.

(b) Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.

Other Comprehensive (Loss) Income

The Company’s comprehensive (loss) income is comprised of net earnings, net amortization of the unrealized loss of the pension obligation, the change in the unrealized gain on natural gas and foreign currency cash flow hedges and foreign currency translation adjustments. The components of and changes in accumulated other comprehensive loss (“AOCL”) as of and for the three months ended March 31, 2020 and 2019, are as follows (in millions):

Three Months Ended March 31, 2020(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.6	)	$	(6.9	)	$	(184.6	)	$	(192.1	)
Other comprehensive income (loss) before reclassifications(b)	2.7			—			(173.5		)	(170.8		)
Amounts reclassified from accumulated other comprehensive loss	(2.6		)	0.2			—			(2.4		)
Net current period other comprehensive income (loss)	0.1			0.2			(173.5		)	(173.2		)
Ending balance	$	(0.5	)	$	(6.7	)	$	(358.1	)	$	(365.3	)

18

Three Months Ended March 31, 2019(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.7	)	$	(4.5	)	$	(205.7	)	$	(210.9	)
Other comprehensive income before reclassifications(b)	0.2			—			14.5			14.7
Amounts reclassified from accumulated other comprehensive loss	(0.1		)	0.1			—			—
Net current period other comprehensive income	0.1			0.1			14.5			14.7
Ending balance	$	(0.6	)	$	(4.4	)	$	(191.2	)	$	(196.2	)

(a) With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive loss presented in the tables above are reflected net of applicable income taxes.

(b) The Company recorded a foreign exchange gain (loss) of $(75.5) million and $2.3 million in the three months ended March 31, 2020 and 2019, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of a long-term investment nature.

The amounts reclassified from AOCL to expense (income) for the three months ended March 31, 2020 and 2019, are shown below (in millions):

	Amount Reclassified from AOCL
	Three Months Ended March 31, 2020			Three Months Ended March 31, 2019			Line Item Impacted in the Consolidated Statements of Operations
Gains (losses) on cash flow hedges:
Natural gas instruments	$	(0.3	)	$	(0.1	)	Product cost
Foreign currency contracts	(3.6		)	(0.1		)	Interest expense
Income tax expense	1.3			0.1
Reclassifications, net of income taxes	(2.6		)	(0.1		)
Amortization of defined benefit pension:
Amortization of loss	$	0.2		$	0.1		Product cost
Reclassifications, net of income taxes	0.2			0.1
Total reclassifications, net of income taxes	$	(2.4	)	$	—

12. Derivative Financial Instruments:

The Company is subject to various types of market risks, including interest rate risk, foreign currency exchange rate transaction and translation risk and commodity pricing risk. Management may take actions to mitigate the exposure to these types of risks, including entering into forward purchase contracts and other financial instruments. Currently, the Company manages a portion of its commodity pricing and foreign currency exchange rate risks by using derivative instruments. The Company does not seek to engage in trading activities or take speculative positions with any financial instrument arrangement. The Company has entered into natural gas derivative instruments and foreign currency derivative instruments with counterparties it views as creditworthy. However, the Company does attempt to mitigate its counterparty credit risk exposures by, among other things, entering into master netting agreements with some of these counterparties. The Company records derivative financial instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets.

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Depending on the exposure being hedged, the Company must designate the hedging instrument as a fair value hedge, a cash flow hedge or a net investment in foreign operations hedge. For the qualifying derivative instruments that have been designated as hedges, the change in fair value is recognized through earnings when the underlying transaction being hedged affects earnings, allowing a derivative’s gains and losses to offset related results from the hedged item in the statements of operations. Any ineffectiveness related to these hedges was not material for any of the periods presented. For derivative instruments that have not been designated as hedges, the entire change in fair value is recorded through earnings in the period of change.

Natural Gas Derivative Instruments

Natural gas is consumed at several of the Company’s production facilities, and changes in natural gas prices impact the Company’s operating margin. The Company’s objective is to reduce the earnings and cash flow impacts of changes in market prices of natural gas by fixing the purchase price of up to 90% of its forecasted natural gas usage. It is the Company’s policy to consider hedging

19

portions of its natural gas usage up to 36 months in advance of the forecasted purchase. As of March 31, 2020, the Company had entered into natural gas derivative instruments to hedge a portion of its natural gas purchase requirements through December 2021. As of March 31, 2020 and December 31, 2019, the Company had agreements in place to hedge forecasted natural gas purchases of 2.8 million MMBtus. All natural gas derivative instruments held by the Company as of March 31, 2020 and December 31, 2019 qualified and were designated as cash flow hedges. As of March 31, 2020, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $0.6 million of net losses on derivative instruments related to its natural gas hedges.

Foreign Currency Derivatives Not Designated as Hedges

In March 2020, the Company entered into forward instruments to swap currency denominated in U.S. dollars to Canadian dollars for a future intercompany payment from a U.S. subsidiary to a Canadian subsidiary. These instruments mature in April 2020 with a combined notional amounts of $89.9 million. The objective of the instruments was to mitigate the foreign currency fluctuation risk related to intercompany payments denominated in a currency other than U.S. dollars, the Company’s functional currency. The instrument was not designated as a hedge. During the three months ended March 31, 2020, the Company recognized a loss of $5.3 million in loss on foreign exchange in its Consolidated Statements of Operations for these agreements.

Foreign Currency Derivatives Designated as Hedges

The Company has entered into U.S. dollar-denominated debt instruments to provide funds for its operations in Brazil. The Company may also concurrently enter into foreign currency agreements whereby the Company agrees to swap interest and principal payments on loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian reais, its Brazil subsidiary’s functional currency. The objective of the swap agreements is to mitigate the foreign currency fluctuation risk related to holding debt denominated in a currency other than the Company’s Brazil subsidiary’s functional currency. As of March 31, 2020, the Company had a swap agreement in place to hedge $9.4 million of a loan denominated in a currency other than its Brazil subsidiary’s functional currency. Payments on this loan are due on various dates extending through February 2021. As of March 31, 2020, this foreign currency derivative instrument qualified and was designated as a cash flow hedge. As of March 31, 2020, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $1.7 million of net gains on derivative instruments related to this foreign currency swap agreement.

The following tables present the fair value of the Company’s hedged items as of March 31, 2020 and December 31, 2019 (in millions):

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Consolidated Balance Sheets Location	March 31, 2020		Consolidated Balance Sheets Location	March 31, 2020
Commodity contracts	Other current assets	$	0.3	Accrued expenses and other current liabilities	$	0.9
Commodity contracts	Other assets	—		Other noncurrent liabilities	0.1
Swap contracts	Other current assets	1.7		Accrued expenses and other current liabilities	—
Total derivatives designated as hedging instruments(a)(b)		$	2.0		$	1.0

(a) The Company has master netting agreements with both of its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets $0.3 million of its commodity contracts that are in a receivable position against its contracts in payable positions.

(b) The Company has commodity hedge agreements with two counterparties and a foreign currency swap agreement with one counterparty. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from one counterparty. 

20

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Consolidated Balance Sheets Location	December 31, 2019		Consolidated Balance Sheets Location	December 31, 2019
Commodity contracts	Other current assets	$	0.3	Accrued expenses and other current liabilities	$	0.8
Commodity contracts	Other assets	0.1		Other noncurrent liabilities	0.2
Swap contracts	Other current assets	2.8		Accrued expenses and other current liabilities	—
Total derivatives designated as hedging instruments(a)(b)		$	3.2		$	1.0

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets $0.4 million of its commodity contracts that are in a receivable position against its contracts in payable positions.

(b) The Company has both commodity hedge and foreign currency swap agreements with two counterparties each. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties, and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from both counterparties. 

13. Fair Value Measurements:

The Company’s financial instruments are measured and reported at their estimated fair values. Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction. When available, the Company uses quoted prices in active markets to determine the fair values for its financial instruments (Level 1 inputs) or, absent quoted market prices, observable market-corroborated inputs over the term of the financial instruments (Level 2 inputs). The Company does not have any unobservable inputs that are not corroborated by market inputs (Level 3 inputs).

The Company holds marketable securities associated with its defined contribution and pre-tax savings plans, which are valued based on readily available quoted market prices. The Company utilizes derivative instruments to manage its risk of changes in natural gas prices and its risk of changes in foreign currency exchange rates (see Note 12). The fair values of the natural gas and foreign currency derivative instruments are determined using market data of forward prices for all of the Company’s contracts. 

The estimated fair values for each type of instrument are presented below (in millions):

	March 31, 2020			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.3		$	1.3		$	—		$	—
Derivatives – foreign currency contracts, net	1.7			—			1.7			—
Total Assets	$	3.0		$	1.3		$	1.7		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.3	)	$	(1.3	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.7		)	—			(0.7		)	—
Total Liabilities	$	(2.0	)	$	(1.3	)	$	(0.7	)	$	—

(a) Includes mutual fund investments of approximately 30% in common stock of large-cap U.S. companies, 10% in common stock of small to mid-cap U.S. companies, 5% in international companies, 20% in bond funds, 10% in short-term investments and 25% in blended funds.

21

	December 31, 2019			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.4		$	1.4		$	—		$	—
Derivatives – foreign currency contracts, net	2.8			—			2.8			—
Total Assets	$	4.2		$	1.4		$	2.8		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.4	)	$	(1.4	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.6		)	—			(0.6		)	—
Total Liabilities	$	(2.0	)	$	(1.4	)	$	(0.6	)	$	—

(a) Includes mutual fund investments of approximately 30% in the common stock of large-cap U.S. companies, 15% in the common stock of small to mid-cap U.S. companies, 5% in the common stock of international companies, 10% in bond funds, 20% in short-term investments and 20% in blended funds.

Cash and cash equivalents, accounts receivable (net of allowance for bad debts) and payables are carried at cost, which approximates fair value due to their liquid and short-term nature. The Company’s investments related to its nonqualified savings plan of $1.3 million and $1.4 million at March 31, 2020 and December 31, 2019, respectively, are stated at fair value based on quoted market prices. As of March 31, 2020 and December 31, 2019, the estimated amount a third party would pay for the Company’s fixed-rate 4.875% Senior Notes due July 2024, based on available trading information (Level 2), totaled $235.0 million and $249.1 million, respectively, compared with the aggregate principal amount at maturity of $250.0 million. As of March 31, 2020 and December 31, 2019, the estimated amount a third party would pay for the Company’s fixed-rate 6.75% Senior Notes due December 2027, based on available trading information (Level 2), totaled $451.4 million and $530.6 million, respectively, compared with the aggregate principal amount at maturity of $500.0 million. The estimated amount a third party would pay at March 31, 2020 and December 31, 2019 for the amounts outstanding under the Company’s term loans and revolving credit facility, based upon available bid information received from the Company’s lender (Level 2), totaled $451.3 million and $552.8 million, respectively, compared with the aggregate principal balance of $456.5 million and $560.0 million, respectively. The Brazilian loans have floating rates and their fair value approximates their carrying value.

14. Earnings per Share:

The Company calculates earnings per share using the two-class method. The two-class method requires allocating the Company’s net earnings to both common shares and participating securities. The following table sets forth the computation of basic and diluted earnings per common share (in millions, except for share and per-share data):

	Three Months Ended March 31,
	2020			2019
Numerator:
Net earnings	$	27.6		$	7.6
Less: net earnings allocated to participating securities(a)	(0.5		)	(0.2		)
Net earnings available to common shareholders	$	27.1		$	7.4
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share	33,892			33,874
Weighted-average awards outstanding(b)	—			—
Shares for diluted earnings per share	33,892			33,874
Net earnings per common share, basic	$	0.80		$	0.22
Net earnings per common share, diluted	$	0.80		$	0.22

(a) Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 412,000 and 233,000 weighted participating securities for the three months ended March 31, 2020 and 2019, respectively.

(b) For the calculation of diluted net earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had 1,266,000 and 788,000 weighted-average equity awards outstanding for the three months ended March 31, 2020 and 2019, respectively.

22

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

All statements, other than statements of historical fact, contained in this Quarterly Report on Form 10-Q constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include, but are not limited to, the following: risks related to the coronavirus (“COVID-19”) pandemic; our mining and industrial operations; geological conditions; dependency on a limited number of key production and distribution facilities and critical equipment; weather conditions; strikes, other forms of work stoppage or slowdown or other union activities; the inability to fund necessary capital expenditures or successfully complete capital projects; supply constraints or price increases for energy and raw materials used in our production processes; our indebtedness and inability to pay our indebtedness; restrictions in our debt agreements that may limit our ability to operate our business or require accelerated debt payments; tax liabilities; financial assurance requirements; the inability of our customers to access credit or a default by our customers of trade credit extended by us or financing we have guaranteed; our payment of any dividends; the impact of competition on the sales of our products; risks associated with our international operations and sales; the impact of anticipated changes in plant nutrition product prices and customer application rates; conditions in the agricultural sector and supply and demand imbalances for competing plant nutrition products; increasing costs or a lack of availability of transportation services; the seasonal demand for our products; our rights and governmental authorizations to mine and operate our properties; compliance with foreign and United States (“U.S.”) laws and regulations related to import and export requirements and anti-corruption laws; compliance with environmental, health and safety laws and regulations; environmental liabilities; misappropriation or infringement claims relating to intellectual property; product liability claims and product recalls; inability to obtain required product registrations or increased regulatory requirements; changes in industry standards and regulatory requirements; our ability to successfully implement our strategies, including the strategic review of our Plant Nutrition South America business; the loss of key personnel; a compromise of our computer systems, information technology or operations technology or the inability to protect confidential or proprietary data; our ability to expand our business through acquisitions, integrate acquired businesses and realize anticipated benefits from acquisitions; climate change; domestic and international general business and economic conditions; and other risks referenced from time to time in this report and our other filings with the Securities and Exchange Commission (the “SEC”), including the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2019.

In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” the negative of these terms or other comparable terminology. Forward-looking statements include without limitation statements about our the impact of COVID-19 pandemic on us; our outlook, including expected sales volumes; our strategic evaluation of our Plant Nutrition South America business; working capital requirements; our reinvestment of foreign earnings outside the U.S.; our ability to optimize cash accessibility, minimize tax expense and meet debt service requirements; future tax payments and tax refunds; outcomes of matters with taxing authorities; the effects of currency fluctuations and inflation; and the seasonality of our business. These forward-looking statements are only predictions. Actual events or results may differ materially.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We undertake no duty to update any of the forward-looking statements after the date hereof or to reflect the occurrence of unanticipated events.

Unless the context requires otherwise, references to the “Company,” “Compass Minerals,” “our,” “us” and “we” refer to Compass Minerals International, Inc. (“CMI,” the parent holding company) and its consolidated subsidiaries. Except where otherwise noted, references to North America include only the continental U.S. and Canada, and references to the United Kingdom (the “U.K.”) include only England, Scotland and Wales. Except where otherwise noted, all references to tons refer to “short tons” and all amounts are in U.S. dollars. One short ton equals 2,000 pounds. Compass Minerals, Protassium+ and Wolf Trax, and combinations thereof, are trademarks of CMI or its subsidiaries in the U.S. and other countries. 

COVID-19 Pandemic

The global spread of the COVID-19 pandemic in recent months has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. As an essential business, we have continued producing and delivering products that support critical industries such as transportation, agriculture, chemical, food, pharmaceutical and animal nutrition. However, we have instituted several measures in response to the COVID-19 pandemic.

23

• Employee welfare: Our management team has taken multiple actions to limit the exposure of employees to the spread of COVID-19, including instituting remote working where possible, adjusting shift schedules and crew sizes, restricting visitation to operational sites, prohibiting all business-related commercial air travel, and increasing sanitation of offices and common areas within our facilities.

• Operations: Our manufacturing facilities in North America and Brazil remained in operation throughout the first quarter. Operations at our U.K. salt mine were idled near the end of March due to the very mild winter weather experienced in that market, along with U.K. government guidance on COVID-19 preventative measures.

• Supply chain and logistics: To date, we have experienced no material supply chain or logistics issues. We continue to evaluate potential supply chain and logistics impacts, proactively increase inventory levels of critical sourced inputs and identify secondary suppliers where possible. Both our operations and our logistics partners are deemed “essential” under current governmental guidance and we have worked to ensure we understand and comply with their safety precautions to limit potential disruptions.

The ultimate impact that COVID-19 will have on our 2020 results is unknown at this time. However, we have identified several potential impacts on our business, which include:

• A protracted North American economic shutdown could lower bid volumes due to budgetary limitations or reduced traffic on the roadways.

• Customer access to retailers in our North American markets could impact consumer and industrial product demand.

• Potential reduced demand in our specialty crop markets in North America. As a result, we have lowered our 2020 Plant Nutrition North America volume guidance to 340,000 to 365,000 tons.

• A significant decline in global demand of crops that use our Plant Nutrition South America products could reduce demand in this segment.

For more information, see “Part II–Item 1A–Risk Factors.”

Critical Accounting Estimates

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Management believes the most complex and sensitive judgments result primarily from the need to make estimates about matters that are inherently uncertain. Management’s Discussion and Analysis and Note 2 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 describe the significant accounting estimates and policies used in preparation of our consolidated financial statements. For a further description of our critical accounting policies, see Note 1 to our Consolidated Financial Statements included in this Quarterly Report on Form 10-Q. Actual results in these areas could differ from management’s estimates.

Company Overview

Compass Minerals is a leading producer of essential minerals, including salt, sulfate of potash (“SOP”) specialty fertilizer and magnesium chloride. As of March 31, 2020, we operated 21 production and packaging facilities, including:

• The largest rock salt mine in the world in Goderich, Ontario, Canada;

• The largest dedicated rock salt mine in the U.K. in Winsford, Cheshire;

• A solar evaporation facility located in Ogden, Utah, which is both the largest SOP production site and the largest solar salt production site in the Western Hemisphere;

• Several mechanical evaporation facilities producing consumer and industrial salt; and

• Several facilities producing essential agricultural nutrients and specialty chemicals in Brazil.

Our salt business provides highway deicing salt to customers in North America and the U.K. as well as consumer deicing and water conditioning products, ingredients used in consumer and commercial food preparation, and other salt-based products for consumer, agricultural and industrial applications in North America. In the U.K., we operate a records management business utilizing excavated areas of our Winsford salt mine with one other surface location in London, England.

Our plant nutrition business produces and markets specialty plant nutrition products worldwide to distributors and retailers of crop inputs, as well as growers. Our principal plant nutrition product in our Plant Nutrition North America segment is SOP, which we market under the trade name Protassium+. We also sell various secondary nutrients as well as premium micronutrient products under our Wolf Trax brand.

24

Our Plant Nutrition South America segment operates two primary businesses in Brazil—agricultural productivity, which manufactures and distributes a broad offering of specialty plant nutrition solution-based products; and chemical solutions, which manufactures and markets specialty chemicals, primarily for the water treatment industry and for use in other industrial processes.

Consolidated Results of Operations

The following is a summary of our consolidated results of operations for the three months ended March 31, 2019 and 2020, respectively. The following discussion should be read in conjunction with the information contained in our consolidated financial statements and the notes thereto included in this Quarterly Report on Form 10-Q.

THREE MONTHS ENDED MARCH 31

* Refer to “—Sensitivity Analysis Related to EBITDA and Adjusted EBITDA” for a reconciliation to the most directly comparable U.S. GAAP financial measure and the reasons we use this non-GAAP measure.

COMMENTARY: THREE MONTHS ENDED MARCH 31, 2019 AND 2020

• Total sales increased 3%, or $10.2 million, due to increases in both plant nutrition businesses, which were partially offset by a decrease in Salt sales.

• Operating earnings increased 33%, or $11.0 million, due to increases in all businesses.

• Earnings before interest, taxes, depreciation and amortization (“EBITDA”)* adjusted for items management believes are not indicative of our ongoing operating performance (“Adjusted EBITDA”)* increased 15%, or $10.4 million.

• Diluted net earnings per share increased 264%, or $0.58.

25

THREE MONTHS ENDED MARCH 31

COMMENTARY: THREE MONTHS ENDED MARCH 31, 2019 AND 2020

Gross Profit: Increased 20%, or $14.7 million; Gross Margin increased by 3 percentage points

• Salt segment gross profit increased $5.4 million primarily due to higher average sales prices, which were partially offset by higher per-unit product cost due to costs resulting from upgrades to our mining equipment and sales of higher cost purchased salt.

• The gross profit of the plant nutrition business, on a combined basis, increased $9.2 million. Plant Nutrition North America segment gross profit increased $5.8 million primarily due to higher sales volumes, lower production costs and lower per-unit shipping and handling costs, which was partially offset by lower average sales prices. Plant Nutrition South America segment gross profit increased $3.4 million primarily due to higher sales volumes and lower per unit product costs, which were partially offset by lower average sales prices.

OTHER EXPENSES AND INCOME

COMMENTARY: THREE MONTHS ENDED MARCH 31, 2019 AND 2020

SG&A: Increased $3.7 million; increased 0.6 percentage points as a percentage of sales from 9.8% to 10.4%

• The increase in SG&A expense was primarily due to higher corporate salaries and wages and incentive compensation in the current year compared to the prior year due, in part, to severance expense incurred in the current period.

Interest Expense: Increased $2.8 million to $19.0 million

• The increase was primarily due to an increase in interest rates due to the refinancing of our debt in the fourth quarter of 2019.

(Gain) Loss on Foreign Exchange: Improved $19.3 million from an expense of $5.0 million to income of $14.3 million

• We realized foreign exchange gains of $14.3 million in the first quarter of 2020 compared to a loss of $5.0 million in the first quarter of 2019 due primarily to changes in translating our intercompany loans from Canadian dollars to U.S. dollars.

Other Expense (Income), Net: Decreased $0.7 million from income of $0.6 million to an expense of $0.1 million

• The decrease in other expense (income) is primarily due to losses incurred in the current period related to our non-qualified plan for certain executives.

Income Tax Expense: Increased $6.8 million from $4.9 million to $11.7 million

• The increase in income tax expense was primarily due to higher pretax income in the first quarter of 2020 versus the first quarter of 2019 offset by the discrete tax expense items in the first quarter of 2019.

• Our income tax provision in both periods differs from the U.S. statutory rate primarily due to U.S. statutory depletion, state income taxes, global intangible low-taxed income, foreign income, mining and withholding taxes and interest expense recognition differences for tax and financial reporting purposes.

• Our effective tax rate declined from 39% in the first quarter of 2019 to 30% in the first quarter of 2020 primarily due to the impact of discrete tax items in the first quarter of 2019.

26

Operating Segment Performance

The following financial results represent consolidated financial information with respect to sales from our Salt, Plant Nutrition North America and Plant Nutrition South America segments. The results of operations of the consolidated records management business and other incidental revenues include sales of $2.7 million and $2.4 million for the first quarter of 2020 and 2019, respectively. These revenues are not material to our consolidated financial results and are not included in the following operating segment financial data.

Salt

THREE MONTHS ENDED MARCH 31

	1Q 2020		1Q 2019
Salt Sales (in millions)	$	287.8	$	306.4
Salt Operating Earnings (in millions)	$	56.9	$	52.3
Salt Sales Volumes (thousands of tons)
Highway deicing	3,104		3,543
Consumer and industrial	469		551
Total tons sold	3,573		4,094
Average Salt Sales Price (per ton)
Highway deicing	$	69.30	$	61.73
Consumer and industrial	$	154.84	$	159.23
Combined	$	80.53	$	74.84

COMMENTARY: THREE MONTHS ENDED MARCH 31, 2019 AND 2020

• Salt sales decreased 6%, or $18.6 million, primarily due to lower Salt sales volumes, which were partially offset by higher highway deicing average sales prices.

• Salt average sales prices increased 8% and contributed $21.4 million to sales due to higher highway deicing prices.

• Highway deicing average sales prices increased 12% due to higher North American highway deicing contract prices for the 2019-2020 winter season. Consumer and industrial average sales prices decreased 3% due to sales mix.

• Salt sales volumes decreased 13%, or 521,000 tons, and unfavorably impacted sales by $40.0 million. Highway deicing sales volumes decreased 12% primarily as result of milder winter weather in the first quarter of 2020 in North America and the U.K. Consumer and industrial sales volumes also decreased 15% due to lower sales of deicing products.

• Salt operating earnings increased 9%, or $4.6 million, due to higher highway deicing prices, which were partially offset by higher per-unit cost primarily due to lower production volumes in the U.K., costs related to upgrading our mining equipment at our Goderich mine and increased sales of higher cost purchased salt.

27

Plant Nutrition North America

THREE MONTHS ENDED MARCH 31

	1Q 2020		1Q 2019
Plant Nutrition North America Sales (in millions)	$	60.6	$	37.2
Plant Nutrition North America Operating Earnings (Loss) (in millions)	$	5.2	$	(1.6	)
Plant Nutrition North America Sales Volumes (thousands of tons)	96		57
Plant Nutrition North America Average Sales Price (per ton)	$	632	$	656

COMMENTARY: THREE MONTHS ENDED MARCH 31, 2019 AND 2020

• Plant Nutrition North America sales increased 63%, or $23.4 million due to higher sales volumes, which was partially offset by lower average sales prices.

• Plant Nutrition North America sales volumes increased 68%, or 39,000 tons, which resulted in a $25.6 million increase in sales. Sales volume in the first quarter of 2019 were lower due to the cold and wet weather experienced in our key markets.

• Plant Nutrition North America average sales prices decreased 4%, providing a $2.2 million offset to the increase in sales.

• Plant Nutrition North America operating earnings increased $6.8 million to $5.2 million due to higher sales volumes, lower per-unit product and shipping and handling costs and lower selling, general and administrative expenses, which were partially offset by lower average sales prices.

Plant Nutrition South America

THREE MONTHS ENDED MARCH 31

28

	1Q 2020		1Q 2019
Plant Nutrition South America Sales (in millions)	$	62.8	$	57.7
Plant Nutrition South America Operating Earnings (Loss) (in millions)	$	0.3	$	(2.6	)
Plant Nutrition South America Sales Volumes (thousands of tons)
Agricultural productivity	68		52
Chemical solutions	90		82
Total tons sold	158		134
Average Plant Nutrition South America Sales Price (per ton)
Agricultural productivity	$	602	$	681
Chemical solutions	$	242	$	275
Combined	$	397	$	431

COMMENTARY: THREE MONTHS ENDED MARCH 31, 2019 AND 2020

• Plant Nutrition South America sales increased 9%, or $5.1 million, due to higher sales volumes, which were partially offset by lower average sales prices due to a 14% unfavorable weighted average change in the Brazilian reais versus the U.S. dollar from the prior year.

• Plant Nutrition South America sales volumes increased 18%, or 24,000 tons, which accounted for $13.4 million of the increase in Plant Nutrition South America sales. Agricultural productivity sales volumes increased 31% due primarily to improvements in farmer economics and affordability of fertilizer products due to foreign exchange and barter rates. Chemical solutions sales volumes increased 10% due to higher sales of water treatment products.

• An 8% decrease in Plant Nutrition South America average sales price reduced sales by $8.3 million. The decrease in average sales price was due to a 12% decrease in both chemical solutions and agricultural productivity prices as a result of the weighted average change in the Brazilian reais versus the U.S. dollar. In local currency, a stronger mix of agricultural productivity sales resulted in a 5% increase in average sales prices.

• Plant Nutrition South America operating earnings increased $2.9 million to $0.3 million due to higher sales volumes and improved margins, partially offset by a weaker reais.

2020 Full-Year Outlook

• As a result of the mild first quarter winter weather, we expect Salt sales volumes for 2020 to range from 10.7 million tons to 11.1 million tons.

• Plant Nutrition North America sales volumes for 2020 are expected to range from 340,000 tons to 365,000 tons.

• We expect 2020 Plant Nutrition South America, sales volumes to range from 800,000 tons to 900,000 tons.

• In light of the COVID-19 pandemic and its impact on the global economy and capital markets, we have temporarily suspended our strategic review of our Plant Nutrition South America business. For more information about the impact of the COVID-19 pandemic on the Company, see “–COVID-19 Pandemic” and “Part II–Item 1A–Risk Factors.”

Liquidity and Capital Resources

Historically, our cash flows from operating activities have generally been adequate to fund our basic operating requirements and ongoing debt service. We have also used cash generated from operations to fund capital expenditures which strengthen our operational position, pay dividends, fund smaller acquisitions and repay our debt. To a certain extent, our ability to meet our short- and long-term liquidity and capital needs is subject to general economic, financial, competitive, legislative, regulatory and weather conditions, effects of climate change, geological variations in our mine deposits and other factors that are beyond our control. Historically, our working capital requirements have been the highest in the fourth quarter and lowest in the second quarter. When needed, we may fund short-term working capital requirements by accessing our $300 million revolving credit facility.

We have been able to manage our cash flows generated and used across Compass Minerals to permanently reinvest earnings in our foreign jurisdictions or efficiently repatriate those funds to the U.S. As of March 31, 2020, we had $33.9 million of cash and cash equivalents (in our Consolidated Balance Sheets) that were either held directly or indirectly by foreign subsidiaries. During the fourth quarter of 2018, we revised our permanently reinvested assertion to indicate that we expect to repatriate approximately $150 million of unremitted foreign earnings on which we have recorded a $4.8 million deferred tax liability as of March 31, 2020 for foreign withholding tax and state income tax. Due to our ability to generate adequate levels of domestic cash flow on an annual basis, it is our current intention to continue to reinvest all remaining undistributed earnings of our foreign subsidiaries indefinitely. We review our tax circumstances on a regular basis with the intent of optimizing cash accessibility and minimizing tax expense.

29

In addition, the amount of permanently reinvested earnings is influenced by, among other things, the profits generated by our foreign subsidiaries and the amount of investment in those same subsidiaries. The profits generated by our domestic and foreign subsidiaries are impacted by the transfer price charged on the transfer of our products between them. As discussed in Note 7 to our Consolidated Financial Statements, our calculated transfer price on certain products between one of our foreign subsidiaries and a domestic subsidiary has been challenged by Canadian federal and provincial governments. In the fourth quarter of 2017, we reached a federal settlement agreement with Canadian and U.S. tax authorities related to our transfer pricing issues for our 2007-2012 tax years. The recording of this settlement resulted in increased sales for our Canadian subsidiary of $85.7 million and increased offsetting expenses for our US subsidiary in 2017 causing a domestic loss and significant foreign income. During 2018, in accordance with the settlement agreement, our U.S. subsidiary made intercompany cash payments of $85.7 million to our Canadian subsidiary and tax payments to Canadian taxing authorities of $17.5 million. The remaining liability was satisfied in 2019 with tax payments of $5.3 million. . Corresponding tax refunds of $21.4 million were received in 2019 from U.S. taxing authorities, with the remaining refund of approximately $1.6 million expected in 2020. Additionally during the fourth quarter of 2018, we reached a federal settlement agreement with Canadian and U.S. tax authorities on transfer pricing and management fees as part of an advanced pricing agreement that covers tax years 2013-2021. The recording of this settlement in 2018 resulted in increased sales for our Canadian subsidiary of $106.1 million and offsetting expenses for our US subsidiary causing a domestic loss and significant foreign income in 2018. During the second quarter of 2019, in accordance with the settlement agreement, our U.S. subsidiary made intercompany cash payments of $106.1 million to our Canadian subsidiary and tax payments to Canadian taxing authorities of $29.9 million with the remaining $1.3 million of tax payments to be paid during 2020. Corresponding tax refunds of $59.2 million have been received as of March 31, 2020 from U.S. taxing authorities, of which $55 million was received during the first quarter of 2020, with the remaining $2.4 million expected in 2020. There are ongoing challenges by Canadian provincial taxing authorities regarding our transfer prices of certain products. The final resolution of these challenges may not occur for several years. We currently expect the outcome of these matters will not have a material impact on our results of operations. However, it is possible the resolution could materially impact the amount of earnings attributable to our domestic and foreign subsidiaries, which could impact the amount of permanently reinvested foreign earnings as well as future cash flows from our domestic operations. See Note 7 to our Consolidated Financial Statements for a discussion regarding our Canadian tax reassessments and settlement.

A portion of our loans in Brazil are denominated in U.S. dollars. We have entered into a foreign currency agreement whereby we agreed to swap interest and principal payments on the loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian reais, the functional currency of our Brazil subsidiary. See Note 12 to our Consolidated Financial Statements for a discussion of our foreign currency agreement.

Cash and cash equivalents as of March 31, 2020 of $109.8 million, increased $75.1 million from December 31, 2019. We generated $228.6 million of operating cash flows in the first three months of 2020. In the first three months of 2020, we used cash on hand and cash flows from operations to pay $97.7 million of net long-term debt, to fund capital expenditures of $25.3 million and pay dividends on our common stock of $24.8 million.

As of March 31, 2020, we had $1.31 billion of indebtedness, consisting of $250.0 million outstanding under our 4.875% Senior Notes due 2024, $500.0 million outstanding under our 6.75% Senior Notes due 2027, $456.5 million of borrowings outstanding under our senior secured credit facilities (consisting of term loans and a revolving credit facility), including $59.0 million borrowed against our revolving credit facility, and $101.3 million of Brazilian debt (see Note 8 to our Consolidated Financial Statements for more detail regarding our debt). We had $10.5 million of outstanding letters of credit as of March 31, 2020, which reduced our revolving credit facility borrowing availability to $230.5 million.

Our debt service obligations could, under certain circumstances, materially affect our financial condition and impair our ability to operate our business or pursue our business strategies. As a holding company, CMI’s investments in its operating subsidiaries constitute substantially all of its assets. Consequently, our subsidiaries conduct substantially all of our consolidated operating activities and own substantially all of our operating assets. The principal source of the cash needed to pay our obligations is the cash generated from our subsidiaries’ operations and their borrowings. Our subsidiaries are not obligated to make funds available to CMI. Furthermore, we must remain in compliance with the terms of our credit agreement governing our term loans and revolving credit facility, including the total leverage ratio and interest coverage ratio, in order to make payments on our debt or pay dividends to our stockholders. We must also comply with the terms of our indenture governing our senior notes. Although we are in compliance with our debt covenants as of March 31, 2020, we can make no assurance that we will remain in compliance with these ratios nor can we make any assurance that the agreements governing the current and future indebtedness of our subsidiaries will permit our subsidiaries to provide us with sufficient dividends, distributions or loans to fund scheduled interest payments on our debt when due. If we consummate an additional acquisition, our debt service requirements could increase. Furthermore, we may need to refinance all or a portion of our indebtedness on or before maturity; however, we cannot provide assurance that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.

30

The table below provides a summary of our cash flows by category:

THREE MONTHS ENDED MARCH 31, 2020	THREE MONTHS ENDED MARCH 31, 2019
Operating Activities:
» Net earnings were $27.6 million.	» Net earnings were $7.6 million.
» Non-cash depreciation and amortization expense was $33.1 million.	» Non-cash depreciation and amortization expense was $35.0 million.
» Working capital items were a source of operating cash flows of $171.7 million.	» Working capital items were a source of operating cash flows of $77.5 million.
Investing Activities:
» Net cash flows used by investing activities included $25.3 million of capital expenditures.	» Net cash flows used by investing activities included $21.5 million of capital expenditures.
Financing Activities:
» Net cash flows used by financing activities included the payment of dividends of $24.8 million. » In addition, we had net payments on our debt $97.7 million.	» Net cash flows used by financing activities included the payment of dividends of $24.6 million. » In addition, we had net payments on our debt of $64.9 million.

Other Matters

See Notes 7 and 9 to our Consolidated Financial Statements for a discussion regarding labor, environmental and litigation matters.

Sensitivity Analysis Related to EBITDA and Adjusted EBITDA

Management uses a variety of measures to evaluate our performance. While our consolidated financial statements, taken as a whole, provide an understanding of our overall results of operations, financial condition and cash flows, we analyze components of the consolidated financial statements to identify certain trends and evaluate specific performance areas. In addition to using U.S. GAAP financial measures, such as gross profit, net earnings and cash flows generated by operating activities, management uses EBITDA and Adjusted EBITDA. Both EBITDA and Adjusted EBITDA are non-GAAP financial measures used to evaluate the operating performance of our core business operations, because our resource allocation, financing methods, cost of capital and income tax positions are managed at a corporate level apart from the activities of the operating segments and our operating facilities are located in different taxing jurisdictions, which can cause considerable variation in net earnings. We also use these measures to assess our operating performance and return on capital, and to evaluate potential acquisitions or other capital projects. These measures are not calculated under U.S. GAAP and should not be considered in isolation or as a substitute for net earnings, operating earnings, cash flows or other financial data prepared in accordance with U.S. GAAP or as a measure of our overall profitability or liquidity. EBITDA and Adjusted EBITDA exclude interest expense, income taxes and depreciation and amortization, each of which are an essential element of our cost structure and cannot be eliminated. Furthermore, Adjusted EBITDA excludes other cash and non-cash items including stock-based compensation, (gain) loss on foreign exchange and other expense (income). Our borrowings are a significant component of our capital structure and interest expense is a continuing cost of debt. We are also required to pay income taxes, a required and ongoing consequence of our operations. We have a significant investment in capital assets and depreciation and amortization reflect the utilization of those assets in order to generate revenues. Consequently, any measure that excludes these elements has material limitations. While EBITDA and Adjusted EBITDA are frequently used as measures of operating performance, these terms are not necessarily comparable to similarly titled measures of other companies due to the potential inconsistencies in the method of calculation. 

31

The calculation of EBITDA and Adjusted EBITDA as used by management is set forth in the table below (in millions):

	Three Months Ended March 31,
	2020			2019
Net earnings	$	27.6		$	7.6
Interest expense	19.0			16.2
Income tax expense	11.7			4.9
Depreciation, depletion and amortization	33.1			35.0
EBITDA	91.4			63.7
Adjustments to EBITDA:
Stock-based compensation - non cash	2.4			1.1
(Gain) loss on foreign exchange	(14.3		)	5.0
Other expense (income), net	0.1			(0.6		)
Adjusted EBITDA	$	79.6		$	69.2

Recent Accounting Pronouncements

See Note 1 to our Consolidated Financial Statements for a discussion of recent accounting pronouncements.

Effects of Currency Fluctuations

Our operations outside of the U.S. are conducted primarily in Canada, Brazil and the U.K. Therefore, our results of operations are subject to both currency transaction risk and currency translation risk. We incur currency transaction risk whenever we or one of our subsidiaries enters into either a purchase or sales transaction using a currency other than the local currency of the transacting entity. With respect to currency translation risk, our financial condition and results of operations are measured and recorded in the relevant local currency and then translated into U.S. dollars for inclusion in our consolidated financial statements. Exchange rates between these currencies and the U.S. dollar have fluctuated significantly from time to time and may do so in the future. The majority of revenues and costs are denominated in U.S. dollars, with Canadian dollars, Brazilian reais and British pounds sterling also being significant. Significant changes in the value of the Canadian dollar, Brazilian reais or British pound sterling relative to the U.S. dollar could have a material effect on our financial condition.

Although inflation has not had a significant impact on our operations, our efforts to recover cost increases due to inflation may be hampered as a result of the competitive industries and countries in which we operate.

Seasonality

We experience a substantial amount of seasonality in our sales. Our sales of our salt deicing products are seasonal. Consequently, our Salt sales and operating income are generally higher in the first and fourth quarters and lower during the second and third quarters of each year. In particular, sales of highway and consumer deicing salt and magnesium chloride products vary based on the severity of the winter conditions in areas where the product is used. Following industry practice in North America, we seek to stockpile sufficient quantities of deicing salt in the second, third and fourth quarters to meet the estimated requirements for the winter season.

Our plant nutrition business is also seasonal. The strongest demand for our Plant Nutrition South America products in Brazil typically occurs during the spring planting season. As a result, we and our customers generally build inventories during the low demand periods of the year to ensure timely product availability during the peak sales season. The seasonality of this demand results in our sales volumes and net sales for our Plant Nutrition South America segment usually being the highest during the third and fourth quarters of each year (as the spring planting season begins in September in Brazil).

32

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Our business is subject to various types of market risks that include interest rate risk, foreign currency exchange rate risk and commodity pricing risk. Management has taken actions to mitigate our exposure to commodity pricing and foreign currency exchange rate risk by entering into natural gas derivative instruments and foreign currency contracts. We may take further actions to mitigate our exposure to interest rates, exchange rates and changes in the cost of transporting our products due to variations in our contracted carriers’ cost of fuel, which is typically diesel fuel. However, there can be no assurance that our hedging activities will eliminate or substantially reduce these risks. We do not enter into any financial instrument arrangements for speculative purposes. Our market risk exposure related to these items has not changed materially since December 31, 2019.

Item 4.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2020 to ensure that information required to be disclosed in the reports it files and submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

For this purpose, disclosure controls and procedures include controls and procedures designed to ensure that information that is required to be disclosed under the Exchange Act is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting during the most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

33

PART II. OTHER INFORMATION

Item 1.    Legal Proceedings

We are involved in the legal proceedings described in Note 7 and Note 9 to our Consolidated Financial Statements and, from time to time, various routine legal proceedings and claims arising from the ordinary course of our business. These primarily involve tax assessments, disputes with former employees and contract labor, commercial claims, product liability claims, personal injury claims and workers’ compensation claims. Management cannot predict the outcome of legal proceedings and claims with certainty. Nevertheless, management believes that the outcome of legal proceedings and claims, which are pending or known to be threatened, even if determined adversely, will not, either individually or in the aggregate, have a material adverse effect on our results of operations, cash flows or financial condition. There have been no material developments since December 31, 2019 with respect to our legal proceedings, except as described in Note 7 and Note 9 to our Consolidated Financial Statements.

Item 1A.    Risk Factors

For a discussion of the risk factors applicable to Compass Minerals, please refer to Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, as updated and supplemented by the discussion below related to the COVID-19 pandemic. 

The COVID-19 pandemic, or other outbreaks of infectious disease or similar public health threats, could materially and adversely affect our business, financial condition and results of operations.

The recent outbreak of COVID-19, and any other outbreaks of contagious diseases or other adverse public health developments in the United States or worldwide, could have a material adverse effect on our business, financial condition and results of operations. As an essential business, we have continued producing and delivering products that support critical industries such as transportation, agriculture, chemical, food, pharmaceutical and animal nutrition. However, COVID-19 has significantly impacted economic activity and markets worldwide in 2020, and it could negatively affect our business in a number of ways. These effects could include, but are not limited to:

• Disruptions or restrictions on our employees’ ability to work effectively due to illness, travel bans, quarantines, shelter-in-place orders or other limitations could impact our business.

• Temporary closures of our facilities or the facilities of our customers or suppliers could reduce demand for our products or affect our ability to timely meet our customer’s orders and negatively impact our supply chain. Compliance with new governmental regulations, such as social distancing regulations, could increase our operational costs. Our mining and manufacturing facilities in North America and Brazil remained in operation throughout the first quarter of 2020; however, operations at our U.K. salt mine were idled near the end of March 2020 due to the mild 2019-2020 winter weather experienced in that market, along with U.K. government guidance on COVID-19 preventative measures.

• Our mining and manufacturing facilities rely on raw materials and components provided by our suppliers. If the ongoing quarantining or similar measures cause delays along our supply chain, we could experience a mining or manufacturing slow-down or seek to obtain alternate sources of supply, which may not be available or may be more expensive. Disruptions to our supply chain and business operations, or to our suppliers’ or customers’ supply chains and business operations, could include disruptions from the closure of supplier and manufacturer facilities, interruptions in the supply of raw materials and components, personnel absences, or restrictions on the shipment of our or our suppliers’ or customers’ products, any of which could have adverse ripple effects on our business.

• Global health concerns, such as COVID-19, could result in social, economic, and labor instability in the countries and localities in which we or our suppliers and customers operate. Any of these uncertainties could have a material adverse effect on our business, financial condition or results of operations.

• The failure of third parties on which we rely, including our suppliers, customers, contractors, commercial banks and external business partners, to meet their respective obligations to the Company, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties, could have an adverse impact on our business, financial condition or results of operations.

• Remote work arrangements for our employees could strain our technology resources and introduce operational risks, including heightened cybersecurity risk. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts that seek to exploit the COVID-19 pandemic. These risks could also impact the third parties on which we rely.

• The COVID-19 pandemic has significantly increased economic and demand uncertainty and has led to disruption and volatility in the global credit and financial markets, which increases the cost of capital and adversely impacts access to capital for both the Company and our customers and suppliers. Disruption and volatility in the global and financial

34

markets or other factors may also cause adverse fluctuations in foreign currency exchange rates, particularly an increase in the value of the U.S. dollar against the Canadian dollar, the Brazilian reais or the U.K. pound sterling, which could negatively affect our business, financial condition and reported results of operations.

The impact of COVID-19 may also exacerbate other risks discussed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, any of which could have a material adverse effect on us. The extent to which the COVID-19 pandemic, or other outbreaks of disease or similar public health threats, materially and adversely impact our business, financial condition and results of operations is highly uncertain and will depend on future developments. Such developments may include the geographic spread and duration of the virus, the severity of the disease and the actions that may be taken by various governmental authorities and other third parties in response to the outbreak. In addition, how quickly, and to what extent, normal economic and operating conditions can resume cannot be predicted, and the resumption of normal business operations may be delayed or constrained by lingering effects on our suppliers, third-party service providers and customers.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

(a)    None.

(b)    None.

(c)     Issuer Purchases of Equity Securities

The Company withheld 1,479 shares with a fair value of $0.1 million related to the vesting of RSUs during the first three months of 2020. The fair value of the shares were valued at the closing price at the vesting date and represent the employee tax withholding for the employee’s compensation. These shares are not considered common stock repurchases under the Company’s equity compensation plans.

Item 3.    Defaults Upon Senior Securities

None.

Item 4.    Mine Safety Disclosures

Information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this Quarterly Report on Form 10-Q.

Item 5.    Other Information

None.

35

Item 6.    Exhibits

Exhibit No.	Exhibit Description
10.1*	Final Release and Waiver of Claims, dated February 24, 2020, between Compass Minerals International, Inc. and Angela Y. Jones.
10.2*	Consulting Agreement, dated February 21, 2020, between Compass Minerals International, Inc. and Angela Y. Jones.
31.1*	Section 302 Certifications of Kevin S. Crutchfield, President and Chief Executive Officer.
31.2*	Section 302 Certifications of James D. Standen, Chief Financial Officer.
32**	Certification Pursuant to 18 U.S.C. §1350 of Kevin S. Crutchfield, President and Chief Executive Officer, and James D. Standen, Chief Financial Officer.
95*	Mine Safety Disclosures.
101**	The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive (Loss) Income, (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) the Notes to the Consolidated Financial Statements.
104	Cover Page Interactive Data File (contained in Exhibit 101).
*    Filed herewith
**    Furnished herewith

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	COMPASS MINERALS INTERNATIONAL, INC.
Date: May 6, 2020	By:	/s/ James D. Standen
		James D. Standen
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

37

EX-10.1

Exhibit 10.1

Final Release and Waiver of Claims

This Final Release and Waiver of Claims (the “Agreement”) is by and between Compass Minerals International, Inc. (the “Company”) and Angela Y. Jones (“You” or “Your”) (collectively, the “Parties”).

Whereas, You worked for the Company as Chief People Officer in Overland Park, Kansas; and

Whereas, the Company and You have agreed to conclude Your employment with the Company on the terms set forth herein as of February 19, 2020 (the “Termination Date”).

Now, therefore, the Parties agree as follows:

1.    Company Consideration. In exchange for the consideration You are providing under this Agreement, the Company (provided You timely sign and do not revoke this Agreement and this Agreement becomes effective) agrees to:

a.    provide You a lump sum severance payment equal to one (1) times Your annual base salary ($370,000.00) (less applicable deductions and withholdings), within 60 days after the Termination Date.

b.    provide You a lump sum payment of $240,500, representing Your annual cash bonus relating to 2020 (less applicable withholdings and deductions), within 60 days after the Termination Date.

c.    provide You a lump sum payment of $206,503, representing Your annual cash bonus relating to 2019 (less applicable withholdings and deductions), within 60 days after the Termination Date.

d.    pay the premiums due ($12,846.00 in aggregate) under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) to continue coverage under the Company’s health, vision and dental plans in effect as of the Termination Date, for You and Your dependents, if any, for 18 months immediately following the Termination Date, directly to the insurer/COBRA administrator on Your behalf; provided You and Your dependents, if any, were enrolled in such plans prior to the Termination Date and further provided You timely enroll for COBRA benefits.

e.    provide You a lump sum payment equal to the value of 7,247 shares of the Company’s stock underlying the restrictive stock units (“RSUs”) granted to You and that would have vested pro rata pursuant to Section 4(c)(i)(A) of the Company’s Executive Severance Plan effective as of January 1, 2019 (the “Severance Plan”), calculated based on the closing market price on the Termination Date, granted in exchange for cancelling such vested RSUs, to be paid in a lump sum payment (less applicable withholdings and deductions), within 60 days after the Termination Date.

f.    provide You with outplacement assistance through Lee Hecht Harrison; provided activation occurs by April 1, 2020.

g.    enter into the Consulting Agreement, attached to this Agreement as Exhibit A, entered into contemporaneously hereto.

2.    Your Consideration and Release. In exchange for the consideration the Company is providing under this Agreement, You agree as follows:

a.    You release and waive, to the maximum extent permitted by law, and without exception, any and all known, unknown, suspected, or unsuspected claims, demands, or causes of action (collectively, “claims”), arising at any time in the past up to and including the date You execute this Agreement, that You have or could have against the Company, as well as its past, present and future parents, subsidiaries, affiliates and all other related entities; its and their predecessors, successors and assigns; the past, present and future officers, directors, shareholders, trustees, members, employees, attorneys and agents of any of the previously listed entities; any benefits plan maintained by any of the previously listed entities at any time; and the past, present and future sponsors, insurers, trustees, fiduciaries and administrators of such benefit plans (collectively, “Affiliates”). The claims You release and waive include but are not limited to:

(1)    claims related to Your employment and the termination of Your employment with the Company or its Affiliates.

(2)    claims under any federal, state, or local constitution, statute, regulation, ordinance, or other legislative or administrative enactment (as amended), including but not limited to:

• The Age Discrimination in Employment Act, The Older Workers Benefit Protection Act, Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 1981-1988, the Civil Rights Act of 1991, the Equal Pay Act, the Pregnancy Discrimination Act, the Americans with Disabilities Act, the Rehabilitation Act, and the Genetic Information Nondiscrimination Act.

• the Employee Retirement Income Security Act (except for any vested benefits under any tax qualified benefit plan).

• the Family and Medical Leave Act.

• the Fair Labor Standards Act.

• the Sarbanes-Oxley Act.

• the Occupational Safety and Health Act.

• the Immigration Reform and Control Act.

• the Worker Adjustment and Retraining Notification Act.

• the Fair Credit Reporting Act.

• the Consolidated Omnibus Budget Reconciliation Act (COBRA).

• the National Labor Relations Act.

• the Kansas Act Against Discrimination.

• the Kansas Age Discrimination in Employment Act.

• the Kansas Service Letter Statute.

• the Kansas Workers’ Compensation Act.

• Kansas state wage payment and work hour laws.

(3)    claims for, based on, or related to discrimination, harassment, or retaliation; retaliation for exercising any right or participating or engaging in any protected activity; fraud or misrepresentation; violation of any public policy; workers’ compensation; the payment of compensation, benefits, sick leave, paid time off, or vacation; any bonus, health, stock option, retirement, or benefit plan; tort; contract; and common law.

(4)    claims to recover costs, fees, or other expenses, including attorneys’ fees, incurred in any matter.

- 2 -

Note 1: You are not releasing any claims that You cannot release or waive by law, including but not limited to the right to file a charge with, or participate in an investigation conducted by, any appropriate federal, state or local government agency. Further, nothing in this Agreement should be construed to prohibit You from such filings or participation. You are, however, releasing and waiving Your right, and the right of anyone claiming on Your behalf, to any monetary recovery should any government agency (such as the Equal Employment Opportunity Commission (“EEOC”), National Labor Relations Board (“NLRB”), Occupational Safety and Health Administration (“OSHA”), Securities and Exchange Commission (“SEC”) or Department of Labor (“DOL”)) pursue any claims on Your behalf. Notwithstanding this Note 1, nothing contained in this Agreement shall impede Your ability to report possible federal securities violations to the SEC and other governmental agencies (i) without the Company’s approval and (ii) without having to forfeit or forego any resulting whistleblower awards.

Note 2: You warrant and represent that (1) You have been paid all compensation due and owing through the Effective Date, including minimum wage, overtime, commissions, and bonuses; (2) You have not suffered any workplace injury or illness; (3) You are not aware of any illegal or fraudulent conduct by or on behalf of the Company or its Affiliates; (4) You have not been denied any requested time off or leave of absence or experienced any retaliation for requesting time off or a leave of absence; and (5) You are not aware of any facts that would substantiate a claim that the Company, or any of its Affiliates, has violated Your rights or the rights of any other employee in any way or with regard to any law, including but not limited to the claims You released and waived in this Agreement.

Note 3: Nothing in this Section 2 is intended to limit or restrict Your right to enforce this Agreement.

b.    You shall reasonably cooperate with the Company and its Affiliates in any ongoing or future investigation or litigation as requested by the Company. The Company shall reimburse You for reasonable and necessary expenses associated with Your cooperation. This requirement does not limit Your right to file a charge with, or participate in, an investigation conducted by any appropriate federal, state or local government agency (such as the EEOC, NLRB, SEC, DOL or OSHA), nor does it require You to provide anything other than truthful information in good faith to the best of Your ability.

c.    You will not disparage in any way, or make negative comments of any sort, about the Company or its Affiliates, their employees, customers, or vendors, whether orally or in writing, and whether to a third party or to an employee of the Company or its Affiliates. The Company agrees to instruct its current executive officers (as listed in the annual report on Form 10-K to be filed with the SEC on or about February 26, 2020) to not disparage You in any way or make negative comments of any sort about You. This prohibition does not limit Your right to file a charge with, or participate in, an investigation conducted by any appropriate federal, state or local government agency (such as the EEOC, NLRB, SEC, DOL or OSHA), nor does it require You to provide anything other than truthful information in good faith to the best of Your ability.

d.    You agree that You will not, on Your own behalf or on behalf of any other person, file or initiate any civil complaint or suit against the Company or its Affiliates in any forum for any claims waived or released by this Agreement. If You violate this provision by filing such complaint or civil suit, and such filing is found to be a violation, the Company shall be entitled to recover and You

- 3 -

shall be liable for the Company’s reasonable attorneys’ fees, expenses and costs of defending such litigation.

e.    You agree that, as of the Termination Date, You resign any officer or director positions at the Company and any subsidiaries of the Company, effective as of the Termination Date.

3.    Business Records and Your Continuing Obligations. You represent that You have returned to the Company any and all property belonging to the Company, including but not limited to business records and documents relating to any activity of the Company or its Affiliates, files, records, documents, plans, drawings, specifications, equipment, software, pictures, and videotapes, whether prepared by You or not and whether in written or electronic form.

4.    Confidentiality and Restrictive Covenant Agreements.

a.    You understand that You remain bound by the Confidentiality and Assignment of Invention Agreement and Restrictive Covenant Agreement signed by You on December 11, 2017, and any other confidentiality, non-competition or non-solicitation agreements You signed during Your employment with the Company, which remain in full force and effect pursuant to their terms. You agree that the consideration provided to You under this Agreement shall serve as additional consideration for the continuing requirements and restrictions contained in such agreements.

b.    You further understand and agree that the terms of this Agreement, and the circumstances and/or discussions leading to this Agreement, are confidential and that You will not disclose such terms or communicate the contents of this Agreement to any third-party, other than to Your immediate family members, attorneys, or accountants (provided that any such party to whom You disclose such information makes a promise, for the benefit of the Company, to keep such information confidential). Nothing in this Agreement shall preclude You from disclosing such information to any governmental taxing authorities or as otherwise required by law.

Note: Notwithstanding any other provision of this Agreement, or any other agreement, You will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; or (2) in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If You file a lawsuit for retaliation by the Company for reporting a suspected violation of law, You may disclose the Company’s trade secrets to Your attorney and use the trade secret information in a court proceeding so long as You (1) file any document containing the trade secret under seal and (2) do not disclose the trade secret, except pursuant to court order.

5.    Your Further Agreements and Acknowledgements. You further agree or acknowledge:

a.    You have carefully read and fully understand all of the provisions of this Agreement, which is written in a manner You clearly understand.

b.    You are entering into this Agreement knowingly, voluntarily, and with full knowledge of its significance, and have not been coerced, threatened, or intimidated into signing this Agreement.

c.    You received a copy of this Agreement to review on the Termination Date.

- 4 -

d.    You have 21 days from the Termination Date to consider whether to accept this Agreement (although You may sign it at any time prior to the expiration of such 21-day review period, if You wish, in Your sole discretion). You may accept this Agreement by signing and returning the signed copy so that it is received bythe Company (c/o Mary L. Frontczak at the Company’s corporate headquarters located at 9900 W. 109th Street, Suite 100, Overland Park, Kansas 66210) via hand-delivery, certified mail, overnight express mail or e-mail (legal@compassminerals.com) within the 21-day period following receipt of this Agreement.

e.    that further revisions or changes to this Agreement, whether material or immaterial, do not restart the running of the 21-day review period.

f.    the Company advises You to consult with independent legal counsel regarding this Agreement.

g.    the Company advises You to consult with an independent financial advisor regarding the tax treatment of any payments or benefits under this Agreement.

h.    You may revoke this Agreement within 7 calendar days after You sign it by providing written revocation, during that time, to the Company (c/o Mary L. Frontczak at the Company’s corporate headquarters located at 9900 W. 109th Street, Suite 100, Overland Park, Kansas 66210) via hand-delivery, certified mail, overnight express mail or e-mail (legal@compassminerals.com) within the 7-day revocation period.

i.    this Agreement shall be effective and enforceable on the 8^th calendar day following the date You execute it, provided You do not earlier revoke it (the “Effective Date”).

j.     the consideration the Company has provided in this Agreement exceeds anything to which You are entitled in connection with Your employment or Your departure from the Company, including under Section 4 of the Severance Plan. You agree that You are not entitled for any reason, or under any other agreement with the Company or its Affiliates, including the Severance Plan, to receive any consideration other than, or in addition to, that which You are receiving under this Agreement.

k.    neither the Company nor its Affiliates has made any representations or warranties to You regarding this Agreement, including the tax treatment of any payments or benefits under this Agreement, and neither the Company nor its Affiliates shall be liable for any taxes, interest, penalties, or other amounts owed by You.

l.    You hereby represent to the Company that You are not a Medicare beneficiary, and no conditional payments have been made by Medicare to or on behalf of You, as of the date You executed this Agreement. You agree to indemnify, defend, and hold harmless the Company and its Affiliates from any Medicare-related claims, including but not limited to any liens, conditional payments, rights to payment, multiple damages, or attorneys’ fees.

6.    The Parties’ Additional Agreements and Acknowledgments. The Parties further agree and acknowledge:

a.    neither the existence of this Agreement nor anything in this Agreement shall constitute an admission of any liability on the part of You, the Company, or any of the Company’s Affiliates, the existence of which liability the Parties expressly deny.

- 5 -

b.    except as provided herein, this Agreement contains the entire agreement between You and the Company with respect to the matters contemplated hereby, and no modification or waiver of any provision of this Agreement will be valid unless in writing and signed by You and the Company.

c.    this Agreement shall be construed in accordance with the laws of the State of Kansas, the federal and state courts of which shall have exclusive jurisdiction over all actions related to this Agreement.

d.    this Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which shall constitute together one and the same Agreement, and a signed copy of this Agreement delivered by facsimile, pdf, e-mail or other means of electronic transmission is deemed to have the same legal effect as delivery of an original.

e.    neither of the Parties is relying on any representation not contained herein; the Parties shall be considered joint authors in the event of any dispute concerning this Agreement, and no provision shall be interpreted against any of the Parties because of alleged authorship; this Agreement shall not be strictly construed by or against You, the Company, or any of the Company’s Affiliates; and the Parties’ intent is that this Agreement shall be interpreted as reasonable and so as to enforce the Parties’ intent and to preserve this Agreement’s purpose.

f.    this Agreement is binding on, and inures to the benefit of, the Company’s successors and assigns and Your heirs, agents, executors, successors and assigns.

g.    that the Company may assign this Agreement, including but not limited to Your releases and waivers, Your additional agreements or prohibitions, and any other confidentiality or restrictive covenant obligations or agreements signed by You, including those referenced in Section 4(a).

[The remainder of this page is intentionally blank]

- 6 -

SIGNATURE PAGE

I have fully and carefully read and considered this Agreement and acknowledge that I understand it. I am signing this Agreement voluntarily with full knowledge I am waiving my legal rights and that I will be bound by all agreements, representations, and acknowledgments set forth herein:

Date:	February 21, 2020		/s/ Angela Y. Jones
			Angela Y. Jones
			COMPASS MINERALS INTERNATIONAL, INC.
Date:	2/24/2020	By:	/s/ Kevin Crutchfield
		Name:	Kevin Crutchfield
		Title:	CEO

- 7 -

EX-10.2

Exhibit 10.2

Consulting Agreement

This Consulting Agreement (this “Agreement”) is entered into as of 21 February, 2020 (the “Effective Date”) by and between Angela Y. Jones (“Consultant”) and Compass Minerals International, Inc., a Delaware corporation (the “Company”) (collectively, the “Parties”).

WHEREAS, Consultant served as the Company’s Chief People Officer until February 19, 2020;

WHEREAS, contemporaneously herewith Consultant and the Company have agreed to that certain Final Release and Waiver of Claims (the “Release”);

WHEREAS, the Company desires to continue to benefit from the expertise and experience of Consultant following her termination of employment; and

WHEREAS, the Company desires to retain Consultant as a consultant of the Company, and Consultant desires to be so retained by the Company, on the terms and subject to the conditions more fully set forth in this Agreement.

Now, Therefore, in consideration of the mutual promises and conditions contained herein, the Parties agree as follows:

1.Consulting Services. In consideration for the Company’s agreement to the terms set forth in the Release, and provided Consultant timely signs, and does not revoke, the Release as provided therein, the Company agrees to retain Consultant effective as of the Effective Date to render such consulting and advisory services (the “Consulting Services”), as the Company may reasonably request from time to time, which Consulting Services shall include providing consultation with respect to human resources and related matters. Consultant shall provide the Consulting Services solely at the request of and pursuant to the direction of the Company’s Chief Executive Officer, Chief Financial Officer, Chief Legal Officer, head of Human Resources, any Vice President in the Company’s Human Resources function or any individual serving in similar functional roles (the “Designated Individuals”). The period in which Consultant shall be available to provide such Consulting Services shall begin on the Effective Date and end on the earlier of December 31, 2020 or the date the Consulting Services are terminated pursuant to this Agreement (the “Consulting Period”). The Consulting Services will require no more than fifteen (15) hours per week, and no more than forty (40) hours per month, of Consultant’s time. Consultant hereby accepts such engagement and agrees to perform such Consulting Services for the Company upon the terms and conditions set forth in this Agreement. Consultant shall perform the Consulting Services only at mutually agreeable times and at a mutually agreeable location, which such agreement shall not be unreasonably withheld. Consultant may accept engagements by or employment with one or more third parties during the Consulting Period, provided Consultant continues to provide the Consulting Services pursuant to the terms of this Agreement and honors all covenants set forth in this Agreement and the Parties’ Confidentiality and Assignment of Invention Agreement and Restrictive Covenant Agreement.

2.Compensation. As compensation for the Consulting Services to be rendered by Consultant and Consultant’s commitments hereunder, the Company shall pay Consultant the total fee of $250,000, payable in substantially equal installments each month of the Consulting Period (the “Monthly Consulting Fee”). The Company will report all compensation paid to Consultant under this Agreement on IRS Form 1099, to the extent required to do so under the Internal Revenue Code. All amounts paid to Consultant under this Agreement shall constitute income from self-employment, and Consultant will be solely responsible for paying any and all federal, state, and local taxes (including FUTA and FICA) on compensation received under this Agreement. Consultant will indemnify the Company for, and hold it harmless from, any and all liability arising from any failure to withhold or pay such taxes and/or Consultant’s tax treatment under this Agreement. Consultant must complete and submit a Form W-9 to the Company before any compensation under this Agreement will be issued. Upon the termination of the Consulting Period for any reason, all future payments pursuant to this Agreement will cease; provided, however, in the event the Consulting Period is terminated by the Company without Cause or by Consultant for Good Reason pursuant to Section 5, the Company’s obligation to pay the Monthly Consulting Fee as provided in this Section 2 shall continue through December 31, 2020. For the avoidance of doubt, if Consultant does not timely execute, or if Consultant revokes, the Release as provided therein, this Agreement shall be null and void, and the Company shall not be obligated to pay any Monthly Consulting Fees or any other remuneration to Consultant under this Agreement.

3.Expenses. Consultant shall be entitled to receive reimbursement for all reasonable expenses, including travel expenses, incurred by Consultant at the request of the Company in connection with the performance of the Consulting Services within thirty (30) calendar days following submission of evidence of such expense by Consultant to the Company in accordance with the policies, practices and procedures of the Company as applied to its executive officers.

4.Independent Contractor Status. Consultant and the Company intend and agree that Consultant shall perform the Consulting Services as an independent contractor and not as an employee of the Company. The manner of and means by which Consultant executes and performs her obligations hereunder are to be determined by Consultant in her reasonable discretion. Consultant is not authorized to and shall not assume or create any obligation or responsibility, express or implied, on behalf of, or in the name of the Company or to bind the Company in any manner. Consultant agrees that she will not describe or hold herself out as an employee or agent of the Company. Consultant shall not be entitled to participate in or receive any benefits under any Company programs maintained for its employees. Should Consultant be deemed to have any rights of participation in any such programs, by signing below, Consultant hereby waives such rights freely, knowingly, and voluntarily. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, or fiduciary relationship between the Parties.

5.Termination of Consulting Arrangement. The consulting arrangement created by Section 2 of this Agreement between the Company and Consultant and the Consulting Period may be terminated only (a) by a mutual written agreement of the Company and Consultant, (b) by the Company for Cause (as defined below), or (c) by Consultant for Good Reason. “Good Reason” means the Company’s failure to pay within the fourteen (14) calendar day period following the date any Monthly Consulting Fee payment is due (as specified in Section 2), provided, that such failure is not cured within fourteen (14) calendar days of receipt by the Company of written notice of the failure to be provided by Consultant no earlier than the 11th day following the date such payment was originally due. “Cause” means (i) Consultant’s willful failure or refusal to perform in all material respects Consultant’s duties or to carry out in all material respects the reasonable and lawful directives of the Company or any Designated Individuals pursuant to this Agreement which remains uncorrected fourteen (14) calendar days after receipt of written notice of such failure or refusal, or (ii) any other material breach by Consultant of the terms of this Agreement after receipt of written notice of such breach that remains uncorrected fourteen (14) calendar days after Consultant receives written notice of such breach. For avoidance of doubt, Consultant’s refusal to perform Consulting Services that Consultant reasonably believes are unlawful or incriminating to Consultant shall not be deemed failure or refusal to perform.

6.Confidentiality and Non-Disparagement. The Parties agree that the confidentiality and non-disparagement clauses and all other covenants contained in the Release shall continue in full force and effect pursuant to their terms, both during and after the Consulting Period.

7.Notices. Any notice or other communication required or permitted hereunder shall be in writing and either personally delivered, sent by a reputable overnight carrier with signature required, or transmitted by email, addressed as follows:

If to Consultant:	If to the Company:
Angela Y. Jones	Compass Minerals International, Inc.
(last known personal address and email)	9900 West 109th Street, Suite 100
	Overland Park, KS 66210
	Attention: Chief Legal Officer
	Email: legal@compassminerals.com

2

8. Miscellaneous.

a.Entire Agreement. Together with the Release, the Confidentiality and Assignment of Invention Agreement, and the Restrictive Covenant Agreement, this Agreement constitutes the entire agreement of the Parties and there are no other promises or conditions in any other agreement whether oral or written. This Agreement supersedes and cancels any prior written or oral agreements between the Parties in respect of the subject matter of this Agreement.

b.Amendment. This Agreement may be modified or amended if the amendment is made in writing and is signed by authorized representatives of both Parties.

c.Severability. If any provision of this Agreement shall be held to be invalid or unenforceable for any reason, the remaining provisions shall continue to be valid and enforceable. If a court finds that any provision of this Agreement is invalid or unenforceable, but that by limiting such provision it would become valid and enforceable, then such provision shall be deemed to be written, construed, and enforced as so limited.

d.Waiver of Contractual Right. The failure of either Party to enforce any provision of this Agreement shall not be construed as a waiver or limitation of that Party's right to subsequently enforce and compel strict compliance with every provision of this Agreement.

e.Applicable Law. This Agreement shall be governed by the laws of the state of Kansas, without regard to principles of conflicts of laws. The Parties consent and submit to the exclusive jurisdiction of the federal and state courts of Johnson County, Kansas for any matters arising out of this Agreement or the relationship between them.

f.Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. In the event that any signature is delivered by electronic transmission, such signature page may serve as an original.

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first set forth above to be effective as of the Effective Date.

Company:		Consultant:
COMPASS MINERALS INTERNATIONAL, INC.
By:	/s/ Kevin Crutchfield	/s/ Angela Y. Jones
	Kevin Crutchfield	By: Angela Y. Jones
	President and CEO

3

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Kevin S. Crutchfield, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Compass Minerals International, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2020	By:	/s/ Kevin S. Crutchfield
		Kevin S. Crutchfield
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, James D. Standen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Compass Minerals International, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2020	By:	/s/ James D. Standen
		James D. Standen
		Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. §1350

Each of the undersigned hereby certifies that this quarterly report on Form 10-Q for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof, based on my knowledge, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Compass Minerals International, Inc.

Date: May 6, 2020	By:	/s/ Kevin S. Crutchfield
		Kevin S. Crutchfield
		President and Chief Executive Officer
	By:	/s/ James D. Standen
		James D. Standen
		Chief Financial Officer

EX-95

Exhibit 95

Mine Safety Disclosure

We understand that to prevent employee and contractor injuries, we must approach safety excellence from many directions at once. We have developed a three-pronged approach towards world class safety performance. This approach consists of (1) setting a high standard of risk mitigation, (2) having robust safety management systems, and (3) supporting a culture of full engagement and personal accountability at all levels of the organization.

We continuously monitor our safety performance by assessing injury and non-injury incidents (e.g., near misses/near hits) as well as key performance indicators. We believe our approach to safety excellence will help us deliver on our commitment to our employees, contractors, their families and our customers to provide a safe working environment.

Mine Safety Data

A subsidiary of Compass Minerals International, Inc. owns and operates the Cote Blanche mine, an underground salt mine located in St. Mary Parish, Louisiana. The Cote Blanche mine is subject to regulation by the Mine Safety and Health Administration (“MSHA”) under the Federal Mine Safety and Health Act of 1977, as amended (the “Mine Act”).

MSHA is required to regularly inspect the Cote Blanche mine and issue a citation, or take other enforcement action, if an inspector or authorized representative believes that a violation of the Mine Act or MSHA’s standards or regulations has occurred. MSHA is required to propose a civil penalty for each alleged violation that it cites.

We have the option to contest any enforcement action or related penalty we receive before the Federal Mine Safety and Health Review Commission. As a result of this process, an enforcement action may be modified or vacated and any civil penalty proposed by MSHA for an alleged violation may be increased, reduced or eliminated. However, under the Mine Act, we are required to abate (or correct) each alleged violation within a specified time period, regardless of whether we contest the alleged violation.

The table below sets forth information for the reporting period ended March 31, 2020 concerning certain mine safety violations and other regulatory matters pursuant to requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act and Securities and Exchange Commission rules and regulations. The information only reflects our U.S. mining operations, as these requirements do not apply to mining operations outside the U.S.

Mine Name/ Mine I.D. Number	Section 104 S&S Citations & Orders1	Section 104(b) Orders2	Section 104(d) Citations & Orders3	Section 110(b)(2) Violations4	Section 107(a) Orders5	Total Dollar Value of MSHA Proposed Assessments (Actual Amount)	Total Number of Mining Related Fatalities	Received Notice of Pattern of Violations under Section 104(e) (Yes/No)6	Legal Actions Pending as of Last Day of Period	Legal Actions Initiated During Period	Legal Actions Resolved During Period
Cote Blanche Mine/16-00358	6	0	2	0	0	$12,824	0	No	0	0	0

1 Represents the number of citations and orders issued under section 104 of the Mine Act for alleged violations of mandatory health or safety standards that could significantly and substantially contribute to a mine health and safety hazard. The number reported includes no orders alleging an S&S violation issued under Section 104(g) of the Mine Act.

2 Represents the number of orders issued under section 104(b) of the Mine Act for alleged failures to abate a citation issued under section 104(a) of the Mine Act within the time period specified in the citation.

3 Represents the number of citations and orders issued under section 104(d) of the Mine Act for alleged unwarrantable failures (aggravated conduct constituting more than ordinary negligence) to comply with mandatory safety or health standards.

4 Represents the number of violations issued under section 110(b)(2) of the Mine Act for alleged “flagrant” failures (reckless or repeated failures) to make reasonable efforts to eliminate a known violation of a mandatory safety or health standard that substantially proximately caused, or reasonably could have been expected to cause, death or serious bodily injury.

5 Represents the number of orders issued under section 107(a) of the Mine Act for alleged conditions or practices which could reasonably be expected to cause death or serious physical harm before the condition or practice can be abated.

6 Section 104(e) written notices are issued for an alleged pattern of violating mandatory health or safety standards that could significantly and substantially contribute to a mine safety or health hazard.

2

XML

Derivative Financial Instruments - Fair Value of Hedged Items (Details) $ in Millions	Mar. 31, 2020 USD ($) counterparty	Dec. 31, 2019 USD ($) counterparty
Commodity contracts
Derivatives, Fair Value [Line Items]
Netting of contracts in a receivable position against contracts in payable position	$ 0.3	$ 0.4
Number of counterparties | counterparty	2	2
Swap contracts
Derivatives, Fair Value [Line Items]
Number of counterparties | counterparty	1	2
Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 2.0	$ 3.2
Liability Derivatives	1.0	1.0
Derivatives Designated as Hedging Instruments | Commodity contracts | Other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.3	0.3
Derivatives Designated as Hedging Instruments | Commodity contracts | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	0.9	0.8
Derivatives Designated as Hedging Instruments | Commodity contracts | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0	0.1
Derivatives Designated as Hedging Instruments | Commodity contracts | Other noncurrent liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	0.1	0.2
Derivatives Designated as Hedging Instruments | Swap contracts | Other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	1.7	2.8
Derivatives Designated as Hedging Instruments | Swap contracts | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	$ 0.0	$ 0.0

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Sales	$ 413.9	$ 403.7
Gross profit	87.3	72.6
Selling, general and administrative expenses	43.1	39.4
Operating earnings	44.2	33.2
Other expense (income):
Interest expense	19.0	16.2
Net loss in equity investee	0.1	0.1
(Gain) loss on foreign exchange	(14.3)	5.0
Other, net	0.1	(0.6)
Earnings before income taxes	39.3	12.5
Income tax expense	11.7	4.9
Net earnings	$ 27.6	$ 7.6
Basic net earnings per common share (in dollars per share)	$ 0.80	$ 0.22
Diluted net earnings per common share (in dollars per share)	$ 0.80	$ 0.22
Weighted-average common shares outstanding (in thousands):
Basic (in shares)	33,892	33,874
Diluted (in shares)	33,892	33,874
Shipping and handling cost
Cost	$ 101.8	$ 112.9
Product cost
Cost	$ 224.8	$ 218.2

XML

Stockholders' Equity and Equity Instruments - Stock-Based Compensation Activity (Details)	3 Months Ended
	Mar. 31, 2020 $ / shares shares
Stock Options
Number
Outstanding at beginning of period (in shares)	887,867
Granted (in shares)	94,945
Cancelled/expired (in shares)	(64,666)
Outstanding at end of period (in shares)	918,146
Weighted-average exercise price
Weighted-average exercise price at beginning of period (in dollars per share) | $ / shares	$ 64.21
Weighted-average exercise price, granted (in dollars per share) | $ / shares	58.91
Weighted-average exercise price, cancelled/expired (in dollars per share) | $ / shares	72.67
Weighted-average exercise price at end of period (in dollars per share) | $ / shares	$ 63.07
RSUs
Number
Outstanding at beginning of period (in shares)	217,413
Granted (in shares)	83,337
Released from restriction (in shares)	(4,517)
Cancelled/expired (in shares)	(27,981)
Outstanding at end of period (in shares)	268,252
Weighted-average fair value
Weighted-average fair value at beginning of period (in dollars per share) | $ / shares	$ 52.07
Weighted-average fair value, granted (in dollars per share) | $ / shares	58.92
Weighted-average fair value, released from restriction (in dollars per share) | $ / shares	39.75
Weighted-average fair value, cancelled/expired (in dollars per share) | $ / shares	50.18
Weighted-average fair value at end of period (in dollars per share) | $ / shares	$ 54.61
PSUs
Number
Outstanding at beginning of period (in shares)	179,397
Granted (in shares)	69,635
Cancelled/expired (in shares)	(26,899)
Outstanding at end of period (in shares)	222,133
Weighted-average fair value
Weighted-average fair value at beginning of period (in dollars per share) | $ / shares	$ 61.43
Weighted-average fair value, granted (in dollars per share) | $ / shares	82.38
Weighted-average fair value, cancelled/expired (in dollars per share) | $ / shares	67.55
Weighted-average fair value at end of period (in dollars per share) | $ / shares	$ 67.26
PSU at grant date (in shares per unit)	1

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Cash dividends per share (in dollars per share)	$ 0.72	$ 0.72

XML

Operating Segments

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Operating Segments

Operating Segments:

The Company’s reportable segments are strategic business units that offer different products and services, and each business requires different technology and marketing strategies. The Company has three reportable segments: Salt, Plant Nutrition North America and Plant Nutrition South America. The Salt segment produces and markets salt, consisting of sodium chloride and magnesium chloride, for use in road deicing for winter roadway safety and for dust control, food processing, water softeners and other consumer, agricultural and industrial applications. Plant nutrients, including SOP, secondary nutrients and micronutrients are produced and marketed through the Plant Nutrition North America segment. The Plant Nutrition South America segment operates two primary businesses in Brazil – agricultural productivity and chemical solutions. The agricultural productivity division manufactures and distributes a broad offering of specialty plant nutrition solution-based products that are used in direct soil and foliar applications, as well as through irrigation systems and for seed treatment. The chemical solutions division manufactures and markets specialty chemicals for the industrial chemical industry.

Segment information is as follows (in millions):

Three Months Ended March 31, 2020	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	287.8	$	60.6	$	62.8	$	2.7		$	413.9
Intersegment sales	—		0.3		0.1		(0.4		)	—
Shipping and handling cost	89.8		9.0		3.0		—			101.8
Operating earnings (loss)	56.9		5.2		0.3		(18.2		)	44.2
Depreciation, depletion and amortization	14.6		10.5		5.0		3.0			33.1
Total assets (as of end of period)	956.5		552.3		561.0		41.0			2,110.8

Three Months Ended March 31, 2019	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)			Total
Sales to external customers	$	306.4	$	37.2		$	57.7		$	2.4		$	403.7
Intersegment sales	—		0.5			1.5			(2.0		)	—
Shipping and handling cost	103.7		6.0			3.2			—			112.9
Operating earnings (loss)	52.3		(1.6		)	(2.6		)	(14.9		)	33.2
Depreciation, depletion and amortization	15.3		11.6			5.6			2.5			35.0
Total assets (as of end of period)	889.7		594.1			710.6			114.2			2,308.6

Disaggregated revenue by product type is as follows (in millions):

Three Months Ended March 31, 2020	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)		Total
Highway Deicing Salt	$	215.1	$	—		$	—		$	—	$	215.1
Consumer & Industrial Salt	72.7		—			—			—		72.7
SOP and Specialty Plant Nutrients	—		60.9			41.1			—		102.0
Industrial Chemicals	—		—			21.8			—		21.8
Eliminations & Other	—		(0.3		)	(0.1		)	2.7		2.3
Sales to external customers	$	287.8	$	60.6		$	62.8		$	2.7	$	413.9

Three Months Ended March 31, 2019	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)		Total
Highway Deicing Salt	$	218.7	$	—		$	—		$	—	$	218.7
Consumer & Industrial Salt	87.7		—			—			—		87.7
SOP and Specialty Plant Nutrients	—		37.7			36.6			—		74.3
Industrial Chemicals	—		—			22.6			—		22.6
Eliminations & Other	—		(0.5		)	(1.5		)	2.4		0.4
Sales to external customers	$	306.4	$	37.2		$	57.7		$	2.4	$	403.7

(a) Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.

The Company’s revenue by geographic area is as follows (in millions):

	Three Months Ended March 31,
Revenue	2020		2019
United States(a)	$	257.9	$	238.3
Canada	77.4		87.4
Brazil	62.1		55.7
United Kingdom	11.8		17.3
Other	4.7		5.0
Total revenue	$	413.9	$	403.7

(a)

United States sales exclude product sold to foreign customers at U.S. ports.

XML

Goodwill and Intangible Assets, Net

3 Months Ended

Mar. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

Goodwill and Intangible Assets, Net:

Amounts related to the Company’s amortization of intangible assets are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Aggregate amortization expense	$	3.2	$	3.6

Amounts related to the Company’s goodwill are as follows (in millions):

	March 31, 2020		December 31, 2019
Goodwill - Plant Nutrition North America Segment	$	50.5	$	55.4
Goodwill - Plant Nutrition South America Segment	218.4		281.6
Other	5.8		6.0
Total	$	274.7	$	343.0

The change in goodwill between December 31, 2019 and March 31, 2020 was due to the impact from translating foreign-denominated amounts to U.S. dollars.

XML

Revenue Recognition

3 Months Ended

Mar. 31, 2020

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition:

Nature of Products and Services

The Company’s Salt segment products include salt and magnesium chloride for use in road deicing and dust control, food processing, water softeners, and agricultural and industrial applications. The Company’s plant nutrition products include SOP, secondary nutrients, micronutrients and chemicals for the industrial chemical industry. In the U.K., the Company operates a records management business utilizing excavated areas of the Winsford salt mine with one other location in London, England.

Identifying the Contract

The Company accounts for a customer contract when there is approval and commitment from both parties, the rights of the parties and payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

Identifying the Performance Obligations

At contract inception, the Company assesses the goods and services it has promised to its customers and identifies a performance obligation for each promise to transfer to the customer a distinct good or service (or bundle of goods or services). Determining whether products and services are considered distinct performance obligations that should be accounted for separately or aggregated together may require significant judgment.

Identifying and Allocating the Transaction Price

The Company’s revenues are measured based on consideration specified in the customer contract, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. In certain cases, the Company’s customer contracts may include promises to transfer multiple products and services to a customer. For multiple-element arrangements, the Company generally allocates the transaction price to each performance obligation in proportion to its stand-alone selling price.

When Performance Obligations Are Satisfied

The vast majority of the Company’s revenues are recognized at a point in time when the performance obligations are satisfied based upon transfer of control of the product or service to a customer. To determine when the control of goods is transferred, the Company typically assesses, among other things, the shipping terms of the contract, as shipping is an indicator of transfer of control. Some of the Company’s products are sold when the control of the goods transfers to the customer at the time of shipment. There are also instances when the Company provides shipping services to deliver its products. Shipping and handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs. The Company recognizes shipping and handling costs that are incurred after the customer obtains control of the goods as fulfillment costs which are accrued at the time of revenue recognition.

Significant Payment Terms

The customer contract states the final terms of the sale, including the description, quantity and price of each product or service purchased. Payment is typically due in full within 30 days of delivery. The Company does not adjust the consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the good or service is transferred to the customer and when the customer pays for that good or service will be one year or less.

Refunds, Returns and Warranties

The Company’s products are generally not sold with a right of return and the Company does not generally provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized. The Company uses historical experience to estimate accruals for refunds due to manufacturing or other defects.

See Note 10 for disaggregation of revenue by segment, type and geographical region.

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Fair Value of Hedges

The following tables present the fair value of the Company’s hedged items as of March 31, 2020 and December 31, 2019 (in millions):

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Consolidated Balance Sheets Location	March 31, 2020		Consolidated Balance Sheets Location	March 31, 2020
Commodity contracts	Other current assets	$	0.3	Accrued expenses and other current liabilities	$	0.9
Commodity contracts	Other assets	—		Other noncurrent liabilities	0.1
Swap contracts	Other current assets	1.7		Accrued expenses and other current liabilities	—
Total derivatives designated as hedging instruments(a)(b)		$	2.0		$	1.0

(a) The Company has master netting agreements with both of its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets $0.3 million of its commodity contracts that are in a receivable position against its contracts in payable positions.

(b) The Company has commodity hedge agreements with two counterparties and a foreign currency swap agreement with one counterparty. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from one counterparty. 

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Consolidated Balance Sheets Location	December 31, 2019		Consolidated Balance Sheets Location	December 31, 2019
Commodity contracts	Other current assets	$	0.3	Accrued expenses and other current liabilities	$	0.8
Commodity contracts	Other assets	0.1		Other noncurrent liabilities	0.2
Swap contracts	Other current assets	2.8		Accrued expenses and other current liabilities	—
Total derivatives designated as hedging instruments(a)(b)		$	3.2		$	1.0

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets $0.4 million of its commodity contracts that are in a receivable position against its contracts in payable positions.

(b)

The Company has both commodity hedge and foreign currency swap agreements with two counterparties each. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties, and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from both counterparties. 

XML

Revenue Recognition (Details)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Payment terms	30 days

XML

Property, Plant and Equipment, Net (Tables)

3 Months Ended

Mar. 31, 2020

Property, Plant and Equipment [Abstract]

Summary of Property, Plant and Equipment, Net

Property, plant and equipment, net, consists of the following (in millions):

	March 31, 2020			December 31, 2019
Land, buildings and structures, and leasehold improvements	$	578.3		$	596.0
Machinery and equipment	974.8			1,001.9
Office furniture and equipment	62.4			60.7
Mineral interests	165.9			171.1
Construction in progress	136.2			141.3
	1,917.6			1,971.0
Less accumulated depreciation and depletion	(963.8		)	(940.2		)
Property, plant and equipment, net	$	953.8		$	1,030.8

XML

Earnings per Share

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share:

The Company calculates earnings per share using the two-class method. The two-class method requires allocating the Company’s net earnings to both common shares and participating securities. The following table sets forth the computation of basic and diluted earnings per common share (in millions, except for share and per-share data):

	Three Months Ended March 31,
	2020			2019
Numerator:
Net earnings	$	27.6		$	7.6
Less: net earnings allocated to participating securities(a)	(0.5		)	(0.2		)
Net earnings available to common shareholders	$	27.1		$	7.4
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share	33,892			33,874
Weighted-average awards outstanding(b)	—			—
Shares for diluted earnings per share	33,892			33,874
Net earnings per common share, basic	$	0.80		$	0.22
Net earnings per common share, diluted	$	0.80		$	0.22

(a) Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 412,000 and 233,000 weighted participating securities for the three months ended March 31, 2020 and 2019, respectively.

(b)

For the calculation of diluted net earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had 1,266,000 and 788,000 weighted-average equity awards outstanding for the three months ended March 31, 2020 and 2019, respectively.

XML

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$ 4.5	$ 4.9
Operating cash flows from finance leases	0.1	0.2
Financing cash flows from finance leases	0.5	0.3
Leased assets obtained in exchange for new operating lease liabilities	1.0	2.4
Leased assets obtained in exchange for new finance lease liabilities	$ 1.2	$ 0.0

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Jun. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2020
Income Tax Disclosure [Line Items]
Increase to tax expense from settlement			$ 5.3
Sales increase				$ 106.1	$ 85.7
Tax Year 2007 Through 2016
Income Tax Disclosure [Line Items]
Intercompany cash payments for tax settlements				85.7
Tax Year 2013 Through 2021
Income Tax Disclosure [Line Items]
Intercompany cash payments for tax settlements		$ 106.1
Tax refund received	$ 55.0
Foreign Tax Authority
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	14.8		18.8
Foreign Tax Authority | NOL carryforwards expire beginning in 2033
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	1.2		1.7
Foreign Tax Authority | NOL carryforwards expire beginning in 2027
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	0.2		0.3
Foreign Tax Authority | Tax Year 2007 Through 2016
Income Tax Disclosure [Line Items]
Payments for income tax settlements				$ 17.5
Foreign Tax Authority | Tax Year 2013 Through 2021
Income Tax Disclosure [Line Items]
Payments for income tax settlements		$ 29.9
Foreign Tax Authority | Tax Year 2013 Through 2021 | Scenario, Forecast
Income Tax Disclosure [Line Items]
Tax liability (refund) from settlement						$ (1.3)
Foreign Tax Authority | Canadian Tax Authority
Income Tax Disclosure [Line Items]
Total reassessments including interest	120.4
Amount of security posted in the form of a performance bond	89.6
Amount of security posted in the form of cash	34.8
Foreign Tax Authority | Canadian Tax Authority | Tax Year 2007 Through 2016
Income Tax Disclosure [Line Items]
Increase to tax expense from settlement					$ 13.8
U.S. Federal | Tax Year 2007 Through 2016
Income Tax Disclosure [Line Items]
Tax refund received			$ 21.4
U.S. Federal | Tax Year 2007 Through 2016 | Scenario, Forecast
Income Tax Disclosure [Line Items]
Tax liability (refund) from settlement						(1.6)
U.S. Federal | Tax Year 2013 Through 2021
Income Tax Disclosure [Line Items]
Tax refund received	$ 59.2
U.S. Federal | Tax Year 2013 Through 2021 | Scenario, Forecast
Income Tax Disclosure [Line Items]
Tax liability (refund) from settlement						$ 2.4

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Summary of Inventories

Inventories consist of the following (in millions):

	March 31, 2020		December 31, 2019
Finished goods	$	185.6	$	235.3
Raw materials and supplies	68.6		76.2
Total inventories	$	254.2	$	311.5

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements:

The Company’s financial instruments are measured and reported at their estimated fair values. Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction. When available, the Company uses quoted prices in active markets to determine the fair values for its financial instruments (Level 1 inputs) or, absent quoted market prices, observable market-corroborated inputs over the term of the financial instruments (Level 2 inputs). The Company does not have any unobservable inputs that are not corroborated by market inputs (Level 3 inputs).

The Company holds marketable securities associated with its defined contribution and pre-tax savings plans, which are valued based on readily available quoted market prices. The Company utilizes derivative instruments to manage its risk of changes in natural gas prices and its risk of changes in foreign currency exchange rates (see Note 12). The fair values of the natural gas and foreign currency derivative instruments are determined using market data of forward prices for all of the Company’s contracts. 

The estimated fair values for each type of instrument are presented below (in millions):

	March 31, 2020			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.3		$	1.3		$	—		$	—
Derivatives – foreign currency contracts, net	1.7			—			1.7			—
Total Assets	$	3.0		$	1.3		$	1.7		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.3	)	$	(1.3	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.7		)	—			(0.7		)	—
Total Liabilities	$	(2.0	)	$	(1.3	)	$	(0.7	)	$	—

(a) Includes mutual fund investments of approximately 30% in common stock of large-cap U.S. companies, 10% in common stock of small to mid-cap U.S. companies, 5% in international companies, 20% in bond funds, 10% in short-term investments and 25% in blended funds.

	December 31, 2019			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.4		$	1.4		$	—		$	—
Derivatives – foreign currency contracts, net	2.8			—			2.8			—
Total Assets	$	4.2		$	1.4		$	2.8		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.4	)	$	(1.4	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.6		)	—			(0.6		)	—
Total Liabilities	$	(2.0	)	$	(1.4	)	$	(0.6	)	$	—

(a) Includes mutual fund investments of approximately 30% in the common stock of large-cap U.S. companies, 15% in the common stock of small to mid-cap U.S. companies, 5% in the common stock of international companies, 10% in bond funds, 20% in short-term investments and 20% in blended funds.

Cash and cash equivalents, accounts receivable (net of allowance for bad debts) and payables are carried at cost, which approximates fair value due to their liquid and short-term nature. The Company’s investments related to its nonqualified savings plan of $1.3 million and $1.4 million at March 31, 2020 and December 31, 2019, respectively, are stated at fair value based on quoted market prices. As of March 31, 2020 and December 31, 2019, the estimated amount a third party would pay for the Company’s fixed-rate 4.875% Senior Notes due July 2024, based on available trading information (Level 2), totaled $235.0 million and $249.1 million, respectively, compared with the aggregate principal amount at maturity of $250.0 million. As of March 31, 2020 and December 31, 2019, the estimated amount a third party would pay for the Company’s fixed-rate 6.75% Senior Notes due December 2027, based on available trading information (Level 2), totaled $451.4 million and $530.6 million, respectively, compared with the aggregate principal amount at maturity of $500.0 million. The estimated amount a third party would pay at March 31, 2020 and December 31, 2019 for the amounts outstanding under the Company’s term loans and revolving credit facility, based upon available bid information received from the Company’s lender (Level 2), totaled $451.3 million and $552.8 million, respectively, compared with the aggregate principal balance of $456.5 million and $560.0 million, respectively. The Brazilian loans have floating rates and their fair value approximates their carrying value.

XML

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 185.6	$ 235.3
Raw materials and supplies	68.6	76.2
Total inventories	$ 254.2	$ 311.5

XML

Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,307.8	$ 1,430.8
Less unamortized debt issuance costs	(14.0)	(14.8)
Total debt	1,293.8	1,416.0
Less current portion	(40.1)	(52.1)
Long-term debt	1,253.7	1,363.9
Term Loan due January 2025
Debt Instrument [Line Items]
Long-term debt, gross	397.5	400.0
6.75% Senior Notes due December 2027
Debt Instrument [Line Items]
Long-term debt, gross	$ 500.0	500.0
Interest rate stated percentage	6.75%
3.7% Banco Itaú loan due March 2020
Debt Instrument [Line Items]
Long-term debt, gross	$ 0.0	15.4
Interest rate stated percentage	3.70%
Banco Santander loan due October 2020
Debt Instrument [Line Items]
Long-term debt, gross	$ 12.5	16.2
Banco Itaú loan due February 2021
Debt Instrument [Line Items]
Long-term debt, gross	9.4	0.0
Banco Rabobank loan due July 2021
Debt Instrument [Line Items]
Long-term debt, gross	13.5	17.4
Banco Santander loan due September 2021
Debt Instrument [Line Items]
Long-term debt, gross	15.4	19.9
Banco do Brasil loan due September 2021
Debt Instrument [Line Items]
Long-term debt, gross	9.6	12.4
Banco Rabobank loan due November 2021
Debt Instrument [Line Items]
Long-term debt, gross	13.5	17.4
Banco Santander loan due December 2021
Debt Instrument [Line Items]
Long-term debt, gross	11.6	14.9
Banco Votorantim loan due February 2022
Debt Instrument [Line Items]
Long-term debt, gross	7.7	0.0
Banco Santander loan due March 2022
Debt Instrument [Line Items]
Long-term debt, gross	2.9	0.0
Financiadora de Estudos e Projetos loan due November 2023
Debt Instrument [Line Items]
Long-term debt, gross	5.2	7.2
Revolving Credit Facility due January 2025 | Revolving Credit Facility due January 2025
Debt Instrument [Line Items]
Long-term debt, gross	59.0	160.0
Senior Notes | 4.875% Senior Notes due July 2024
Debt Instrument [Line Items]
Long-term debt, gross	$ 250.0	$ 250.0
Interest rate stated percentage	4.875%	4.875%
Senior Notes | 6.75% Senior Notes due December 2027
Debt Instrument [Line Items]
Interest rate stated percentage	6.75%

XML

Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator:
Net earnings	$ 27.6	$ 7.6
Less: net earnings allocated to participating securities	(0.5)	(0.2)
Net earnings available to common shareholders	$ 27.1	$ 7.4
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share (in shares)	33,892,000	33,874,000
Weighted-average awards outstanding (in shares)	0	0
Shares for diluted earnings per share (in shares)	33,892,000	33,874,000
Net earnings per common share, basic (in dollars per share)	$ 0.80	$ 0.22
Net earnings per common share, diluted (in dollars per share)	$ 0.80	$ 0.22
Participating securities (in shares)	412,000	233,000
Weighted anti-dilutive awards outstanding (in shares)	1,266,000	788,000

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net earnings	$ 27.6	$ 7.6
Adjustments to reconcile net earnings to net cash flows provided by operating activities:
Depreciation, depletion and amortization	33.1	35.0
Finance fee amortization	0.8	0.7
Stock-based compensation	2.4	1.1
Deferred income taxes	7.5	(0.1)
Net loss in equity investee	0.1	0.1
Unrealized foreign exchange (gain) loss	(18.0)	5.1
Other, net	3.4	1.4
Changes in operating assets and liabilities:
Receivables	87.1	72.0
Inventories	36.6	41.0
Other assets	54.5	17.3
Accounts payable and accrued expenses and other current liabilities	(4.9)	(46.7)
Other liabilities	(1.6)	(6.1)
Net cash provided by operating activities	228.6	128.4
Cash flows from investing activities:
Capital expenditures	(25.3)	(21.5)
Other, net	(0.6)	(0.3)
Net cash used in investing activities	(25.9)	(21.8)
Cash flows from financing activities:
Proceeds from revolving credit facility borrowings	46.2	61.7
Principal payments on revolving credit facility borrowings	(147.2)	(139.6)
Proceeds from issuance of long-term debt	22.0	18.5
Principal payments on long-term debt	(18.7)	(5.5)
Dividends paid	(24.8)	(24.6)
Deferred financing costs	(0.1)	0.0
Shares withheld to satisfy employee tax obligations	(0.1)	(0.2)
Other, net	(0.1)	(0.3)
Net cash used in financing activities	(122.8)	(90.0)
Effect of exchange rate changes on cash and cash equivalents	(4.8)	0.2
Net change in cash and cash equivalents	75.1	16.8
Cash and cash equivalents, beginning of the year	34.7	27.0
Cash and cash equivalents, end of period	109.8	43.8
Supplemental cash flow information:
Interest paid, net of amounts capitalized	11.3	17.3
Income taxes paid, net of refunds	$ (37.7)	$ 10.2

XML

Derivative Financial Instruments - Narrative (Details) MMBTU in Millions, $ in Millions			3 Months Ended
	Mar. 31, 2020 USD ($) MMBTU	Dec. 31, 2019 MMBTU	Mar. 31, 2020 USD ($)
Natural gas instruments
Derivatives, Fair Value [Line Items]
Notional amount (in MMBtus) | MMBTU	2.8	2.8
Net losses to be reclassified from accumulated other comprehensive loss to earnings during the next 12 months	$ (0.6)
Natural gas instruments | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Percent of forecasted usage to be hedged	90.00%		90.00%
Maximum period which the Company hedges in advance of forecasted purchase			36 months
Foreign currency contracts | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional amount	$ 89.9		$ 89.9
Loss on foreign exchange derivative not designated as hedging instruments			5.3
Swap contracts | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount	9.4		9.4
Gain (loss) expected to be reclassified during the next twelve months	$ 1.7		$ 1.7

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net earnings	$ 27.6	$ 7.6
Other comprehensive income (loss):
Unrealized gain from change in pension obligations, net of tax of $(0.0) in both 2020 and 2019	0.2	0.1
Unrealized gain on cash flow hedges, net of tax of $(0.0) in both 2020 and 2019	0.1	0.1
Cumulative translation adjustment	(173.5)	14.5
Comprehensive (loss) income	$ (145.6)	$ 22.3

XML

Stockholders' Equity and Equity Instruments - Schedule of Fair Value and Inputs Used to Calculate Fair Value for Options Granted (Details)	3 Months Ended
	Mar. 31, 2020 $ / shares
Equity [Abstract]
Fair value of options granted (in dollars per share)	$ 10.91
Exercise price (in dollars per share)	$ 58.91
Expected term (years)	4 years 9 months
Expected volatility	29.30%
Dividend yield	3.50%
Risk-free rate of return	1.60%

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2020	May 01, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	001-31921
Entity Registrant Name	Compass Minerals International, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-3972986
Entity Address, Address Line One	9900 West 109th Street
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Overland Park
Entity Address, State or Province	KS
Entity Address, Postal Zip Code	66210
City Area Code	913
Local Phone Number	344-9200
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	CMP
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		33,904,602
Entity Central Index Key	0001227654
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Property, Plant and Equipment, Net

3 Months Ended

Mar. 31, 2020

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment, Net

Property, Plant and Equipment, Net:

Property, plant and equipment, net, consists of the following (in millions):

	March 31, 2020			December 31, 2019
Land, buildings and structures, and leasehold improvements	$	578.3		$	596.0
Machinery and equipment	974.8			1,001.9
Office furniture and equipment	62.4			60.7
Mineral interests	165.9			171.1
Construction in progress	136.2			141.3
	1,917.6			1,971.0
Less accumulated depreciation and depletion	(963.8		)	(940.2		)
Property, plant and equipment, net	$	953.8		$	1,030.8

XML

Accounting Policies and Basis of Presentation

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Accounting Policies and Basis of Presentation

Accounting Policies and Basis of Presentation:

Compass Minerals International, Inc. (“CMI”), through its subsidiaries (collectively, the “Company”), is a leading producer of essential minerals that solve nature’s challenges, including salt for winter roadway safety and other consumer, industrial and agricultural uses, specialty plant nutrition minerals that improve the quality and yield of crops, and specialty chemicals for water treatment and other industrial processes. The Company’s principal products are salt, consisting of sodium chloride and magnesium chloride; plant nutrients, consisting of sulfate of potash (“SOP”), secondary nutrients and micronutrients; and specialty chemicals. The Company also provides records management services to businesses located in the United Kingdom (the “U.K.”). The Company’s production sites are located in the United States (“U.S.”), Canada, Brazil and the U.K. Except where otherwise noted, references to North America include only the continental U.S. and Canada, and references to the U.K. include only England, Scotland and Wales. References to “Compass Minerals,” “our,” “us” and “we” refer to CMI and its consolidated subsidiaries.

CMI is a holding company with no significant operations other than those of its wholly-owned subsidiaries. The consolidated financial statements include the accounts of CMI and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company uses the equity method of accounting for equity securities when it has significant influence or when it has more than a minor ownership interest or more than minor influence over an investee’s operations but does not have a controlling financial interest. Initial investments are recorded at cost (including certain transaction costs) and are adjusted by the Company’s share of the investees’ undistributed earnings and losses.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2019, as filed with the Securities and Exchange Commission in its Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included.

The Company experiences a substantial amount of seasonality in its sales with respect to its deicing salt products. As a result, sales and operating earnings are generally higher in the first and fourth quarters and lower during the second and third quarters of each year. In particular, sales of highway and consumer deicing salt and magnesium chloride products vary based on the severity of the winter conditions in areas where the products are used. Following industry practice in North America and the U.K., the Company seeks to stockpile sufficient quantities of deicing salt throughout the second, third and fourth quarters to meet the estimated requirements for the upcoming winter season. Production of deicing salt can also vary based on the severity or mildness of the preceding winter season. Due to the seasonal nature of the deicing product lines, operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.

The Company’s plant nutrition business is also seasonal. For example, the strongest demand for the Company’s plant nutrition products in Brazil typically occurs during the spring planting season. As a result, the Company and its customers generally build inventories during the low demand periods of the year to ensure timely product availability during the peak sales season. The seasonality of this demand results in the Company’s sales volumes and operating income for the Plant Nutrition South America segment usually being the highest during the third and fourth quarters of each year (as the spring planting season begins in September in Brazil).

Significant Accounting Policies

The Company’s significant accounting policies are detailed in “Note 2 – Summary of Significant Accounting Policies” within Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Recent Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed

the carrying amount of goodwill. All other goodwill impairment guidance remains largely unchanged. The adoption of this guidance on January 1, 2020 did not have an impact on the Company’s consolidated financial statements.

On January 1, 2020, the Company adopted guidance related to credit losses for financial instruments, which replaces the incurred lost methodology with a current expected credit loss methodology (“CECL”). The Company has determined that its trade receivables are the only financial instrument that is within scope of the new CECL guidance issued by FASB. The CECL methodology requires financial assets to be recorded at the net amount expected to be collected over the lifetime of the asset such that the estimated losses are accrued on the day the asset is acquired. The CECL methodology also requires financial assets to be aggregated and evaluated within pools with similar risk characteristics.

The Company has accrued an allowance on its trade receivables based on historical loss rates modified to consider supportable forecasts related to customer-specific and macroeconomic factors. For instance, the Company’s first quarter 2020 allowance for doubtful accounts considered the potential impact that the coronavirus (“COVID-19”) pandemic could have on the collectability of its outstanding receivables. The Company’s customer pools are comprised of North American highway deicing customers, North American consumer and industrial customers, Plant Nutrition North America customers, Plant Nutrition South America customers and customers whose outstanding receivable balances have been sent to collections. Customers grouped within these pools have similar risk characteristics. The Company’s allowance for doubtful accounts consists of estimates of expected credit losses and accruals for returns and allowances. At the transition date of January 1, 2020, the implementation of CECL had an immaterial impact of less than $0.1 million on the Company’s consolidated financial statements. Under CECL, the Company had an allowance for doubtful accounts of $9.4 million and $7.9 million as of January 1, 2020, and March 31, 2020, respectively.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies:

The Wisconsin Department of Agriculture, Trade and Consumer Protection (“DATCP”) and the Wisconsin Department of Natural Resources (“DNR”) have information indicating that agricultural chemicals are present within the subsurface area of the Company’s property located in Kenosha, Wisconsin. The agricultural chemicals were used by previous owners and operators of the site. None of the identified chemicals have been used in association with the Company’s operations since it acquired the property in 2002. DATCP and DNR have directed the Company to conduct further investigations into the environmental conditions at the Kenosha property. The Company continues on-property investigations and has provided the findings to DATCP and DNR as they have become available. All investigations and mitigation activities to date, and any potential future remediation work, are being conducted under the Wisconsin Agricultural Chemical Cleanup Program, which provides for reimbursement of some of the costs.

The Company conducts business operations in several countries and is subject to various federal and local labor, social security, environmental and tax laws. While the Company believes it complies with such laws, they are complex and subject to interpretation.

In addition to the tax assessments discussed in Note 7, the Company’s Brazilian subsidiaries are party to administrative tax proceedings and claims which totaled $7.9 million and $15.8 million as of March 31, 2020 and December 31, 2019, respectively, and relate primarily to value added tax, state tax (ICMS) and social security tax (PIS and COFINS) assessments. The Company has assessed the likelihood of a loss at less than probable and therefore, has not established a reserve for these matters. The Company also assumed liabilities for labor-related matters in connection with the 2016 acquisition of Compass Minerals South America, which are primarily related to compensation, labor benefits and consequential tax claims that totaled $3.9 million and $5.6 million as of March 31, 2020 and December 31, 2019, respectively. The Company believes the maximum exposure for these other labor matters totaled approximately $18 million and $25 million as of March 31, 2020 and December 31, 2019, respectively.

The Division of Enforcement of the U.S. Securities and Exchange Commission (“SEC”) is investigating the Company’s disclosures concerning the operation of the Goderich mine. The Company has cooperated with this investigation and will continue to do so. While it is not possible to predict the timing or the outcome of the SEC inquiry, the Company believes that this matter will not have a material impact on its results of operation, cash flows or financial position.

The Company is also involved in legal and administrative proceedings and claims of various types from the ordinary course of the Company’s business.

Management cannot predict the outcome of legal claims and proceedings with certainty. Nevertheless, management believes the outcome of legal proceedings and claims, which are pending or known to be threatened, even if determined adversely, will not, individually or in the aggregate, have a material adverse effect on the Company’s results of operations, cash flows or financial position.

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Summary of Estimated Fair Value of Assets and Liabilities

The estimated fair values for each type of instrument are presented below (in millions):

	March 31, 2020			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.3		$	1.3		$	—		$	—
Derivatives – foreign currency contracts, net	1.7			—			1.7			—
Total Assets	$	3.0		$	1.3		$	1.7		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.3	)	$	(1.3	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.7		)	—			(0.7		)	—
Total Liabilities	$	(2.0	)	$	(1.3	)	$	(0.7	)	$	—

(a) Includes mutual fund investments of approximately 30% in common stock of large-cap U.S. companies, 10% in common stock of small to mid-cap U.S. companies, 5% in international companies, 20% in bond funds, 10% in short-term investments and 25% in blended funds.

	December 31, 2019			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.4		$	1.4		$	—		$	—
Derivatives – foreign currency contracts, net	2.8			—			2.8			—
Total Assets	$	4.2		$	1.4		$	2.8		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.4	)	$	(1.4	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.6		)	—			(0.6		)	—
Total Liabilities	$	(2.0	)	$	(1.4	)	$	(0.6	)	$	—

(a)

Includes mutual fund investments of approximately 30% in the common stock of large-cap U.S. companies, 15% in the common stock of small to mid-cap U.S. companies, 5% in the common stock of international companies, 10% in bond funds, 20% in short-term investments and 20% in blended funds.

XML

Leases - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect to retained earnings from change in accounting principle	$ (610.1)	$ (607.4)
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect to retained earnings from change in accounting principle			$ 0.1

XML

Goodwill and Intangible Assets, Net (Tables)

3 Months Ended

Mar. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets

Amounts related to the Company’s amortization of intangible assets are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Aggregate amortization expense	$	3.2	$	3.6

Summary of Goodwill

Amounts related to the Company’s goodwill are as follows (in millions):

	March 31, 2020		December 31, 2019
Goodwill - Plant Nutrition North America Segment	$	50.5	$	55.4
Goodwill - Plant Nutrition South America Segment	218.4		281.6
Other	5.8		6.0
Total	$	274.7	$	343.0

XML

Accounting Policies and Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Basis of Consolidation

CMI is a holding company with no significant operations other than those of its wholly-owned subsidiaries. The consolidated financial statements include the accounts of CMI and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Equity Method Investments

The Company uses the equity method of accounting for equity securities when it has significant influence or when it has more than a minor ownership interest or more than minor influence over an investee’s operations but does not have a controlling financial interest. Initial investments are recorded at cost (including certain transaction costs) and are adjusted by the Company’s share of the investees’ undistributed earnings and losses.

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2019, as filed with the Securities and Exchange Commission in its Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included.

Significant and Recent Accounting Pronouncements

Significant Accounting Policies

The Company’s significant accounting policies are detailed in “Note 2 – Summary of Significant Accounting Policies” within Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Recent Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed

the carrying amount of goodwill. All other goodwill impairment guidance remains largely unchanged. The adoption of this guidance on January 1, 2020 did not have an impact on the Company’s consolidated financial statements.

On January 1, 2020, the Company adopted guidance related to credit losses for financial instruments, which replaces the incurred lost methodology with a current expected credit loss methodology (“CECL”). The Company has determined that its trade receivables are the only financial instrument that is within scope of the new CECL guidance issued by FASB. The CECL methodology requires financial assets to be recorded at the net amount expected to be collected over the lifetime of the asset such that the estimated losses are accrued on the day the asset is acquired. The CECL methodology also requires financial assets to be aggregated and evaluated within pools with similar risk characteristics.

The Company has accrued an allowance on its trade receivables based on historical loss rates modified to consider supportable forecasts related to customer-specific and macroeconomic factors. For instance, the Company’s first quarter 2020 allowance for doubtful accounts considered the potential impact that the coronavirus (“COVID-19”) pandemic could have on the collectability of its outstanding receivables. The Company’s customer pools are comprised of North American highway deicing customers, North American consumer and industrial customers, Plant Nutrition North America customers, Plant Nutrition South America customers and customers whose outstanding receivable balances have been sent to collections. Customers grouped within these pools have similar risk characteristics. The Company’s allowance for doubtful accounts consists of estimates of expected credit losses and accruals for returns and allowances. At the transition date of January 1, 2020, the implementation of CECL had an immaterial impact of less than $0.1 million on the Company’s consolidated financial statements. Under CECL, the Company had an allowance for doubtful accounts of $9.4 million and $7.9 million as of January 1, 2020, and March 31, 2020, respectively.

Derivative Financial Instruments

The Company is subject to various types of market risks, including interest rate risk, foreign currency exchange rate transaction and translation risk and commodity pricing risk. Management may take actions to mitigate the exposure to these types of risks, including entering into forward purchase contracts and other financial instruments. Currently, the Company manages a portion of its commodity pricing and foreign currency exchange rate risks by using derivative instruments. The Company does not seek to engage in trading activities or take speculative positions with any financial instrument arrangement. The Company has entered into natural gas derivative instruments and foreign currency derivative instruments with counterparties it views as creditworthy. However, the Company does attempt to mitigate its counterparty credit risk exposures by, among other things, entering into master netting agreements with some of these counterparties. The Company records derivative financial instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets.

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Depending on the exposure being hedged, the Company must designate the hedging instrument as a fair value hedge, a cash flow hedge or a net investment in foreign operations hedge. For the qualifying derivative instruments that have been designated as hedges, the change in fair value is recognized through earnings when the underlying transaction being hedged affects earnings, allowing a derivative’s gains and losses to offset related results from the hedged item in the statements of operations. Any ineffectiveness related to these hedges was not material for any of the periods presented. For derivative instruments that have not been designated as hedges, the entire change in fair value is recorded through earnings in the period of change.

Earnings Per Share

The Company calculates earnings per share using the two-class method. The two-class method requires allocating the Company’s net earnings to both common shares and participating securities.

XML

Stockholders' Equity and Equity Instruments

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Stockholders' Equity and Equity Instruments

Stockholders’ Equity and Equity Instruments:

In May 2015, the Company’s stockholders approved the 2015 Incentive Award Plan (as amended, the “2015 Plan”), which authorizes the issuance of 3,000,000 shares of Company common stock. Since the date the 2015 Plan was approved, the Company ceased issuing equity awards under the 2005 Incentive Award Plan (as amended, the “2005 Plan”). The 2005 Plan and 2015 Plan allow for grants of equity awards to executive officers, other employees and directors, including restricted stock units (“RSUs”), performance stock units (“PSUs”), stock options and deferred stock units. The grants occur following approval by the compensation committee of the Company’s board of directors, with the amount and terms communicated to employees shortly thereafter. 

Options

Most of the stock options granted under the 2005 Plan and 2015 Plan vest ratably, in tranches, over a four-year service period. Unexercised options expire after seven years. Options do not have dividend or voting rights. Upon vesting, each option can be exercised to purchase one share of the Company’s common stock. The exercise price of options is equal to the closing stock price on the grant date.

To estimate the fair value of options on the grant date, the Company uses the Black-Scholes option valuation model. Award recipients are grouped according to expected exercise behavior. Unless better information is available to estimate the expected term of the options, the estimate is based on historical exercise experience. The risk-free rate, using U.S. Treasury yield curves in effect at the time of grant, is selected based on the expected term of each group. The Company’s historical stock price is used to estimate expected volatility. The fair value and inputs used to calculate fair value for options granted in 2020 are included in the table below:

Fair value of options granted	$10.91
Exercise price	$58.91
Expected term (years)	4.75
Expected volatility	29.3%
Dividend yield	3.5%
Risk-free rate of return	1.6%

RSUs

Typically, the RSUs granted under the 2015 Plan vest after three years of service. RSUs entitle the holders to one share of common stock for each vested RSU. Unvested RSUs do not have voting rights but are entitled to receive non-forfeitable dividends (generally after a performance hurdle has been satisfied for the year of the grant) or other distributions equal to those declared on the Company’s common stock for RSUs that are earned as a result of the satisfaction of the performance hurdle. The closing stock price on the grant date is used to determine the fair value of RSUs.

PSUs

The PSUs granted under the 2015 Plan are either total shareholder return PSUs (“TSR PSUs”) or return on invested capital PSUs (“ROIC PSUs”). The actual number of shares of the Company’s common stock that may be earned with respect to TSR PSUs is calculated by comparing the Company’s total shareholder return to the total shareholder return for each company comprising the Russell 3000 Index (for TSR PSUs granted in 2017 and earlier) or the Company’s peer group (for TSR PSUs granted in 2018 and later) over the three-year performance period and may range from 0% to 200% of the target number of shares based upon the attainment of these market conditions. The actual number of shares of common stock that may be earned with respect to ROIC PSUs is calculated based on the average of the Company’s annual return on invested capital for each year in the three-year performance period and may range from 0% to 200% of the target number of shares based upon the attainment of these performance conditions.

PSUs represent a target number of shares of the Company’s common stock that may be earned before adjustment based upon the attainment of certain conditions. Holders of PSUs do not have voting rights but are entitled to receive non-forfeitable dividends or other distributions equal to those declared on the Company’s common stock for PSUs that are earned, which are paid when the shares underlying the PSUs are paid.

To estimate the fair value of the TSR PSUs on the grant date, the Company uses a Monte-Carlo simulation model, which simulates future stock prices of the Company as well as the companies comprising the Russell 3000 Index or the Company’s peer group

depending on the year granted. This model uses historical stock prices to estimate expected volatility and the Company’s correlation to the Russell 3000 Index or peer group. The risk-free rate was determined using the same methodology as the option valuations as discussed above. The Company’s closing stock price on the grant date was used to estimate the fair value of the ROIC PSUs. The Company will adjust the expense of the ROIC PSUs based upon its estimate of the number of shares that will ultimately vest at each interim date during the vesting period.

During the three months ended March 31, 2020, the Company reissued the following number of shares from treasury stock: no shares related to the exercise of stock options, 4,517 shares related to the release of RSUs which vested and 3,377 shares related to stock payments. In 2019, the Company issued 32,197 shares from treasury stock. The Company withheld 1,479 shares with a fair value of $0.1 million related to the vesting of RSUs during the first three months of 2020. The fair value of the shares were valued at the closing price at the vesting date and represent the employee tax withholding for the employee’s compensation. The Company recognized a tax deficiency of $0.2 million from its equity compensation awards as an increase to income tax expense during the first three months of 2020. During the first three months of 2020 and 2019, the Company recorded $2.9 million (includes $0.5 million to be paid in cash) and $1.1 million, respectively, of compensation expense pursuant to its stock-based compensation plans. No amounts have been capitalized. The following table summarizes stock-based compensation activity during the three months ended March 31, 2020:

	Stock Options				RSUs				PSUs(a)
	Number		Weighted-average exercise price		Number		Weighted-average fair value		Number		Weighted-average fair value
Outstanding at December 31, 2019	887,867		$	64.21	217,413		$	52.07	179,397		$	61.43
Granted	94,945		58.91		83,337		58.92		69,635		82.38
Exercised(b)	—		—		—		—		—		—
Released from restriction(b)	—		—		(4,517	)	39.75		—		—
Cancelled/expired	(64,666	)	72.67		(27,981	)	50.18		(26,899	)	67.55
Outstanding at March 31, 2020	918,146		$	63.07	268,252		$	54.61	222,133		$	67.26

(a) Until the performance period is completed, PSUs are included in the table at the target level at their grant date and at that level represent one share of common stock per PSU.

(b) Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.

Other Comprehensive (Loss) Income

The Company’s comprehensive (loss) income is comprised of net earnings, net amortization of the unrealized loss of the pension obligation, the change in the unrealized gain on natural gas and foreign currency cash flow hedges and foreign currency translation adjustments. The components of and changes in accumulated other comprehensive loss (“AOCL”) as of and for the three months ended March 31, 2020 and 2019, are as follows (in millions):

Three Months Ended March 31, 2020(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.6	)	$	(6.9	)	$	(184.6	)	$	(192.1	)
Other comprehensive income (loss) before reclassifications(b)	2.7			—			(173.5		)	(170.8		)
Amounts reclassified from accumulated other comprehensive loss	(2.6		)	0.2			—			(2.4		)
Net current period other comprehensive income (loss)	0.1			0.2			(173.5		)	(173.2		)
Ending balance	$	(0.5	)	$	(6.7	)	$	(358.1	)	$	(365.3	)

Three Months Ended March 31, 2019(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.7	)	$	(4.5	)	$	(205.7	)	$	(210.9	)
Other comprehensive income before reclassifications(b)	0.2			—			14.5			14.7
Amounts reclassified from accumulated other comprehensive loss	(0.1		)	0.1			—			—
Net current period other comprehensive income	0.1			0.1			14.5			14.7
Ending balance	$	(0.6	)	$	(4.4	)	$	(191.2	)	$	(196.2	)

(a) With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive loss presented in the tables above are reflected net of applicable income taxes.

(b) The Company recorded a foreign exchange gain (loss) of $(75.5) million and $2.3 million in the three months ended March 31, 2020 and 2019, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of a long-term investment nature.

The amounts reclassified from AOCL to expense (income) for the three months ended March 31, 2020 and 2019, are shown below (in millions):

	Amount Reclassified from AOCL
	Three Months Ended March 31, 2020			Three Months Ended March 31, 2019			Line Item Impacted in the Consolidated Statements of Operations
Gains (losses) on cash flow hedges:
Natural gas instruments	$	(0.3	)	$	(0.1	)	Product cost
Foreign currency contracts	(3.6		)	(0.1		)	Interest expense
Income tax expense	1.3			0.1
Reclassifications, net of income taxes	(2.6		)	(0.1		)
Amortization of defined benefit pension:
Amortization of loss	$	0.2		$	0.1		Product cost
Reclassifications, net of income taxes	0.2			0.1
Total reclassifications, net of income taxes	$	(2.4	)	$	—

XML

Label	Element	Value
Accounting Standards Update 2016-02 [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (100,000)
Accounting Standards Update 2016-02 [Member] | Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (100,000)

XML

Leases - Schedule of Lease Terms and Discount Rates (Details)	Mar. 31, 2020	Dec. 31, 2019
Weighted Average Lease Term [Abstract]
Operating leases	7 years 8 months 12 days	7 years 8 months 12 days
Finance leases	6 years 2 months 12 days	7 years 2 months 12 days
Weighted Average Discount Rate [Abstract]
Operating leases	4.30%	4.30%
Finance leases	7.10%	7.60%

XML

Goodwill and Intangible Assets, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Goodwill [Line Items]
Aggregate amortization expense	$ 3.2	$ 3.6
Goodwill	274.7		$ 343.0
Other
Goodwill [Line Items]
Goodwill	5.8		6.0
Goodwill - Plant Nutrition North America Segment | Operating Segments
Goodwill [Line Items]
Goodwill	50.5		55.4
Goodwill - Plant Nutrition South America Segment | Operating Segments
Goodwill [Line Items]
Goodwill	$ 218.4		$ 281.6

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Loss Contingencies [Line Items]
Maximum exposure for other labor matters	$ 18.0	$ 25.0
Produquímica
Loss Contingencies [Line Items]
Contingent liabilities assumed	3.9	5.6
Brazilian Tax Litigation and Assessments
Loss Contingencies [Line Items]
Amount of potential payments	$ 7.9	$ 15.8

XML

Fair Value Measurements - Summary of Estimated Fair Values (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Mutual Fund Investments, Concentration Risk | Common Stock, Large Cap US Companies
Liability Class:
Concentration risk percentage	30.00%	30.00%
Mutual Fund Investments, Concentration Risk | Common Stock of Small to Mid Cap US Companies
Liability Class:
Concentration risk percentage	10.00%	15.00%
Mutual Fund Investments, Concentration Risk | Common Stock, International Companies
Liability Class:
Concentration risk percentage	5.00%	5.00%
Mutual Fund Investments, Concentration Risk | Bond Funds
Liability Class:
Concentration risk percentage	20.00%	10.00%
Mutual Fund Investments, Concentration Risk | Short-Term Investments
Liability Class:
Concentration risk percentage	10.00%	20.00%
Mutual Fund Investments, Concentration Risk | Blended Funds
Liability Class:
Concentration risk percentage	25.00%	20.00%
Fair Value, Measurements, Recurring
Asset Class:
Mutual fund investments in a non-qualified savings plan	$ 1.3	$ 1.4
Derivatives – foreign currency contracts, net	1.7	2.8
Total Assets	3.0	4.2
Liability Class:
Liabilities related to non-qualified savings plan	(1.3)	(1.4)
Derivatives – natural gas instruments, net	(0.7)	(0.6)
Total Liabilities	(2.0)	(2.0)
Fair Value, Measurements, Recurring | Level One
Asset Class:
Mutual fund investments in a non-qualified savings plan	1.3	1.4
Derivatives – foreign currency contracts, net	0.0	0.0
Total Assets	1.3	1.4
Liability Class:
Liabilities related to non-qualified savings plan	(1.3)	(1.4)
Derivatives – natural gas instruments, net	0.0	0.0
Total Liabilities	(1.3)	(1.4)
Fair Value, Measurements, Recurring | Level Two
Asset Class:
Mutual fund investments in a non-qualified savings plan	0.0	0.0
Derivatives – foreign currency contracts, net	1.7	2.8
Total Assets	1.7	2.8
Liability Class:
Liabilities related to non-qualified savings plan	0.0	0.0
Derivatives – natural gas instruments, net	(0.7)	(0.6)
Total Liabilities	(0.7)	(0.6)
Fair Value, Measurements, Recurring | Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan	0.0	0.0
Derivatives – foreign currency contracts, net	0.0	0.0
Total Assets	0.0	0.0
Liability Class:
Liabilities related to non-qualified savings plan	0.0	0.0
Derivatives – natural gas instruments, net	0.0	0.0
Total Liabilities	$ 0.0	$ 0.0

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2018	$ 540.2	$ 0.4	$ 110.1	$ (2.9)	$ 643.5	$ (210.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	22.3				7.6	14.7
Dividends on common stock	(24.5)		0.1		(24.6)
Shares issued for stock units, net of shares withheld for taxes	(0.2)			(0.2)
Stock-based compensation	1.1		1.1
Ending balance at Mar. 31, 2019	538.8	0.4	111.3	(3.1)	626.4	(196.2)
Beginning balance at Dec. 31, 2019	529.6	0.4	117.1	(3.2)	607.4	(192.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	(145.6)				27.6	(173.2)
Dividends on common stock	(24.8)		0.1		(24.9)
Shares issued for stock units, net of shares withheld for taxes	(0.1)			(0.1)
Stock-based compensation	2.4		2.4
Ending balance at Mar. 31, 2020	$ 361.5	$ 0.4	$ 119.6	$ (3.3)	$ 610.1	$ (365.3)

XML

Stockholders' Equity and Equity Instruments - Components and Changes In AOCL (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	$ 529.6	$ 540.2
Other comprehensive income (loss) before reclassifications	(170.8)	14.7
Amounts reclassified from accumulated other comprehensive loss	(2.4)	0.0
Net current period other comprehensive income	(173.2)	14.7
Ending balance	361.5	538.8
Gains (loss) on foreign exchange of intercompany notes of long-term nature	(75.5)	2.3
Gains and (Losses) on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(0.6)	(0.7)
Other comprehensive income (loss) before reclassifications	2.7	0.2
Amounts reclassified from accumulated other comprehensive loss	(2.6)	(0.1)
Net current period other comprehensive income	0.1	0.1
Ending balance	(0.5)	(0.6)
Defined Benefit Pension
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(6.9)	(4.5)
Other comprehensive income (loss) before reclassifications	0.0	0.0
Amounts reclassified from accumulated other comprehensive loss	0.2	0.1
Net current period other comprehensive income	0.2	0.1
Ending balance	(6.7)	(4.4)
Foreign Currency
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(184.6)	(205.7)
Other comprehensive income (loss) before reclassifications	(173.5)	14.5
Amounts reclassified from accumulated other comprehensive loss	0.0	0.0
Net current period other comprehensive income	(173.5)	14.5
Ending balance	(358.1)	(191.2)
Total
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(192.1)	(210.9)
Ending balance	$ (365.3)	$ (196.2)

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Allowance for doubtful accounts	$ 9.5	$ 10.7
Stockholders’ equity:
Common stock, par or stated value per share (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares issued (in shares)	35,367,264	35,367,264
Treasury stock, shares (in shares)	1,475,196	1,481,611

XML

Operating Segments (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020 USD ($) Business segment	Mar. 31, 2019 USD ($)	Dec. 31, 2019 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	3
Segment Reporting Information [Abstract]
Sales	$ 413.9	$ 403.7
Operating earnings (loss)	44.2	33.2
Depreciation, depletion and amortization	33.1	35.0
Total assets (as of end of period)	2,110.8	2,308.6	$ 2,443.2
United States
Segment Reporting Information [Abstract]
Sales	257.9	238.3
Canada
Segment Reporting Information [Abstract]
Sales	77.4	87.4
Brazil
Segment Reporting Information [Abstract]
Sales	62.1	55.7
United Kingdom
Segment Reporting Information [Abstract]
Sales	11.8	17.3
Other
Segment Reporting Information [Abstract]
Sales	4.7	5.0
Shipping and handling cost
Segment Reporting Information [Abstract]
Shipping and handling cost	101.8	112.9
Highway Deicing Salt
Segment Reporting Information [Abstract]
Sales	215.1	218.7
Consumer & Industrial Salt
Segment Reporting Information [Abstract]
Sales	72.7	87.7
SOP and Specialty Plant Nutrients
Segment Reporting Information [Abstract]
Sales	102.0	74.3
Industrial Chemicals
Segment Reporting Information [Abstract]
Sales	21.8	22.6
Operating Segments | Salt
Segment Reporting Information [Abstract]
Sales	287.8	306.4
Operating earnings (loss)	56.9	52.3
Depreciation, depletion and amortization	14.6	15.3
Total assets (as of end of period)	956.5	889.7
Operating Segments | Salt | Shipping and handling cost
Segment Reporting Information [Abstract]
Shipping and handling cost	89.8	103.7
Operating Segments | Salt | Highway Deicing Salt
Segment Reporting Information [Abstract]
Sales	215.1	218.7
Operating Segments | Salt | Consumer & Industrial Salt
Segment Reporting Information [Abstract]
Sales	72.7	87.7
Operating Segments | Salt | SOP and Specialty Plant Nutrients
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Salt | Industrial Chemicals
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Salt | Eliminations & Other
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Plant Nutrition North America
Segment Reporting Information [Abstract]
Sales	60.6	37.2
Operating earnings (loss)	5.2	(1.6)
Depreciation, depletion and amortization	10.5	11.6
Total assets (as of end of period)	552.3	594.1
Operating Segments | Plant Nutrition North America | Shipping and handling cost
Segment Reporting Information [Abstract]
Shipping and handling cost	9.0	6.0
Operating Segments | Plant Nutrition North America | Highway Deicing Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Plant Nutrition North America | Consumer & Industrial Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Plant Nutrition North America | SOP and Specialty Plant Nutrients
Segment Reporting Information [Abstract]
Sales	60.9	37.7
Operating Segments | Plant Nutrition North America | Industrial Chemicals
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Plant Nutrition North America | Eliminations & Other
Segment Reporting Information [Abstract]
Sales	$ (0.3)	(0.5)
Operating Segments | Plant Nutrition South America
Segment Reporting Information [Line Items]
Number of primary businesses | Business	2
Segment Reporting Information [Abstract]
Sales	$ 62.8	57.7
Operating earnings (loss)	0.3	(2.6)
Depreciation, depletion and amortization	5.0	5.6
Total assets (as of end of period)	561.0	710.6
Operating Segments | Plant Nutrition South America | Shipping and handling cost
Segment Reporting Information [Abstract]
Shipping and handling cost	3.0	3.2
Operating Segments | Plant Nutrition South America | Highway Deicing Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Plant Nutrition South America | Consumer & Industrial Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Operating Segments | Plant Nutrition South America | SOP and Specialty Plant Nutrients
Segment Reporting Information [Abstract]
Sales	41.1	36.6
Operating Segments | Plant Nutrition South America | Industrial Chemicals
Segment Reporting Information [Abstract]
Sales	21.8	22.6
Operating Segments | Plant Nutrition South America | Eliminations & Other
Segment Reporting Information [Abstract]
Sales	(0.1)	(1.5)
Corporate & Other
Segment Reporting Information [Abstract]
Sales	2.7	2.4
Operating earnings (loss)	(18.2)	(14.9)
Depreciation, depletion and amortization	3.0	2.5
Total assets (as of end of period)	41.0	114.2
Corporate & Other | Shipping and handling cost
Segment Reporting Information [Abstract]
Shipping and handling cost	0.0	0.0
Corporate & Other | Highway Deicing Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Corporate & Other | Consumer & Industrial Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Corporate & Other | SOP and Specialty Plant Nutrients
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Corporate & Other | Industrial Chemicals
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Corporate & Other | Eliminations & Other
Segment Reporting Information [Abstract]
Sales	2.7	2.4
Intersegment Eliminations
Segment Reporting Information [Abstract]
Sales	(0.4)	(2.0)
Intersegment Eliminations | Eliminations & Other
Segment Reporting Information [Abstract]
Sales	2.3	0.4
Intersegment Eliminations | Salt
Segment Reporting Information [Abstract]
Sales	0.0	0.0
Intersegment Eliminations | Plant Nutrition North America
Segment Reporting Information [Abstract]
Sales	0.3	0.5
Intersegment Eliminations | Plant Nutrition South America
Segment Reporting Information [Abstract]
Sales	$ 0.1	$ 1.5

XML

Stockholders' Equity and Equity Instruments (Tables)

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Schedule of Fair Value and Inputs Used to Calculate Fair Value for Options Granted

The fair value and inputs used to calculate fair value for options granted in 2020 are included in the table below:

Fair value of options granted	$10.91
Exercise price	$58.91
Expected term (years)	4.75
Expected volatility	29.3%
Dividend yield	3.5%
Risk-free rate of return	1.6%

Summary of Stock-Based Compensation Activity

The following table summarizes stock-based compensation activity during the three months ended March 31, 2020:

	Stock Options				RSUs				PSUs(a)
	Number		Weighted-average exercise price		Number		Weighted-average fair value		Number		Weighted-average fair value
Outstanding at December 31, 2019	887,867		$	64.21	217,413		$	52.07	179,397		$	61.43
Granted	94,945		58.91		83,337		58.92		69,635		82.38
Exercised(b)	—		—		—		—		—		—
Released from restriction(b)	—		—		(4,517	)	39.75		—		—
Cancelled/expired	(64,666	)	72.67		(27,981	)	50.18		(26,899	)	67.55
Outstanding at March 31, 2020	918,146		$	63.07	268,252		$	54.61	222,133		$	67.26

(a) Until the performance period is completed, PSUs are included in the table at the target level at their grant date and at that level represent one share of common stock per PSU.

(b) Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.

Summary of Components and Changes in Accumulated Other Comprehensive Income (Loss)

The components of and changes in accumulated other comprehensive loss (“AOCL”) as of and for the three months ended March 31, 2020 and 2019, are as follows (in millions):

Three Months Ended March 31, 2020(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.6	)	$	(6.9	)	$	(184.6	)	$	(192.1	)
Other comprehensive income (loss) before reclassifications(b)	2.7			—			(173.5		)	(170.8		)
Amounts reclassified from accumulated other comprehensive loss	(2.6		)	0.2			—			(2.4		)
Net current period other comprehensive income (loss)	0.1			0.2			(173.5		)	(173.2		)
Ending balance	$	(0.5	)	$	(6.7	)	$	(358.1	)	$	(365.3	)

Three Months Ended March 31, 2019(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.7	)	$	(4.5	)	$	(205.7	)	$	(210.9	)
Other comprehensive income before reclassifications(b)	0.2			—			14.5			14.7
Amounts reclassified from accumulated other comprehensive loss	(0.1		)	0.1			—			—
Net current period other comprehensive income	0.1			0.1			14.5			14.7
Ending balance	$	(0.6	)	$	(4.4	)	$	(191.2	)	$	(196.2	)

(a) With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive loss presented in the tables above are reflected net of applicable income taxes.

(b)

The Company recorded a foreign exchange gain (loss) of $(75.5) million and $2.3 million in the three months ended March 31, 2020 and 2019, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of a long-term investment nature.

Summary of Reclassifications out of Accumulated Other Comprehensive Income

The amounts reclassified from AOCL to expense (income) for the three months ended March 31, 2020 and 2019, are shown below (in millions):

	Amount Reclassified from AOCL
	Three Months Ended March 31, 2020			Three Months Ended March 31, 2019			Line Item Impacted in the Consolidated Statements of Operations
Gains (losses) on cash flow hedges:
Natural gas instruments	$	(0.3	)	$	(0.1	)	Product cost
Foreign currency contracts	(3.6		)	(0.1		)	Interest expense
Income tax expense	1.3			0.1
Reclassifications, net of income taxes	(2.6		)	(0.1		)
Amortization of defined benefit pension:
Amortization of loss	$	0.2		$	0.1		Product cost
Reclassifications, net of income taxes	0.2			0.1
Total reclassifications, net of income taxes	$	(2.4	)	$	—

XML

Accounting Policies and Basis of Presentation Accounting Policies and Basis of Presentation (Details) - Accounting Standards Update 2016-13 - USD ($) $ in Millions	Mar. 31, 2020	Jan. 01, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative period adjustment, less than		$ 0.1
Allowance for doubtful accounts	$ 7.9	$ 9.4

XML

Leases - Operating and Finance Leases by Income Statement Location (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Amortization of lease assets	$ 0.5	$ 0.3
Interest on lease liabilities	0.1	0.2
Operating lease cost	4.6	4.8
Variable lease cost	5.1	6.1
Net lease cost	$ 10.3	$ 11.4

XML

Income Taxes

3 Months Ended

Mar. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes:

The Company’s effective income tax rate differs from the U.S. statutory federal income tax rate primarily due to U.S. statutory depletion, state income taxes (net of federal tax benefit), foreign income, mining and withholding taxes, global intangible low-taxed income and interest expense recognition differences for book and tax purposes. The Company’s effective rate is impacted by permanent tax deductions which have a less favorable impact as pretax income increases.

The Company had $14.8 million and $18.8 million as of March 31, 2020 and December 31, 2019, respectively, of gross foreign federal net operating loss (“NOL”) carryforwards that have no expiration date, $1.2 million and $1.7 million, respectively, of gross foreign federal NOL carryforwards which expire beginning in 2033 and $0.2 million and $0.3 million, respectively, of net operating tax-effected state NOL carryforwards which expire beginning in 2027.

Canadian provincial tax authorities have challenged tax positions claimed by one of the Company’s Canadian subsidiaries and have issued tax reassessments for years 2002-2014. The reassessments are a result of ongoing audits and total $120.4 million, including interest, through March 31, 2020. The Company disputes these reassessments and will continue to work with the appropriate authorities in Canada to resolve the dispute. There is a reasonable possibility that the ultimate resolution of this dispute, and any related disputes for other open tax years, may be materially higher or lower than the amounts the Company has reserved for such disputes. In connection with this dispute, local regulations require the Company to post security with the tax authority

until the dispute is resolved. The Company has posted collateral in the form of an $89.6 million performance bond and has paid $34.8 million to the Canadian tax authorities (most of which is recorded in other assets in the Consolidated Balance Sheets).

The Company expects that it will be required by local regulations to provide security for additional interest on the above unresolved disputed amounts and for any future reassessments issued by these Canadian tax authorities in the form of cash, letters of credit, performance bonds, asset liens or other arrangements agreeable with the tax authorities until the disputes are resolved.

The Company expects that the ultimate outcome of these matters will not have a material impact on its results of operations or financial condition. However, the Company can provide no assurance as to the ultimate outcome of these matters, and the impact could be material if they are not resolved in the Company’s favor. As of March 31, 2020, the Company believes it has adequately reserved for these reassessments.

Additionally, the Company has other uncertain tax positions as well as assessments and disputed positions with taxing authorities in its various jurisdictions, which are consistent with those matters disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Settlements

In the fourth quarter of 2017, the Company, the Canadian Revenue Authority (“CRA”) and the U.S. Internal Revenue Service (“IRS”) reached a settlement agreement on transfer pricing issues for the Company’s 2007-2012 tax years. As a result of this settlement agreement, the Company recognized $13.8 million of tax expense in its 2017 Consolidated Statements of Operations related to the Company’s Canadian tax positions for the years 2007-2016. The recording of this settlement resulted in increased sales for the Company’s Canadian subsidiary of $85.7 million and increased offsetting expenses for the Company’s U.S. subsidiary in 2017 causing a domestic loss and significant foreign income. During 2018, in accordance with the settlement agreement, the Company’s U.S. subsidiary made intercompany cash payments of $85.7 million to its Canadian subsidiary and tax payments to Canadian taxing authorities of $17.5 million. The remaining liability was satisfied in 2019 with tax payments of $5.3 million. Corresponding tax refunds of $21.4 million were received in 2019 from U.S. taxing authorities, with the remaining refund of approximately $1.6 million expected in 2020 (recorded in other current assets in the Consolidated Balance Sheets).

In the fourth quarter of 2018, the Company, the CRA and the IRS reached a settlement agreement on transfer pricing and management fees as part of an advanced pricing agreement that covers tax years 2013-2021. The tax expense was previously recognized in 2017, however the recording of this settlement resulted in increased sales for the Company’s Canadian subsidiary of $106.1 million and offsetting expenses for the Company’s U.S. subsidiary in 2018 causing a domestic loss and significant foreign income. During 2019, in accordance with the settlement agreement, the Company’s U.S. subsidiary made intercompany cash payments of $106.1 million to its Canadian subsidiary and tax payments to Canadian taxing authorities of $29.9 million, with the remaining $1.3 million of tax payments to be paid during 2020. Corresponding tax refunds of $59.2 million have been received as of March 31, 2020 from U.S. taxing authorities, of which $55 million was received during the first quarter of 2020, with the remaining $2.4 million expected in 2020 (recorded in other current assets in its Consolidated Balance Sheets).

XML

Leases

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Leases

Leases:

In February 2016, the FASB issued guidance which requires lessees to recognize on their balance sheet a right-of-use asset which represents a lessee’s right to use the underlying asset and a lease liability which represents a lessee’s obligation to make lease payments for the right to use the asset. In addition, the guidance requires expanded qualitative and quantitative disclosures. The Company has adopted this guidance beginning in the first quarter of 2019, using a modified retrospective transition method, which required the cumulative effect of this change in accounting of $0.1 million to be recorded as an adjustment to beginning retained earnings. The Company elected the package of transition provisions available for existing contracts, which allowed entities to carryforward the historical assessment of whether the contract contained a lease and the lease classification.

The Company enters into leases for warehouses and depots, rail cars, vehicles, mobile equipment, office space and certain other types of property and equipment. The Company determines whether an arrangement is or contains a lease at the inception of the contract. The right-of-use asset and lease liability are recognized based on the present value of the future minimum lease payments over the estimated lease term. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company estimates its incremental borrowing rate for each lease based upon the estimated lease term, the type of asset and the location of the leased asset. The most significant judgments in the application of the FASB guidance include whether a contract contains a lease and the lease term.

Leases with an initial term of 12 months or less are not recorded on the Company’s Consolidated Balance Sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. Many of the Company’s leases include one or more options to renew and extend the initial lease term. The exercise of lease renewal options is generally at the Company’s discretion. The lease term includes renewal periods in only those instances in which the Company determines it is reasonably assured of renewal.

The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. In these instances, the assets are depreciated over the useful life of the asset.

The Company has elected the practical expedient available under the FASB guidance to not separate lease and nonlease components on all of its lease categories. As a result, many of the Company’s leases include variable payments for services (such as handling or storage) or payments based on the usage of the asset. In addition, certain of the Company’s lease agreements include rental payments that are adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or any material restrictive covenants. The Company’s sublease income is immaterial.

The Company’s Consolidated Balance Sheets includes the following (in millions):

	Consolidated Balance Sheets Location	March 31, 2020		December 31, 2019
Assets
Operating lease assets	Other assets	$	49.7	$	53.7
Finance lease assets	Property, plant and equipment, net	5.9		5.8
Total leased assets		$	55.6	$	59.5
Liabilities
Current liabilities:
Operating	Accrued expenses and other current liabilities	$	9.5	$	12.8
Finance	Accrued expenses and other current liabilities	1.7		1.1
Noncurrent liabilities:
Operating	Other noncurrent liabilities	40.4		41.0
Finance	Other noncurrent liabilities	5.3		6.2
Total lease liabilities		$	56.9	$	61.1

The Company’s components of lease cost are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Finance lease cost:
Amortization of lease assets	$	0.5	$	0.3
Interest on lease liabilities	0.1		0.2
Operating lease cost	4.6		4.8
Variable lease cost(a)	5.1		6.1
Net lease cost	$	10.3	$	11.4

(a) Short-term leases are immaterial and included in variable lease cost.

Maturities of lease liabilities under the new guidance (“Topic 842”) are as follows (in millions):

Topic 842
March 31, 2020	Operating Leases			Finance Leases			Total
Remainder of 2020	$	8.7		$	1.6		$	10.3
2021	10.1			1.6			11.7
2022	7.5			0.9			8.4
2023	6.2			0.9			7.1
2024	5.3			0.9			6.2
After 2024	22.4			2.8			25.2
Total lease payments	60.2			8.7			68.9
Less: Interest	(10.3		)	(1.7		)	(12.0		)
Present value of lease liabilities	$	49.9		$	7.0		$	56.9

Topic 842
December 31, 2019	Operating Leases			Finance Leases			Total
2020	$	13.0		$	1.6		$	14.6
2021	10.0			1.3			11.3
2022	7.5			1.1			8.6
2023	6.3			1.1			7.4
2024	5.3			1.1			6.4
After 2024	22.8			3.3			26.1
Total lease payments	64.9			9.5			74.4
Less: Interest	(11.1		)	(2.2		)	(13.3		)
Present value of lease liabilities	$	53.8		$	7.3		$	61.1

Supplemental lease term and discount rate information related to leases is as follows:

	March 31, 2020		December 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.7		7.7
Finance leases	6.2		7.2
Weighted-average discount rate
Operating leases	4.3	%	4.3	%
Finance leases	7.1	%	7.6	%

Supplemental cash flow information related to leases is as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4.5	$	4.9
Operating cash flows from finance leases	0.1		0.2
Financing cash flows from finance leases	0.5		0.3
Leased assets obtained in exchange for new operating lease liabilities	1.0		2.4
Leased assets obtained in exchange for new finance lease liabilities	1.2		—

Leases

Leases:

In February 2016, the FASB issued guidance which requires lessees to recognize on their balance sheet a right-of-use asset which represents a lessee’s right to use the underlying asset and a lease liability which represents a lessee’s obligation to make lease payments for the right to use the asset. In addition, the guidance requires expanded qualitative and quantitative disclosures. The Company has adopted this guidance beginning in the first quarter of 2019, using a modified retrospective transition method, which required the cumulative effect of this change in accounting of $0.1 million to be recorded as an adjustment to beginning retained earnings. The Company elected the package of transition provisions available for existing contracts, which allowed entities to carryforward the historical assessment of whether the contract contained a lease and the lease classification.

The Company enters into leases for warehouses and depots, rail cars, vehicles, mobile equipment, office space and certain other types of property and equipment. The Company determines whether an arrangement is or contains a lease at the inception of the contract. The right-of-use asset and lease liability are recognized based on the present value of the future minimum lease payments over the estimated lease term. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company estimates its incremental borrowing rate for each lease based upon the estimated lease term, the type of asset and the location of the leased asset. The most significant judgments in the application of the FASB guidance include whether a contract contains a lease and the lease term.

Leases with an initial term of 12 months or less are not recorded on the Company’s Consolidated Balance Sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. Many of the Company’s leases include one or more options to renew and extend the initial lease term. The exercise of lease renewal options is generally at the Company’s discretion. The lease term includes renewal periods in only those instances in which the Company determines it is reasonably assured of renewal.

The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. In these instances, the assets are depreciated over the useful life of the asset.

The Company has elected the practical expedient available under the FASB guidance to not separate lease and nonlease components on all of its lease categories. As a result, many of the Company’s leases include variable payments for services (such as handling or storage) or payments based on the usage of the asset. In addition, certain of the Company’s lease agreements include rental payments that are adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or any material restrictive covenants. The Company’s sublease income is immaterial.

The Company’s Consolidated Balance Sheets includes the following (in millions):

	Consolidated Balance Sheets Location	March 31, 2020		December 31, 2019
Assets
Operating lease assets	Other assets	$	49.7	$	53.7
Finance lease assets	Property, plant and equipment, net	5.9		5.8
Total leased assets		$	55.6	$	59.5
Liabilities
Current liabilities:
Operating	Accrued expenses and other current liabilities	$	9.5	$	12.8
Finance	Accrued expenses and other current liabilities	1.7		1.1
Noncurrent liabilities:
Operating	Other noncurrent liabilities	40.4		41.0
Finance	Other noncurrent liabilities	5.3		6.2
Total lease liabilities		$	56.9	$	61.1

The Company’s components of lease cost are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Finance lease cost:
Amortization of lease assets	$	0.5	$	0.3
Interest on lease liabilities	0.1		0.2
Operating lease cost	4.6		4.8
Variable lease cost(a)	5.1		6.1
Net lease cost	$	10.3	$	11.4

(a) Short-term leases are immaterial and included in variable lease cost.

Maturities of lease liabilities under the new guidance (“Topic 842”) are as follows (in millions):

Topic 842
March 31, 2020	Operating Leases			Finance Leases			Total
Remainder of 2020	$	8.7		$	1.6		$	10.3
2021	10.1			1.6			11.7
2022	7.5			0.9			8.4
2023	6.2			0.9			7.1
2024	5.3			0.9			6.2
After 2024	22.4			2.8			25.2
Total lease payments	60.2			8.7			68.9
Less: Interest	(10.3		)	(1.7		)	(12.0		)
Present value of lease liabilities	$	49.9		$	7.0		$	56.9

Topic 842
December 31, 2019	Operating Leases			Finance Leases			Total
2020	$	13.0		$	1.6		$	14.6
2021	10.0			1.3			11.3
2022	7.5			1.1			8.6
2023	6.3			1.1			7.4
2024	5.3			1.1			6.4
After 2024	22.8			3.3			26.1
Total lease payments	64.9			9.5			74.4
Less: Interest	(11.1		)	(2.2		)	(13.3		)
Present value of lease liabilities	$	53.8		$	7.3		$	61.1

Supplemental lease term and discount rate information related to leases is as follows:

	March 31, 2020		December 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.7		7.7
Finance leases	6.2		7.2
Weighted-average discount rate
Operating leases	4.3	%	4.3	%
Finance leases	7.1	%	7.6	%

Supplemental cash flow information related to leases is as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4.5	$	4.9
Operating cash flows from finance leases	0.1		0.2
Financing cash flows from finance leases	0.5		0.3
Leased assets obtained in exchange for new operating lease liabilities	1.0		2.4
Leased assets obtained in exchange for new finance lease liabilities	1.2		—

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Unrealized gain from change in pension obligations, tax	$ 0.0	$ 0.0
Unrealized gain on cash flow hedges, tax	$ 0.0	$ 0.0

XML

Stockholders' Equity and Equity Instruments - Reclassifications From AOCL (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	$ (19.0)	$ (16.2)
Income tax expense	11.7	4.9
Net earnings	27.6	7.6
Product cost
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product cost	(224.8)	(218.2)
Amount Reclassified from AOCL
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net earnings	(2.4)	0.0
Amount Reclassified from AOCL | Gains (losses) on cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income tax expense	1.3	0.1
Net earnings	(2.6)	(0.1)
Amount Reclassified from AOCL | Amortization of defined benefit pension:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net earnings	0.2	0.1
Amount Reclassified from AOCL | Amortization of defined benefit pension: | Product cost
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product cost	0.2	0.1
Natural gas instruments | Amount Reclassified from AOCL | Gains (losses) on cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product cost	(0.3)	(0.1)
Foreign currency contracts | Amount Reclassified from AOCL | Gains (losses) on cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	$ (3.6)	$ (0.1)

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 109.8	$ 34.7
Receivables, less allowance for doubtful accounts of $9.5 in 2020 and $10.7 in 2019	225.0	342.4
Inventories	254.2	311.5
Other	37.2	96.4
Total current assets	626.2	785.0
Property, plant and equipment, net	953.8	1,030.8
Intangible assets, net	88.6	103.0
Goodwill	274.7	343.0
Investment in equity investee	23.1	24.9
Other	144.4	156.5
Total assets	2,110.8	2,443.2
Current liabilities:
Current portion of long-term debt	40.1	52.1
Accounts payable	112.8	126.2
Accrued salaries and wages	24.7	34.4
Income taxes payable	2.7	10.4
Accrued interest	16.9	11.3
Accrued expenses and other current liabilities	62.1	61.5
Total current liabilities	259.3	295.9
Long-term debt, net of current portion	1,253.7	1,363.9
Deferred income taxes, net	81.9	89.9
Other noncurrent liabilities	154.4	163.9
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock: $0.01 par value, 200,000,000 authorized shares; 35,367,264 issued shares	0.4	0.4
Additional paid-in capital	119.6	117.1
Treasury stock, at cost — 1,475,196 shares at March 31, 2020 and 1,481,611 shares at December 31, 2019	(3.3)	(3.2)
Retained earnings	610.1	607.4
Accumulated other comprehensive loss	(365.3)	(192.1)
Total stockholders’ equity	361.5	529.6
Total liabilities and stockholders’ equity	$ 2,110.8	$ 2,443.2

XML

Stockholders' Equity and Equity Instruments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2018	May 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reissued shares of treasury stock (in shares)	3,377
Treasury stock reissued (in shares)			32,197
Shares withheld related to vesting of restricted stock units (in shares)	1,479
Fair value of stock withheld related to vesting of restricted stock units	$ 0.1
Tax deficiency from equity compensation awards recorded as an increase to income tax expense	0.2
Compensation expense recorded during period pursuant to stock-based compensation plans	2.9	$ 1.1
Compensation expense to be paid in cash	$ 0.5
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Options expiration period	7 years
Number of shares available from conversion (in shares)	1
Reissued shares of treasury stock (in shares)	0
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available from conversion (in shares)	1
Service period	3 years
Reissued shares of treasury stock (in shares)	4,517
TSR PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period of PSUs	3 years
TSR PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned	0.00%
TSR PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned	200.00%
ROIC PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period of PSUs	3 years
ROIC PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned	0.00%
ROIC PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned	200.00%
2015 Incentive Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance (in shares)				3,000,000

XML

Fair Value Measurement - Narrative (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
6.75% Senior Notes due December 2027
Debt Instrument [Line Items]
Interest rate stated percentage	6.75%
Senior Notes | 4.875% Senior Notes due July 2024
Debt Instrument [Line Items]
Interest rate stated percentage	4.875%	4.875%
Fair value of senior notes	$ 235,000,000.0	$ 249,100,000
Aggregate principal amount due at maturity	$ 250,000,000.0	250,000,000.0
Senior Notes | 6.75% Senior Notes due December 2027
Debt Instrument [Line Items]
Interest rate stated percentage	6.75%
Fair value of senior notes	$ 451,400,000	530,600,000
Senior Notes due 2027
Debt Instrument [Line Items]
Debt fair value amount	500,000,000.0	500,000,000
Term Loan
Debt Instrument [Line Items]
Aggregate principal amount due at maturity	456,500,000	560,000,000.0
Fair value of credit agreement debt	451,300,000	552,800,000
Fair Value, Measurements, Recurring
Debt Instrument [Line Items]
Mutual fund investments in a non-qualified savings plan	1,300,000	1,400,000
Fair Value, Measurements, Recurring | Level One
Debt Instrument [Line Items]
Mutual fund investments in a non-qualified savings plan	$ 1,300,000	$ 1,400,000

XML

Leases - Operating and Finance Leases by Balance Sheets Location (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Assets
Operating lease assets	$ 49.7	$ 53.7
Finance lease assets	5.9	5.8
Total leased assets	55.6	59.5
Current liabilities:
Current operating lease liabilities	9.5	12.8
Current finance lease liabilities	1.7	1.1
Noncurrent liabilities:
Other noncurrent operating lease liabilities	40.4	41.0
Other noncurrent finance lease liabilities	5.3	6.2
Total lease liabilities	$ 56.9	$ 61.1

XML

Operating Segments (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Summary of Segment Information

Segment information is as follows (in millions):

Three Months Ended March 31, 2020	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	287.8	$	60.6	$	62.8	$	2.7		$	413.9
Intersegment sales	—		0.3		0.1		(0.4		)	—
Shipping and handling cost	89.8		9.0		3.0		—			101.8
Operating earnings (loss)	56.9		5.2		0.3		(18.2		)	44.2
Depreciation, depletion and amortization	14.6		10.5		5.0		3.0			33.1
Total assets (as of end of period)	956.5		552.3		561.0		41.0			2,110.8

Three Months Ended March 31, 2019	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)			Total
Sales to external customers	$	306.4	$	37.2		$	57.7		$	2.4		$	403.7
Intersegment sales	—		0.5			1.5			(2.0		)	—
Shipping and handling cost	103.7		6.0			3.2			—			112.9
Operating earnings (loss)	52.3		(1.6		)	(2.6		)	(14.9		)	33.2
Depreciation, depletion and amortization	15.3		11.6			5.6			2.5			35.0
Total assets (as of end of period)	889.7		594.1			710.6			114.2			2,308.6

Summary of Disaggregated Revenue by Product Type

Disaggregated revenue by product type is as follows (in millions):

Three Months Ended March 31, 2020	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)		Total
Highway Deicing Salt	$	215.1	$	—		$	—		$	—	$	215.1
Consumer & Industrial Salt	72.7		—			—			—		72.7
SOP and Specialty Plant Nutrients	—		60.9			41.1			—		102.0
Industrial Chemicals	—		—			21.8			—		21.8
Eliminations & Other	—		(0.3		)	(0.1		)	2.7		2.3
Sales to external customers	$	287.8	$	60.6		$	62.8		$	2.7	$	413.9

Three Months Ended March 31, 2019	Salt		Plant Nutrition North America			Plant Nutrition South America			Corporate & Other(a)		Total
Highway Deicing Salt	$	218.7	$	—		$	—		$	—	$	218.7
Consumer & Industrial Salt	87.7		—			—			—		87.7
SOP and Specialty Plant Nutrients	—		37.7			36.6			—		74.3
Industrial Chemicals	—		—			22.6			—		22.6
Eliminations & Other	—		(0.5		)	(1.5		)	2.4		0.4
Sales to external customers	$	306.4	$	37.2		$	57.7		$	2.4	$	403.7

(a)

Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.

Summary of Revenue by Geographic Area

The Company’s revenue by geographic area is as follows (in millions):

	Three Months Ended March 31,
Revenue	2020		2019
United States(a)	$	257.9	$	238.3
Canada	77.4		87.4
Brazil	62.1		55.7
United Kingdom	11.8		17.3
Other	4.7		5.0
Total revenue	$	413.9	$	403.7

(a)

United States sales exclude product sold to foreign customers at U.S. ports.

XML

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Summary of Basic and Diluted Earnings Per Common Share

The following table sets forth the computation of basic and diluted earnings per common share (in millions, except for share and per-share data):

	Three Months Ended March 31,
	2020			2019
Numerator:
Net earnings	$	27.6		$	7.6
Less: net earnings allocated to participating securities(a)	(0.5		)	(0.2		)
Net earnings available to common shareholders	$	27.1		$	7.4
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share	33,892			33,874
Weighted-average awards outstanding(b)	—			—
Shares for diluted earnings per share	33,892			33,874
Net earnings per common share, basic	$	0.80		$	0.22
Net earnings per common share, diluted	$	0.80		$	0.22

(a) Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 412,000 and 233,000 weighted participating securities for the three months ended March 31, 2020 and 2019, respectively.

(b) For the calculation of diluted net earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had 1,266,000 and 788,000 weighted-average equity awards outstanding for the three months ended March 31, 2020 and 2019, respectively.

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Long-Term Debt

Long-Term Debt:

Long-term debt consists of the following (in millions):

	March 31, 2020			December 31, 2019
4.875% Senior Notes due July 2024	$	250.0		$	250.0
Term Loan due January 2025	397.5			400.0
Revolving Credit Facility due January 2025	59.0			160.0
6.75% Senior Notes due December 2027	500.0			500.0
3.7% Banco Itaú loan due March 2020	—			15.4
Banco Santander loan due October 2020	12.5			16.2
Banco Itaú loan due February 2021	9.4			—
Banco Rabobank loan due July 2021	13.5			17.4
Banco Santander loan due September 2021	15.4			19.9
Banco do Brasil loan due September 2021	9.6			12.4
Banco Rabobank loan due November 2021	13.5			17.4
Banco Santander loan due December 2021	11.6			14.9
Banco Votorantim loan due February 2022	7.7			—
Banco Santander loan due March 2022	2.9			—
Financiadora de Estudos e Projetos loan due November 2023	5.2			7.2
	1,307.8			1,430.8
Less unamortized debt issuance costs	(14.0		)	(14.8		)
Total debt	1,293.8			1,416.0
Less current portion	(40.1		)	(52.1		)
Long-term debt	$	1,253.7		$	1,363.9

In the first quarter of 2020, the Company entered into three loans totaling $20.0 million which mature between February 2021 and March 2022, respectively. Two of the loans were denominated in Brazilian reais and one loan was denominated in euros. In connection with the loan denominated in euros, the Company entered into a swap to exchange principal and interest payments denominated in euros to Brazilian reais (see Note 12). These loans bear interest ranging from 143% - 150% of CDI. As of March 31, 2020, the weighted average interest rate of all the Company’s outstanding debt was approximated 5.69%.

During the first quarter of 2020, the Company sold approximately $3.4 million of Brazilian receivables for $3.3 million. The proceeds of the transaction were used to maintain liquidity for working capital needs. The Company is contingently liable for up to 20% of the sale balance up to $0.7 million if the banks are unable to collect on these accounts.

As of March 31, 2020, the term loans and revolving credit facility under the Company’s credit agreement were secured by substantially all existing and future U.S. assets, the Goderich mine in Ontario, Canada and capital stock of certain subsidiaries.

XML

Inventories

3 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Inventories

Inventories:

Inventories consist of the following (in millions):

	March 31, 2020		December 31, 2019
Finished goods	$	185.6	$	235.3
Raw materials and supplies	68.6		76.2
Total inventories	$	254.2	$	311.5

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Schedule of Operating and Finance Leases by Balance Sheets Location

The Company’s Consolidated Balance Sheets includes the following (in millions):

	Consolidated Balance Sheets Location	March 31, 2020		December 31, 2019
Assets
Operating lease assets	Other assets	$	49.7	$	53.7
Finance lease assets	Property, plant and equipment, net	5.9		5.8
Total leased assets		$	55.6	$	59.5
Liabilities
Current liabilities:
Operating	Accrued expenses and other current liabilities	$	9.5	$	12.8
Finance	Accrued expenses and other current liabilities	1.7		1.1
Noncurrent liabilities:
Operating	Other noncurrent liabilities	40.4		41.0
Finance	Other noncurrent liabilities	5.3		6.2
Total lease liabilities		$	56.9	$	61.1

Schedule of Lease Cost, Lease Terms and Supplemental Cash Flow Information

Supplemental lease term and discount rate information related to leases is as follows:

	March 31, 2020		December 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.7		7.7
Finance leases	6.2		7.2
Weighted-average discount rate
Operating leases	4.3	%	4.3	%
Finance leases	7.1	%	7.6	%

Supplemental cash flow information related to leases is as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4.5	$	4.9
Operating cash flows from finance leases	0.1		0.2
Financing cash flows from finance leases	0.5		0.3
Leased assets obtained in exchange for new operating lease liabilities	1.0		2.4
Leased assets obtained in exchange for new finance lease liabilities	1.2		—

The Company’s components of lease cost are as follows (in millions):

	Three Months Ended March 31,
	2020		2019
Finance lease cost:
Amortization of lease assets	$	0.5	$	0.3
Interest on lease liabilities	0.1		0.2
Operating lease cost	4.6		4.8
Variable lease cost(a)	5.1		6.1
Net lease cost	$	10.3	$	11.4

(a)

Short-term leases are immaterial and included in variable lease cost.

Schedule of Operating Lease Maturities

Maturities of lease liabilities under the new guidance (“Topic 842”) are as follows (in millions):

Topic 842
March 31, 2020	Operating Leases			Finance Leases			Total
Remainder of 2020	$	8.7		$	1.6		$	10.3
2021	10.1			1.6			11.7
2022	7.5			0.9			8.4
2023	6.2			0.9			7.1
2024	5.3			0.9			6.2
After 2024	22.4			2.8			25.2
Total lease payments	60.2			8.7			68.9
Less: Interest	(10.3		)	(1.7		)	(12.0		)
Present value of lease liabilities	$	49.9		$	7.0		$	56.9

Topic 842
December 31, 2019	Operating Leases			Finance Leases			Total
2020	$	13.0		$	1.6		$	14.6
2021	10.0			1.3			11.3
2022	7.5			1.1			8.6
2023	6.3			1.1			7.4
2024	5.3			1.1			6.4
After 2024	22.8			3.3			26.1
Total lease payments	64.9			9.5			74.4
Less: Interest	(11.1		)	(2.2		)	(13.3		)
Present value of lease liabilities	$	53.8		$	7.3		$	61.1

Schedule of Financing Lease Maturities

Maturities of lease liabilities under the new guidance (“Topic 842”) are as follows (in millions):

Topic 842
March 31, 2020	Operating Leases			Finance Leases			Total
Remainder of 2020	$	8.7		$	1.6		$	10.3
2021	10.1			1.6			11.7
2022	7.5			0.9			8.4
2023	6.2			0.9			7.1
2024	5.3			0.9			6.2
After 2024	22.4			2.8			25.2
Total lease payments	60.2			8.7			68.9
Less: Interest	(10.3		)	(1.7		)	(12.0		)
Present value of lease liabilities	$	49.9		$	7.0		$	56.9

Topic 842
December 31, 2019	Operating Leases			Finance Leases			Total
2020	$	13.0		$	1.6		$	14.6
2021	10.0			1.3			11.3
2022	7.5			1.1			8.6
2023	6.3			1.1			7.4
2024	5.3			1.1			6.4
After 2024	22.8			3.3			26.1
Total lease payments	64.9			9.5			74.4
Less: Interest	(11.1		)	(2.2		)	(13.3		)
Present value of lease liabilities	$	53.8		$	7.3		$	61.1

XML

Derivative Financial Instruments

3 Months Ended

Mar. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments:

The Company is subject to various types of market risks, including interest rate risk, foreign currency exchange rate transaction and translation risk and commodity pricing risk. Management may take actions to mitigate the exposure to these types of risks, including entering into forward purchase contracts and other financial instruments. Currently, the Company manages a portion of its commodity pricing and foreign currency exchange rate risks by using derivative instruments. The Company does not seek to engage in trading activities or take speculative positions with any financial instrument arrangement. The Company has entered into natural gas derivative instruments and foreign currency derivative instruments with counterparties it views as creditworthy. However, the Company does attempt to mitigate its counterparty credit risk exposures by, among other things, entering into master netting agreements with some of these counterparties. The Company records derivative financial instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets.

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Depending on the exposure being hedged, the Company must designate the hedging instrument as a fair value hedge, a cash flow hedge or a net investment in foreign operations hedge. For the qualifying derivative instruments that have been designated as hedges, the change in fair value is recognized through earnings when the underlying transaction being hedged affects earnings, allowing a derivative’s gains and losses to offset related results from the hedged item in the statements of operations. Any ineffectiveness related to these hedges was not material for any of the periods presented. For derivative instruments that have not been designated as hedges, the entire change in fair value is recorded through earnings in the period of change.

Natural Gas Derivative Instruments

Natural gas is consumed at several of the Company’s production facilities, and changes in natural gas prices impact the Company’s operating margin. The Company’s objective is to reduce the earnings and cash flow impacts of changes in market prices of natural gas by fixing the purchase price of up to 90% of its forecasted natural gas usage. It is the Company’s policy to consider hedging

portions of its natural gas usage up to 36 months in advance of the forecasted purchase. As of March 31, 2020, the Company had entered into natural gas derivative instruments to hedge a portion of its natural gas purchase requirements through December 2021. As of March 31, 2020 and December 31, 2019, the Company had agreements in place to hedge forecasted natural gas purchases of 2.8 million MMBtus. All natural gas derivative instruments held by the Company as of March 31, 2020 and December 31, 2019 qualified and were designated as cash flow hedges. As of March 31, 2020, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $0.6 million of net losses on derivative instruments related to its natural gas hedges.

Foreign Currency Derivatives Not Designated as Hedges

In March 2020, the Company entered into forward instruments to swap currency denominated in U.S. dollars to Canadian dollars for a future intercompany payment from a U.S. subsidiary to a Canadian subsidiary. These instruments mature in April 2020 with a combined notional amounts of $89.9 million. The objective of the instruments was to mitigate the foreign currency fluctuation risk related to intercompany payments denominated in a currency other than U.S. dollars, the Company’s functional currency. The instrument was not designated as a hedge. During the three months ended March 31, 2020, the Company recognized a loss of $5.3 million in loss on foreign exchange in its Consolidated Statements of Operations for these agreements.

Foreign Currency Derivatives Designated as Hedges

The Company has entered into U.S. dollar-denominated debt instruments to provide funds for its operations in Brazil. The Company may also concurrently enter into foreign currency agreements whereby the Company agrees to swap interest and principal payments on loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian reais, its Brazil subsidiary’s functional currency. The objective of the swap agreements is to mitigate the foreign currency fluctuation risk related to holding debt denominated in a currency other than the Company’s Brazil subsidiary’s functional currency. As of March 31, 2020, the Company had a swap agreement in place to hedge $9.4 million of a loan denominated in a currency other than its Brazil subsidiary’s functional currency. Payments on this loan are due on various dates extending through February 2021. As of March 31, 2020, this foreign currency derivative instrument qualified and was designated as a cash flow hedge. As of March 31, 2020, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $1.7 million of net gains on derivative instruments related to this foreign currency swap agreement.

The following tables present the fair value of the Company’s hedged items as of March 31, 2020 and December 31, 2019 (in millions):

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Consolidated Balance Sheets Location	March 31, 2020		Consolidated Balance Sheets Location	March 31, 2020
Commodity contracts	Other current assets	$	0.3	Accrued expenses and other current liabilities	$	0.9
Commodity contracts	Other assets	—		Other noncurrent liabilities	0.1
Swap contracts	Other current assets	1.7		Accrued expenses and other current liabilities	—
Total derivatives designated as hedging instruments(a)(b)		$	2.0		$	1.0

(a) The Company has master netting agreements with both of its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets $0.3 million of its commodity contracts that are in a receivable position against its contracts in payable positions.

(b) The Company has commodity hedge agreements with two counterparties and a foreign currency swap agreement with one counterparty. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from one counterparty. 

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Consolidated Balance Sheets Location	December 31, 2019		Consolidated Balance Sheets Location	December 31, 2019
Commodity contracts	Other current assets	$	0.3	Accrued expenses and other current liabilities	$	0.8
Commodity contracts	Other assets	0.1		Other noncurrent liabilities	0.2
Swap contracts	Other current assets	2.8		Accrued expenses and other current liabilities	—
Total derivatives designated as hedging instruments(a)(b)		$	3.2		$	1.0

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets $0.4 million of its commodity contracts that are in a receivable position against its contracts in payable positions.

(b)

The Company has both commodity hedge and foreign currency swap agreements with two counterparties each. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties, and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from both counterparties.

XML

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Summary of Long-Term Debt

Long-term debt consists of the following (in millions):

	March 31, 2020			December 31, 2019
4.875% Senior Notes due July 2024	$	250.0		$	250.0
Term Loan due January 2025	397.5			400.0
Revolving Credit Facility due January 2025	59.0			160.0
6.75% Senior Notes due December 2027	500.0			500.0
3.7% Banco Itaú loan due March 2020	—			15.4
Banco Santander loan due October 2020	12.5			16.2
Banco Itaú loan due February 2021	9.4			—
Banco Rabobank loan due July 2021	13.5			17.4
Banco Santander loan due September 2021	15.4			19.9
Banco do Brasil loan due September 2021	9.6			12.4
Banco Rabobank loan due November 2021	13.5			17.4
Banco Santander loan due December 2021	11.6			14.9
Banco Votorantim loan due February 2022	7.7			—
Banco Santander loan due March 2022	2.9			—
Financiadora de Estudos e Projetos loan due November 2023	5.2			7.2
	1,307.8			1,430.8
Less unamortized debt issuance costs	(14.0		)	(14.8		)
Total debt	1,293.8			1,416.0
Less current portion	(40.1		)	(52.1		)
Long-term debt	$	1,253.7		$	1,363.9

XML

Long-Term Debt - Narrative (Details)	3 Months Ended
	Mar. 31, 2020 USD ($) loan
Debt Instrument [Line Items]
Amount of receivables sold	$ 3,400,000
Proceeds from sale of receivable	$ 3,300,000
Amount of receivables liable for (as a percent)	20.00%
Amount of receivables liable for	$ 700,000
Certificado de Deposito Interbancario (CDI)
Debt Instrument [Line Items]
Effective interest rate on outstanding debt (as a percent)	5.69%
Brazilian Reais-denominated Loans
Debt Instrument [Line Items]
Number of debt instruments | loan	3
Face amount	$ 20,000,000.0
Number of loans denominated in foreign currency | loan	2
Euro-Denominated Loans
Debt Instrument [Line Items]
Number of loans denominated in foreign currency | loan	1
Minimum | Brazilian Reais-denominated Loans | Certificado de Deposito Interbancario (CDI)
Debt Instrument [Line Items]
Variable rate, percentage of reference rate	143.00%
Maximum | Brazilian Reais-denominated Loans | Certificado de Deposito Interbancario (CDI)
Debt Instrument [Line Items]
Variable rate, percentage of reference rate	150.00%

XML

Leases - Schedule of Operating and Finance Lease Maturities (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Operating Leases, After Adoption of 842
Remainder of 2020	$ 8.7	$ 13.0
2021	10.1	10.0
2022	7.5	7.5
2023	6.2	6.3
2024	5.3	5.3
After 2024	22.4	22.8
Total lease payments	60.2	64.9
Less: Interest	(10.3)	(11.1)
Present value of lease liabilities	49.9	53.8
Finance Leases, After Adoption of 842
Remainder of 2020	1.6	1.6
2021	1.6	1.3
2022	0.9	1.1
2023	0.9	1.1
2024	0.9	1.1
After 2024	2.8	3.3
Total lease payments	8.7	9.5
Less: Interest	(1.7)	(2.2)
Present value of lease liabilities	7.0	7.3
Total, After Adoption of 842
Remainder of 2020	10.3	14.6
2021	11.7	11.3
2022	8.4	8.6
2023	7.1	7.4
2024	6.2	6.4
After 2024	25.2	26.1
Total lease payments	68.9	74.4
Less: Interest	(12.0)	(13.3)
Present value of lease liabilities	$ 56.9	$ 61.1

XML

Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 1,917.6	$ 1,971.0
Less accumulated depreciation and depletion	(963.8)	(940.2)
Property, plant and equipment, net	953.8	1,030.8
Land, buildings and structures, and leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	578.3	596.0
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	974.8	1,001.9
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	62.4	60.7
Mineral interests
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	165.9	171.1
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 136.2	$ 141.3